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  Abstract   Polyhydroxyalkanoates (PHAs) are a family of polyhydroxyesters of 3-, 4-, 5- and 6- hydroxyalkanoic acids produced by bacterial fermentation in a nutrient limiting conditions  with  excess  carbon.  They  can  be  produced  easily  using  renewable carbon  sources.  They  are  biodegradable  and  biocompatible  in  nature.   Their physical properties are highly tailorable and a range of desired properties can be achieved based on the type  of application. Owing to these properties, there has been a considerable interest in the commercial exploitation of PHAs, particularly for biomedical applications.  The main aim of this research project was to produce MCL-PHAs from Pseudomonas 
mendocina and use them for biomedical applications. In this study, an economical production of MCL-PHAs using renewable and cheap carbon sources such as sugarcane molasses, biodiesel waste and pure glycerol was carried out. Maximum PHA yield of 43.2% dcw was obtained in the media containing biodiesel waste. The results demonstrated the successful utilisation of these cheap carbon sources by P. 
mendocina for the economical production of MCL-PHAs.  One of the main objectives of this project was to utilize the PHAs produced for biomedical applications. Multifunctional novel 2D P(3HO)/bacterial cellulose composite films were developed for their potential use in tissue engineering applications.  Chemically  modified bacterial  cellulose  microcrystals were  used as the reinforcing agent to improve the properties of P(3HO). Mechanical properties such as the Young’s modulus and tensile strength values of the P(3HO)/bacterial cellulose  composite  films  were  significantly  higher  in  comparison  to  the  neat P(3HO) film. Also, the composite film had a rougher and more hydrophilic surface compared  to  the  neat  P(3HO)  film.  It  is  known  from  literature  that  surface roughness and hydrophilicity affects protein adsorption on the surface of the biomaterial. Protein adsorption, in turn, plays an important role in determining the biocompatibility of a material being used for medical applications (Das et al., 2007). In this study, protein adsorption was higher in the P(3HO)/25% bacterial cellulose composite film compared to the neat P(3HO) film. In vitro biocompatibility studies using Human microvascular endothelial cells (HMEC-1) was carried out. Both neat and  composite  films  were  able  to  support  the  proliferation  of  HMEC-1  cells. However, the biocompatibility of the P(3HO)/25% bacterial cellulose composite 
  films had increased. The cell proliferation significantly higher on the P(3HO)/25%  bacterial cellulose composite film as compared to the neat P(3HO) film on day 7.   In  addition,  multifunctional  2D  P(3HO)/P(3HB)  blend  films  with  varying percentages  of   P(3HO)  and   P(3HB)  were   developed  and   assessed  for   their suitability in the development of biodegradable stents. Mechanical, thermal and microstructural properties of the P(3HO)/P(3HB) blends were characterised. The results highlighted the role of P(3HB) in enhancing the mechanical properties and thermal stability of the blend films compared to the neat P(3HO) films. However, the results suggested that the mechanical properties of the P(3HO)/P(3HB) had to be further improved to meet the desired values required for the development of a biodegradable stent. The overall protein adsorption and % cell viability was significantly higher in the blend films compared to the neat P(3HO) film. Hydrolytic degradation was faster in the blend films and the degradation rate could potentially be   tailored  to   achieve  the  optimum   rate   required  for  a   particular  medical application.  From the literature, it is known that the surface topography determines the compatibility of a biomaterial by governing important processes such as wettability, protein adsorption, cell  adhesion and proliferation (Duncan  et al.,  2007). In  this part of the study, P(3HO)/P(3HB) 50:50 blend films were micropatterned using the laser micropatterning technique to improve their biocompatibility. The results demonstrated an increase in hydrophilicity and protein adsorption on the micropatterned blend  films  compared  to  the  plain  P(3HO)/P(3HB) 50:50  blend films. Cell attachment, proliferation and alignment was significantly higher on the micropatterned blend  films  compared  to  the  P(3HO)/P(3HB) 50:50  blend  films which was a desirable outcome.  Furthermore, an investigation of the P(3HO)/P(3HB) 50:50 2D films as the base material for the development of a drug eluting biodegradable stent was carried out by incorporating aspirin within the film. The percentage viability of the HMEC-1 cells was higher in the blend films with aspirin compared to the blend films without aspirin indicating an increased biocompatibility of the P(3HO)/P(3HB) 50:50 blend film  containing  aspirin.  Controlled release  of  aspirin  was  observed without  any burst release and 96.6% release was achieved within 25 days, ideal for the development of biodegradable drug eluting stents. 
  Finally,   a   drug   delivery   system   for   the   controlled  delivery   of   aspirin   was successfully developed. In this part of the study, 2D solvent cast films and microspheres (average size=30 µm) were developed using P(3HB). Drug release pattern from P(3HB) films as well as P(3HB) microspheres were monitored. The results demonstrated that the P(3HB) films with aspirin were suitable for sustained long term drug release whereas P(3HB) microspheres with aspirin were more suitable for fast release.  In conclusion, this project has led to the successful production of PHAs, and their utilisation in the development of a range of composites, blends and drug elution structures with promising potential medical applications. 
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Chapter 1       
INTRODUCTION 







 Plastics have become a part of our daily lives. They are cheap, durable, resistant to corrosion, lightweight and can be readily moulded into various products. They are widely used for several applications ranging from packaging to the manufacture of medical devices. The production of plastics has increased significantly over the last 60 years to  meet their ever increasing demand. However, there are two major  drawbacks of using plastics. Firstly, plastics are made up of petrochemicals derived from non-renewable sources. Production of plastics account for the usage of 4% of petroleum reserves produced annually. Secondly, most of the plastics are non- degradable in nature (Hopewell et al., 2009). They accumulate in the environment causing contamination to the terrestrial and marine habitat.  It is a known fact that the chemicals that are used in the production of plastics are toxic in nature. Biomonitoring data has revealed that these toxic chemicals are present within the human body posing a threat to human health. Dwindling petroleum reserves and the environmental threat posed by the traditional plastics have resulted in an extensive research to find an alternative. Biodegradable polymers have emerged as a potential substitute. They have several advantages over traditional plastics. They are degraded by a variety of microorganisms eliminating any kind of threat to the environment and the human population. The economical production of these biodegradable polymers could provide potential solutions to the problems created by these traditional plastics (Hopewell et al., 2009; Thomson et al., 2009).  
1.1    Polyhydroxyalkanoates (PHAs)  Polyhydroxyalkanoates (PHAs), also referred to as bacterial or microbial polyesters, are  produced  by  the  bacteria  in  an  environment  where  one  of  the  essential nutrients such as nitrogen, phosphorus or potassium is limited, whereas the carbon source   is   present   in   excess.   PHAs   are   accumulated   as   intracellular   storage compounds within the bacteria (Khanna and Srivastava, 2005; Hazer and Steinbuchel, 2007). They are biodegradable, biocompatible, hydrophobic and also exhibit thermoplastic properties. They can be produced readily from renewable carbon sources. 








Figure 1.1: The general structure of polyhydroxyalkanoate (x = 1, 2, 3; n = 100-  30000; R1, R2 = alkyl groups, C1-C13) (Philip et al., 2007)    The presence of PHAs within bacterial cells was identified for the first time by Lemoigne in 1926. Around 300 different species of PHA producing bacteria have been identified so far (Lee, 1996). Staining methods using Sudan Black and Nile Blue A have been used in the past  to detect the presence of PHAs accumulated within bacterial cells. The PHAs produced by the bacteria can be chemically characterized using gas chromatography techniques (Lee, 1996).  The properties of PHAs have been found to be similar to that of the traditional plastics such as polypropylene. Previous studies have established that PHAs are biocompatible in nature and are well tolerated by the mammalian system, therefore, they have been considered for tissue engineering applications (Reddy et al., 2003). PHAs are biodegradable in nature.  Under  aerobic  conditions,  PHAs  are  degraded  into  carbon  dioxide  and water whereas under anaerobic conditions, PHAs are degraded into carbon dioxide and methane.  They are also  degraded within the human  body.    In  recent years, PHAs have been used in the manufacture of several medical devices such as sutures, surgical mesh, tendon repair devices, ocular cell implants, skin substitutes, vein valves, orthopaedic pins, bone plates and bone plating system. PHAs have some fascinating  physical  properties  such  as  piezoelectricity activity  which  broadens their area of application (Chen and Wu, 2005). 





1.2    Types of PHAs and their properties  Depending on the number of carbon atoms present in their monomer units, PHAs can  be  classified into two main  types, short chain length PHAs (SCL-PHAs) that have 3-5 carbon atoms and medium chain length PHAs (MCL-PHAs) that have 6-14 carbon atoms in their monomers (Khanna and Srivastava, 2005). Apart from the number of carbon atoms, PHAs can also be classified based on the type of the monomer units present. PHAs containing a single type of monomer unit are called homopolymers such as Poly(3-hydroxybutyrate) or P(3HB), Poly(3- hydroxyhexanoate) or P(3HHx) and Poly(3-hydroxyoctanoate) or P(3HO) whereas PHAs containing more than one type of monomer unit are called heteropolymers such as Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or P(3HB-co-3HV), and Poly(3-hydroxyhexanoate-co-3-hydroxyoctanoate)  or   P(3HHx-co-3HO)(  Byrom, 1987; Asrar et al., 2002).  The physical properties of PHAs are greatly influenced by the length of the side chain and the functional group present. Therefore, SCL-PHAs are generally brittle in nature  with  a  very  high  melting  point  and  crystallinity  (with  the  exception  of poly(4-hydroxybutyrate), P(4HB), whereas MCL-PHAs have a low melting temperature, crystallinity, tensile strength and are extremely elastomeric in nature (Martin and William, 2003). SCL-PHAs are produced by numerous bacteria such as 
Cuprivadus necator, Alcaligenes latus, Bacillus megaterium and Bacillus cereus while MCL-PHAs are synthesized by bacteria such as Pseudomonas putida, Pseudomonas 
mendocina and Pseudomonas oleovorans. Examples of SCL-PHAs include P(3HB), P(4HB) and P(3HB-co-3HV). The examples of MCL-PHAs include P(3HHx) and P(3HO) (Lee, 1996; Khanna and Srivastava, 2005).   
1.2.1 P(3HB)  P(3HB) is a type of SCL-PHA which has been extensively studied since its discovery in 1926 by Lemoigne. From literature, it is known that low molecular weight P(3HB) is  a  component  of  human  blood  and  is  degraded  within  the  body  into  3- hydroxybutyric acid.  Therefore, P(3HB)  is  biocompatible  and  biodegradable in nature (Misra et al., 2006). P(3HB) is crystalline with a crystallinity percentage ranging between 60-80%. However, it exists in an amorphous form within the cells. P(3HB) is rigid, brittle and highly crystalline due to the presence of a short methyl side chain within its structure (Kawaguchi and Doi, 1992). Mechanical properties of 




  P(3HB) such as its tensile strength is comparable to that of the synthetic polymer such as polypropylene (Engelberg and Kohn, 1991). P(3HB) also possesses properties such as piezoelectricity and optical activity (Ha and Cho, 2002). Thermal and mechanical properties of P(3HB) is shown in Table 1.1.   
Properties Values   Tm (˚C) Tg (˚C) Crystallinity (%) Tensile strength (MPa) Young’s Modulus (GPa) % Elongation at break 
175-179   4   60– 80   40   1.1  – 3.5   5-6   
Table 1.1: Physical properties of P(3HB)( Misra et al., 2006)   Properties of P(3HB) differ depending on various factors such as the type of the organism used for the production, the method used for the extraction and the preparation of the sample, molecular weight and polydispersity index. Based upon the type of application, properties of P(3HB) can be    controlled by blending or making composites with natural or synthetic polymers (Misra et al., 2006).   
1.2.2 P(4HB)  P(4HB) is also  a type of SCL-PHA. Its physical properties are different compared to that of the other SCL-PHAs. This has a semi-crystalline nature with a crystallinity percentage of around 35%. P(4HB) has      a low melting and glass transition temperature but a very high tensile strength and elongation at break value. The physical properties of P(4HB) is very similar to that of the traditional plastics. P(4HB) has gained a lot of attention in recent times and has been used for a variety of medical applications such as heart valves, vascular grafts and sutures due to its unique properties (Martin and Williams, 2003). The physical properties of P(4HB) are shown in Table 1.2. 





Properties Values   Tm (˚C) Tg (˚C) Crystallinity (%) Tensile strength (MPa) % Elongation at break 
54   -48   34   104   1000    
Table1.2: Physical properties of P(4HB) (Tsuge, 2002; Martin and Williams, 2003; Khanna and Srivastava, 2005).   
1.2.3 P(3HO)  P(3HO) is  a type of MCL-PHA.  It has a low crystallinity percentage of around 37.5% due to the presence of an uneven pendant side chain within its structure. P(3HO) is elastomeric in nature and has a low melting temperature, low crystallinity and a high elongation at break value (Rai et al., 2011). The properties of P(3HO) is shown in Table 1.3.    
Properties Values   Tm (˚C) Tg (˚C) Crystallinity (%) Tensile strength (MPa) Young’s Modulus (MPa)   % Elongation at break 
39 - 50   -35 to -36   37.5   1.8   11.4   278   
Table 1.3: Physical properties of P(3HO)(Rai et al., 2011)  The mechanical properties such as tensile strength and Young’s modulus of P(3HO) is very low compared to P(3HB)(Rai et al., 2011). Based on the desired application, the mechanical properties of P(3HO) can be manipulated by blending, forming composites with natural and synthetic polymers as  well as  by chemical modification. 







1.3. Discovery of PHAs  Intracellular granules within bacterial cells were first observed by Beijerinck in  1888. These intracellular granules were identified to be P(3HB) by Lemoigne in  1926 (Lee, 1996).                        
Figure 1.2: SEM images of synthesized and intracellularly accumulated discrete granules of P(3HB) in bacteria (Sudesh et al., 2000). PHAs  did  not  attract  any  attention  until  1958,  when  Macrae  and  Wilkinson  reported the biodegradable nature of the P(3HB) (Macrae and Wilkinson, 1958). In  1974, Wallen and Rohwedder reported the presence of other 3-hydroxyacids such as  3-hydroxyvalerate (3HV), 3-hydroxyhexanoate (3HHx)  and  3- hydroxyheptanoate (3HHp) along with 3-hydroxybutyrate (3HB) in the chloroform extracts of activated sewage sludge (Wallen and Rohwedder, 1974). Similar reports of the presence of other 3-hydroxyacids along with 3HB were made by Findlay and White in 1983. They stated that the Gas chromatographic (GC) analysis of the PHAs extracted from marine sediments showed the presence of 11 different 3- hydroxyacids. However, the major constituents were 3HB and 3HV. From literature, it is now known that around 150 different types of PHA constituents have been identified (Anderson and Dawes, 1990; Braunegg et al., 1998). 









1.4 Biosynthesis of PHAs in microorganisms  
1.4.1 Biosynthesis of SCL-PHAs  PHAs produced by a wide variety of bacterial species are chemically diverse. However, P(3HB) is commonly produced and most extensively studied. The biosynthetic pathway for the production of P(3HB) involves three main enzymes and the respective genes encoding these enzymes. These enzymes involved are present in the cytosol of the cell. Biosynthesis of P(3HB) involves three key steps. (1) The condensation of two acetyl CoA molecules to form acetoacetyl CoA. This step is catalysed by β- ketothiolase which is coded by the phaA gene. (2) The reduction of acetoacetyl CoA to (R)- 3-hydroxybutyryl CoA. This step is catalysed by acetoacetyl-CoA-reductase which is in turn coded by the phaB gene. (3) The polymerisation of (R)- 3-hydroxybutyryl CoA to form P(3HB). This key step is catalysed by  PHA synthase which is coded by  phaC gene (Huisman et al.,  1989; Reddy et al., 2003; Khanna and Srivastava, 2005). The biosynthetic pathway of SCL- PHA in C. necator is shown in Figure 1.3.                           
Figure 1.3: Biosynthetic pathway of SCL-PHAs production in C. necator (Khanna and Srivastava, 2005).    
1.4.2 Biosynthesis of MCL-PHAs  Synthesis of MCL-PHAs involves three different pathways namely: (1) de novo fatty acid biosynthesis, (2) β-oxidation pathway and (3) chain elongation pathway. 




  (1) de novo fatty acid biosynthesis: This is the metabolic route by which non related carbon sources such as glucose generate (R)-3-hydroxyacyl-CoA precursors. In  this  pathway,  (R)-3-hydroxyacyl-ACP is  converted to  (R)-3-hydroxyacyl CoA. This reaction is  catalysed by  the  enzyme (R)-3-hydroxyacyl-CoA-ACP transferase which is encoded by the phaG gene (Taguchi et al., 1999; Sudesh et al., 2000). (2) β- 
oxidation pathway produces MCL-PHA precursor molecules from fatty acids. The three key enzymes involved in this pathway include 3-hydroxyacyl-CoA epimerase which converts (S)-3-hydroxyacyl-CoA into (R)-3-hydroxyacyl CoA, enoyl-CoA hydratase   which   converts   2-trans-enoyl-CoA   into   (R)-3-hydroxyacyl  CoA   and finally 3-ketoacyl-CoA reductase which converts 3-ketoacyl-CoA         to (R)-3- hydroxyacyl CoA (Huisman et al., 1989). (3) Chain elongation pathway also produces MCL-PHA precursor from non-related carbon sources by extending the acetyl CoA to acyl CoA. The contribution of this pathway in generating MCL-PHA precursors by the elongation of acyl CoA derived from fatty acids is significant, however, it only forms a very small fraction of the total PHA accumulated within the bacterial cells.   The final step which involves the polymerization of the (R)-3- hydroxyacyl CoA into poly-(R)-3-hydroxyacyl CoA is catalysed by the PHA synthase enzyme with the release of CoA (Dawes and Senior, 1973; Zinn et al., 2001). The biosynthetic pathway of MCL-PHAs is shown in Figure 1.4. 












                                
Figure 1.4: Biosynthetic pathways of MCL-PHAs (Kim et al., 2007).   
1.4.3   Polyhydroxyalkanoate  synthases  or   PHA   synthases  and   the   PHA  
biosynthetic genes  The enzyme that catalyses the final polymerization of the (R)-3-hydroxyacyl CoA into poly-(R)-3-hydroxyacyl CoA is the PHA synthase (Rehm, 2003).  Based on their subunit composition and substrate specificity, the PHA synthase enzyme can be classified into four different classes as shown in Figure 1.5.                        
Figure 1.5: Classification of PHA synthases based on their subunit composition and substrate specificity (Adapted from Rehm, 2003). 




  Class  I  and  II  PHA  synthase  enzymes  consist  of  the  PhaC  subunit  and  are represented by the PHA synthase of C. necator and P. aeroginosa respectively. Molecular masses of these PhaC subunits  range  between 61 to  73 KDa  (Qi  and Rehm, 2001). Class I PHA synthase prefers thioesters of (R)-3-hydroxy fatty acids made up of 3 to 5 carbon atoms. Class II PHA synthases, however prefers CoA thioesters of (R)-3- hydroxy fatty acids made up of 6 to 14 carbon atoms (Peoples and Sinskey, 1989; Rehm, 2003). The Class III PHA synthase enzyme comprises of PhaC and PhaE subunits. This  class of PHA synthase is represented by the PHA synthases of Allochromatium 
vinosum. The PhaC subunit present in this class of PHA synthase has a molecular mass of 40 kDa and exhibits 21-28% similarity in their amino acid sequence with the PhaC subunit present in Class I and II PHA synthases. They prefer to utilize CoA thioesters of (R)-3-hydroxy fatty acids made up of 3 to 5 carbon atoms (Stubbe and Tian, 2003). Finally, Class IV PHA synthases include the PhaC and PhaR subunits and are represented by the PHA synthase of Bacillus megaterium. Molecular masses of the PhaC and PhaR subunits are 40 and 22 kDa respectively. Class IV PHA synthases also have substrate specificity towards the CoA thioesters of (R)-3- hydroxy fatty acids made up of 3 to 5 carbon atoms (McCool and Cannon, 2001). The organization of the genes encoding different classes of PHA synthases is shown in Figure 1.6: 






                                 
Figure 1.6: Organisation of the genes encoding different classes of PHA synthases  (Adapted from Rehm, 2003)  
1.5 Microbial production of PHAs  Based on the culture condition requirements, PHA producing microorganisms can be classified into two groups. Organisms such as B. cereus, C. necator, and 
Methylobacterium organophilum that require a nutrient limiting condition for the production of PHAs belong to the first group whereas organisms such as Alcaligenes 
latus and recombinant E. coli that produce PHAs during their growth in the cultivation medium belong to the second group (Lee, 1996). Most commonly used organisms for the production of PHAs include C. necator, Pseudomonas spp, A. latus and Bacillus spp. 
C. necator is the most widely studied organism for the production of PHAs. It has the  ability  to  utilize  a  wide  range  of  carbon  sources and  produce  a  significant amount of P(3HB) (Ryu et al., 1997). A metabolically engineered glucose utilizing mutant of C. necator produces 80% (wt/wt) of P(3HB) using glucose as the sole carbon source. The addition of propionic acid along with the glucose resulted in the production of Poly(hydroxybutyrate-co-hydroxyvalerate), a copolymer of 3HB and 3HV  (Anderson  and   Dawes,  1990).  The  ratio  of  propionic  acid  to   glucose  determined the 3HV content in the accumulated PHA. It has been reported that C. 





necator are also able to utilize a wide range of plant oils such as olive oil, corn oil and palm oil to produce 80% (wt/wt) of P(3HB) (Fukui and Doi, 1998). 
Bacillus  spp  have  been  extensively  investigated  for  the  production  of  PHAs. Various characteristics that make these bacteria ideal candidates for the production of PHAs include lack of endotoxin and the presence of enzymes such as amylase and proteinase that helps them to utilize agricultural waste as the carbon source for the production of PHAs (Law and Slepecky, 1961). This helps in the economical production of PHAs.  P(3HB) production by  Bacillus megaterium was first reported by Findlay and White in 1983.   This finding was followed by the production of P(3HB) by the Bacillus sp IPCB-403. Approximately, 70% (wt/wt) of P(3HB) was produced.     Bacillus  spp  also  accumulate  copolymers  such  as  P(3HB-co-3HV), P(3HB-co-3HHx) and terpolymer of 3-hydroxybutyrate, 6-hydroxyhexanoate and 3-hydroxyhexanoate  or   P(3HB-co-6HHx-co-3HHx)  when   grown   using   carbon sources such as   butyrate, valerate, hexanoate, octanoate,   decanoate and caprolactone (Tajima et al., 2003). Valappil et al., reported the production of P(3HB) by Bacillus cereus SPV when grown in Kannan and Rehacek media. B. cereus SPV when grown in odd chain fatty acids such as propionate, heptanoate and nonanoate resulted in the production of P(3HB-co-HV). The highest yield of 45.5% (wt/wt) of P(3HB-co-HV) was produced when the bacteria was grown in nonanoate. B. cereus SPV when grown in even chain fatty acids such as acetate, hexanoate, decanoate and dodecanoate resulted in the production of P(3HB). The highest yield of 74.5% (wt/wt)  of  P(3HB) was  produced when  grown  in  dodecanoate (Valappil  et al., 2007). Other strains of Bacillus spp that are involved in the production of PHAs include B. cereus INT005, B. mycoides RLJB-017 and B. cereus UW85. 
Alcaligenes latus is a fast growing bacterium that has been widely studied for the production of PHAs. They are able to utilize sucrose as well as the cheap carbon sources such as the sugarcane and beet molasses to produce PHAs.  50% of P(3HB) was obtained using these cheap carbon sources. To improve the yield, A. latus was grown  in  a  nutrient  limiting  medium.  Wang  and  Lee  in  1997  carried  out  an extensive study by allowing A. latus to grow in various nutrient limiting conditions such as nitrogen, phosphorus, magnesium and sulphur. They reported that P(3HB) production  increased  when  grown  in  nutrient  limiting  condition.  A  fed  batch culture of A. latus under nutrient limiting conditions resulted in the accumulation of 88% (wt/wt) of P(3HB) content (Wang and Lee, 1997). 





Pseudomonas spp have been used extensively for the production of MCL-PHAs (Diard et al., 2002). They utilize both structurally related and unrelated carbon sources and accumulate diverse MCL-PHA monomer units. P. putida produced a copolymer of 3-hydroxydecanoate (3HD), 3-hydroxydodecanoate (3HDD), (3HHx) and  (3HO) using  glucose  as  the  sole  carbon  source (Kim  et al., 2007).     It  was reported by Kim et al., that Pseudomonas spp produced 3HO as the main monomer unit when grown on fatty acids with even number of carbon atoms. They also reported that Pseudomonas spp produced 3-hydroxynonanoate, 3HNN as the main monomer unit when grown on carbon sources with odd number of carbon atoms (Kim  et al., 2007). Chen et al., reported that  Pseudomonas sp DSY-82, P. stutzeri, 
Pseudomonas sp. 61-3, and Pseudomonas spp A33 accumulated SCL monomer units alongside the MCL  monomer units  such as P(3HB-co-3HHx) (Chen et al.,  2004). This was confirmed when Hang et al., reported that Pseudomonas spp such as P. 
nitroreducens produced a copolymer containing SCL and MCL monomer units such as    P(3HB-co-3HO) when  grown  using  octanoic  acid  as  the sole carbon source (Hang et al., 2002). A similar observation was made when P.  pseudoalkaligenus was cultured using octanoic acid as the only carbon source where P(3HB-co-3HO-co- 3HD) was produced. This observation suggested that Pseudomonas spp were able to accumulate copolymers and terpolymers when grown on structurally related carbon sources. However, this finding was challenged when Pseudomonas sp. 61-3 produced copolymers of SCL and MCL monomers when cultured using carbon sources such as glucanoate and other alkanoic acids (Kato et al.,, 1996). It has been reported that the organisms producing SCL-MCL copolymers and terpolymers are rare in  nature  (Kim  et al., 2007). Apart  from producing copolymers and terpolymers, these Pseudomonas spp are also known to produce aliphatic as well as aromatic PHAs when grown on aromatic hydrocarbons (Tobin and O'Connor, 2005). The examples of aromatic and aliphatic PHAs producing Pseudomonas spp include P. 
putida, P. oleovorans P. citronellolis, P. fluorescens and P. jessenii.       In another experiment, phaC1 and phaC2 genes from P. putida were expressed in E. coli for the production of MCL-PHAs. The authors observed that a high level of expression of 
phaC genes were required for a significant production of PHAs. Therefore, they developed a system comprising of a strong heterologous promoter combined with a low copy number plasmid within the E. coli which resulted in the production of MCL-PHAs (Ren et al., 2005). 





1.6 Production of PHAs using inexpensive carbon sources  There has been a great interest in the commercial exploitation of PHAs. However, their high production cost has been the limiting factor. It is a known fact that the expensive carbon sources used for the production of PHAs account for 50% of the total production costs and therefore, reduction in the cost of carbon would automatically lower the cost of production and enhance the commercial viability of PHAs (Kim et al., 2000a). The use of inexpensive carbon substrates such as waste by products from the agriculture or food based industry for the production of PHAs has been considered to be the best approach in reducing the production cost. Apart from bringing down the production costs, the utilization of waste material for PHA production would also  help in waste management. Previous studies have shown that the use of inexpensive carbon sources for PHA production reduced the overall production cost by approximately 50% (Marangoni et al., 2001; Marangoni et al., 2002).   
1.6.1 SCL-PHA production using vegetable oils as the carbon source  The production of SCL-PHA using inexpensive carbon substrates was first reported by Shimamura and his colleagues in 1994. They observed that Aeromonas caviae when grown in unsaponified olive oil resulted in the production of P(3HB-co-3HHx) with an HHx content of less than 20% (Shimamura et al., 1994). Fukui and Doi in 1998 reported the production of  P(3HB) and P(3HB-co- 3HHx) when the wild type strain of C. necator H16 and a recombinant strain of C. necator containing the PHA synthase gene of A. caviae  were cultured in the presence of olive oil, corn and palm oil (Fukui and Doi, 1998). Taniguchi et al., utilised waste edible oils and tallow as the carbon source for the production of SCL-PHAs. They observed that C. necator when grown in a media containing edible oil produced P(3HB) whereas in a media containing tallow, P(3HB-co-3HV) was produced (Taniguchi et al., 2003). Kahar et 
al., demonstrated that the wild type strain of C. necator H16 gave higher yield of P(3HB) compared to the recombinant C. necator when grown in soybean oil as the sole carbon source (Kahar et al., 2004). Furthermore, Loo et al., investigated the utilisation of palm kernel oil, palm olein oil, crude palm oil and palm acid oil for the production of PHAs by the recombinant strain of C. necator containing the PHA synthase gene of A. caviae. They reported the production of P(3HB-co-HHx) containing 5% of the HHx content (Loo et al., 2005). Alias and Tan in 2005 isolated a palm oil utilizing Gram negative bacteria named FLP1 from the waste materials of 




  a palm oil mill.  They reported the production of P(3HB) when FLP1 was grown in crude palm oil and palm kernel oil. They also observed that the addition of odd chain fatty acids such as valerate and propionate alongside crude palm oil and palm kernel oil led to the production of copolymers such as P(3HB-co-3HV) (Alias and Tan, 2005). Akiyama et al., in 2003, carried out a comparative study to demonstrate that the P(3HB) production by the recombinant strain of C. necator containing the PHA synthase gene of A. caviae using soybean oil as the sole carbon source. They demonstrated that less energy was required for the production of P(3HB) and a low level of carbon dioxide was emitted compared to the production of P(3HB) using glucose as the main carbon source (Akiyama et al., 2003). From these studies, it was evident that a variety of microorganisms were able to utilize vegetable oil as the main carbon source and produce SCL-PHAs. Optimisation of the media, physical parameters  and  the  mode  of  fermentation  for  the  production  of  PHAs  using vegetable oils as the main carbon source would enhance the economical production of SCL-PHAs.   
1.6.2 SCL-PHA production using whey as the carbon source  Whey is a by-product which is generated in large quantities during the manufacture of dairy products such as cheese. It is considered to be a rich substrate for fermentation process. It contains nutrients such as lactose, lipids and proteins (Athanasiadis et al., 2002). Utilisation of whey for the production of PHAs would not only decrease the production cost but also solve the problem of its disposal which is currently a huge environmental concern. Lee et al., reported the production of P(3HB) by the recombinant strain of  E. coli  GCSC 4401 and E. coli GCSC 6576 containing the PHA synthase genes of C. necator using whey as the carbon substrate (Lee et al., 1997). The P(3HB) yield of 4.5 g/L and 5.2 g/L was obtained respectively. Ahn et al., demonstrated an increase in the P(3HB) yield obtaining a value of 96.2 g/L. They reported a high P(3HB) yield by the recombinant strain of E. coli GCSC 4401, containing the PHA synthase genes of A. 
latus, when grown in whey, under high cell density conditions. This was further improved when these recombinant E. coli GCSC 4401 cells were cultured in a cell recycle fed batch mode. The P(3HB) yield of 168 g/L was reported (Ahn et al., 2000). Yellore and Desai in 1998, isolated a whey utilising methylbacterium which produced P(3HB), the yield obtained was 1.1 g/L. but the addition of ammonium 




  sulphate to the whey medium increased the P(3HB) yield from 1.1g/L to 3 g/L. (Yellore and Desai, 1998). Marangoni et al., reported the production of P(3HB-co- 3HV) by C. necator when grown in whey media containing equal proportions of glucose and fructose and the addition of propionic acid at specific intervals. The yield however was 0.17g/L which was quite low (Marangoni et al., 2002).  Several other organisms such  as  Sinorhizobium meliloti  41,  Hydrogenophaga pseudoflava DSM 1034, Azotobacter vinelandii and P. cepacia have been explored for the production of PHAs using whey as the carbon substrate (Povolo and Casella, 2003; Dhanasekar and Viruthagiri, 2005).   
1.6.3 SCL-PHA production using molasses  Sucrose rich molasses are generated as a by-product from the crop refining industries such as sugar beet and sugar cane refining industries. Large volume of sugar rich molasses generated at these refining plants has been used as a carbon feedstock for the production of PHAs. Apart from sugar molasses, soy molasses which is a by-product released from the soy processing plants, are rich in sucrose, raffinose and stachyose. Soy molasses can be utilized by the microorganisms containing enzymes such as α-galactosidases and β-furanosidases. The use of molasses as the cheap carbon source for the production of PHAs could also help in their disposal (Solaiman et al., 2006). Production of a copolymer such as P(3HB-co-HV) was first reported by Page in  1992, when A. vinelandii was grown in beet molasses with the addition of valerate (Page, 1992). Bonatto et al., 2004 isolated the Rastolnia pickettii 61A6 from the subtropical rainforest which produced P(3HB) in a medium containing sugarcane molasses supplemented with vitamins and minerals. However, the polymer yield was very low (Bonatto et al., 2004). Jiang et al., isolated the strain P. fluorescens and cultivated the bacteria in a medium containing sucrose rich sugarcane liquor for the production of P(3HB) (Jiang et al., 2008a). The results of the use of molasses as the carbon feedstock for the production of SCL-PHAs have been very encouraging. The optimisation of the fermentation strategy for the increased production of PHAs could help in the commercialization of SCL- PHAs. 





1.6.4 SCL-PHA production using biodiesel waste  The waste by product generated during the production of biodiesel or ethanol is rich  in  glycerol  content.  This  glycerol  rich  waste  effluent  is  generated  in  a significant amount and their utilisation as a carbon source for the production of PHA could enhance the market value of the biodiesel production. Organisms  such  as   Methylobacterium  rhodesianum  and   C.  necator  have  been  reported to have utilised glycerol rich biodiesel waste for the production of P(3HB) (Bormann and Roth, 1999). Ashby et al., demonstrated the production of a low molecular weight P(3HB) by an SCL-PHA producing strain of Pseudomonas 
oleovorans NRRL B-14682 in a basal medium containing biodiesel waste with 30% glycerol content. They reported that the molecular weight of the P(3HB) produced decreased with the increase in the glycerol content in the medium (Ashby et al., 2004).  The  use  of  biodiesel  waste  as  the  carbon  feedstock  for  fermentation  purposes has gained momentum in the last few years.  Their use in the production of PHAs has not yet been fully exploited. The increased SCL-PHA production using biodiesel waste would be a huge boost to the economic viability of SCL-PHAs.   
1.6.5 MCL-PHA production using triacylglycerols  Apart from the production of SCL-PHAs, the cheap sources of carbon have also been investigated for the production of MCL-PHAs. From literature, it is known that fatty acids are the ideal substrates for the production of MCL-PHAs (Solaiman et al., 2006). Therefore, the use of triacylglycerols directly without the saponification would lead to an economical production of MCL-PHAs. Cromwick   et   al.,    demonstrated   that    P.   resinovorans   was    able    to    utilise  triacylglycerols for the production of MCL-PHAs (Cromwick et al., 1996). Subsequently, the production of MCL-PHAs by P. resinovorans using unsaponified fats and oils as the carbon source was carried out by Ashby and Foglia in 1998. They observed that the monomer composition of the polymer produced corresponded to the fatty acid composition of the oil used as the carbon source (Ashby and Foglia, 1998).   He et al., reported the production of MCL-PHAs by P. 
stutzeri when grown using soybean oil as the main carbon source (He et al., 1998). Several Pseudomonas species such as P. putida, P. oleovorans and P. corrugata were metabolically engineered to utilise triacylglycerols for the production of MCL-PHAs (Solaiman et al., 2006). Fuchtenbusch et al., investigated the use of residual oil 




  generated during rhamnose production as a carbon feedstock for the production of PHAs. They observed that P. oleovorans was able to utilise this residual oil for the production of a heteropolymer comprising of (3HD), (3HO) and (3HDD) units (Fuchtenbusch et al., 2000). These studies confirmed that Pseudomonas spp which is commonly used for MCL-PHA production was able to utilize a wide variety of triacylglycerols as the carbon source for the production of MCL-PHAs.   
1.6.6 MCL-PHA production using biodiesel waste  Biodiesel waste which is rich in glycerol content have been utilised previously for the  production of  SCL-PHAs. Similarly,  Ashby  et al.,  reported the production of MCL-PHAs by P. corrugata using biodiesel waste as the carbon source (Ashby et al., 2004). P. oleovorans NRRL B-14682 which produced a low molecular weight SCL-  PHA when grown in biodiesel waste was also used for the production of MCL-PHAs. MCL-PHAs produced by P. oleovorans NRRL B-14682 using biodiesel waste did not show the trend of decrease in the molecular weight with increase in the glycerol content of the biodiesel waste observed in the case of SCL-PHA production (Ashby 
et al., 2004). Not many investigations have been carried out to study the use of biodiesel waste as the source of carbon for MCL-PHA production. However, the results obtained have been very encouraging.   
1.6.7 MCL-PHA production using molasses  Molasses which is  a  waste  by  product generated in  the crop refining industries have been explored extensively for the production of SCL-PHAs. However, molasses have not been commonly used as a carbon source for the production of MCL-PHAs. Solaiman  et al.,  identified P. corrugata as  a  molasses utilising  strain of 
Pseudomonas  for  the  production  of  PHAs  (Solaiman  et  al.,  2006).  The  use  of molasses as the source of carbon for the MCL-PHA production has not yet been fully exploited. The results of the investigations so far have demonstrated that molasses have a great potential to be used as a carbon source for the increased production of MCL-PHAs.   Several strategies have been employed to bring down the cost of the production of the PHAs. Apart from using the cheap carbon sources, some of the other effective strategies include the use of efficient polymer extraction processes, metabolically 




  engineered strains, the use of efficient mode of fermentation and the optimisation of the operating conditions using statistical analysis method   (Lee and Gilmore, 2005; Follonier et al., 2011; Hong et al., 2009).    
1.7 Synthesis of PHA blends  As discussed earlier, PHAs are biocompatible and biodegradable in nature and therefore, they have been used for various biomedical applications. Due to the differences in their structure, the properties of PHAs vary, with SCL-PHAs such as P(3HB) being highly crystalline, rigid and brittle in nature, whereas MCL-PHAs such as P(3HO) and P(3HHx) being elastomeric in nature with  low crystallinity and poor mechanical properties (Misra et al., 2006).    Inspite of being biodegradable and biocompatible, the brittle nature of P(3HB) and the poor mechanical and thermal properties  of  the  MCL-PHAs  limit  their  potential  in  the  field  of  regenerative medicine (Wang et al., 2002). Therefore, synthesis of blends has generated biomaterials with novel properties to suit various biomedical applications (Yu et al., 2006).  Satoh et al., studied the hydrolytic degradation pattern of the P(3HB)/P(3HB-co-  3HV) blends. They observed that the presence of P(3HB-co-3HV) influenced the degradation behaviour of P(3HB).  They concluded that the degradation rate of the blend films exhibited a linear correlation with the crystallinity (Satoh et al., 1994). Chen and Wu in 2005, synthesised a blend of P(3HB) and P(3HB-co-HHx) for tissue engineering applications. They investigated the biocompatibility of the P(3HB)/P(3HB-co-HHx) blends by growing L929 cells on these novel blend films. They observed that there was a significant improvement in the growth of the cells on these blend films compared to neat P(3HB). They also demonstrated that chondrocytes flourished on these blend films compared to neat P(3HB) films (Chen and   Wu,   2005).   The   outcome   of   these   experiments   made   it   evident   that intermediate properties suitable for desired applications could be achieved by blending different types of PHAs.   
1.7.1 Synthesis of PHA blends with synthetic polymers  Apart  from synthesizing blends within  the  PHA  family,  several novel  blends of PHAs with synthetic biodegradable, non-biodegradable polymers and natural polymers have been created. A lot of research has been done to obtain miscible, low 




  cost, biocompatible and biodegradable blends and composites with optimum properties suitable for various biomedical applications (Yang and Hu, 2008). Zhang 
et al., synthesized blends of P(3HB) and PLA and studied their miscibility and mechanical properties. They observed that  both P(3HB) and PLA  were miscible when the sample was melt blended at a high temperature. They concluded that there was a  significant enhancement in the mechanical properties of the P(3HB)/PLA blends compared to the neat P(3HB) (Zhang et al., 1996). Yoon et al., reported a  blend  of P(3HB) and poly(cis-1,4-isoprene)(PIP) which is a synthetic polymer of amorphous nature. This blend was created to enhance the mechanical properties  of  P(3HB).  However,  they  found  out   that   P(3HB)  and  PIP  were immiscible. In order to overcome this issue, they grafted poly(vinyl acetate)(PVC) which has a good compatibility with P(3HB), onto PIP which was in turn  blended with P(3HB). Mechanical property such as the tensile strength of the PHB/PIP-g- PVC blend was found to be higher compared to the P(3HB)/PIP blends (Yoon et al., 1999).  Ikejima et al., investigated the hydrolytic degradation properties of P(3HB) and polyvinyl alcohol (PVA). They demonstrated that the degradation rate of the blends was  influenced  by  their  surface  properties.  They  also  demonstrated  that  the degradation rate of the P(3HB)/PLA blend was higher compared to the degradation rate of the neat P(3HB) and neat PVA (Ikejima et al., 1998). Huang et al., studied the miscibility of the blends of P(3HB) and 80% hydrolyzed PVA. P(3HB)/PVA blend was  created  to  improve  the  mechanical properties of  P(3HB)  by  reducing the brittleness,  crystallinity  and  high  melting  temperature which  limits  the  use  of P(3HB). PVA is hydrophilic and biodegradable in nature. They observed that P(3HB) and PVA were miscible when the concentration of P(3HB) in the blend was less that 20 wt% (Huang et al., 2005).  Blends of P(3HB) with non-biodegradable poly(ethylene oxide)(PEO) has also been studied. They have been found to have excellent compatibility with P(3HB) (Park et 
al., 2001). Duarte et al., blended P(3HB) with poly(ε-caprolactone) (PCL), a semi crystalline polymer with a glass transition temperature of -70˚C. Their aim was to synthesize a novel blend with high flexibility, ideal for use in the packaging industry. They demonstrated that the P(3HB)/PCL blends had a low crystallinity and high elongation at break values confirming that P(3HB)/PCL blends were highly flexible (Duarte  et  al.,  2006).  P(3HB-co-3HHx)  with  the  HHx  content  of  11  mol%  was blended with PEO to improve the mechanical properties of P(3HB-co-3HHx). It was 




  found that the blend was miscible in the amorphous state when the concentration of PEO in the blend  was lesser than  20 wt%.  The mechanical properties of the P(3HB-co-3HHx)/PEO was significantly improved when the concentration of PEO in the blend was within the range of 5-17% (Yu et al., 2009). P(3HO) is a type of MCL-PHA.   It   is   elastomeric   in   nature   with   low   crystallinity,   low     melting temperature and  poor  mechanical properties. From literature,  it  is  known  that PHAs  are  hydrophobic  in  nature  and  therefore,  the  hydrolytic  degradation  of P(3HO)  is  very  slow.   In  order  to  improve  the  physical  properties  and  the degradation rate of P(3HO), it was blended with PLA. Novel blends with increased degradation rates were obtained (Takagi et al., 2004). In another study, P(3HB-co-3HV) was combined with PLA via bicomponent melt spinning to obtain fibres with enhanced functional properties relevant for various applications.   The authors successfully spun fibres with P(3HB-co-3HV) core and PLA sheath which demonstrated enhanced mechanical properties as well as cytocompatibility (Hufenus et al., 2012).    
1.7.2 Synthesis of PHA blends with natural polymers  Natural polymers such as starch, cellulose and protein based polymers such as collagen, are biodegradable and renewable in nature. The formation of blends and composites of PHAs with these natural polymers has attracted a lot of attention in the recent times. Parulekar and Mohanty in 2007 developed a novel flexible biomaterial by blending  plasticized starch derived from the plant source and P(3HB-co-3HV). The most common plasticizer used for starch is glycerol. Amylose rich starch plasticized with glycerol was blended with P(3HB-co-3HV) using a process engineering technique and cast into films by extrusion (Parulekar and Mohanty, 2007). Reis et al., studied the blends of PHBV with varying percentages of corn starch. They characterised the microstructural, mechanical and chemical properties of the resulting P(3HB-co- 3HV)/starch blends. Chemical analysis using Fourier Transform Infrared Spectroscopy (FTIR) confirmed that there was no chemical interaction between the P(3HB-co-3HV)  and  the  starch  and  hence,  the  blend   was  considered  to   be immiscible in nature. The blends exhibited poor crystalline properties. The mechanical properties such as the tensile strength and the Young’s Modulus decreased with the increase in the content of starch within the blend (Reis et al., 








  2008). Rubber is another type of a natural polymer which is biodegradable, highly elastomeric and  has  a  high  melting  point.  It  was  blended with  varying concentrations of MCL-PHAs which is known to have a low melting temperature and  crystallinity.  These  blends  were  synthesized  to  obtain  biomaterials  with desired properties such has high melting temperature, high ductility and a low crystallinity. The resulting MCL-PHA/rubber blend had a high melting temperature. The mechanical properties of these blends were not characterised (Bhatt  et al., 2008).    
1.7.3 Cellulose  In recent times, there has been a great interest in utilising natural fibres as the reinforcement material to enhance the mechanical properties of the biodegradable polymers. One of the most commonly used reinforcing elements is cellulose. It is a major component of the plant biomass and an extracellular polymer in microorganisms belonging  to  the  genera  Acetobacter, Rhizobium, Agrobacterium, and Sarcina. The major difference between plant and bacterial cellulose is the absence  of  hemicelluloses  and  lignin  residues  in  the  latter  which  makes  them highly pure (Soykeabkaew et al., 2009). Cellulose is a naturally occurring polymer made up of glucose monomer units. The glucose molecules are linked with each other by β (1-4) glycosidic linkages. They possess excellent mechanical properties such as modulus ranging around 16.9 GPa and the tensile strength around 2 GPa.            
Figure 1.7: Structure of cellulose (Soykeabkaew et al., 2009)  Due  to  its  excellent  mechanical  properties, hydrophilic nature  and  most importantly, its biodegradability, bacterial cellulose has been widely used as a reinforcement material in the synthesis of novel composite materials (Klemm et al., 2001).      Grunert  and  Winter  in  2000,  synthesized novel  nanocomposites with  polydimethylsiloxane and bacterial cellulose where the storage modulus of pure polydimethylsiloxane was increased two times with the addition of bacterial cellulose (Grunert and Winter, 2000). Similarly, bacterial cellulose reinforced epoxy 




  resin composite also exhibited dramatic improvement in its mechanical properties (Gabr et al., 2010). Jiang et al., synthesized novel poly(3-hydroxybutyrate-co-3- hydroxyvalerate)/cellulose nanowhisker composites where there was an increase in  the  tensile  strength  as  well  as  the  Young’s  modulus  (Jiang  et  al.,  2008b). Polylactic acid reinforced with cellulose nanowhiskers obtained by acid hydrolysis showed an improvement in the Young’s modulus and tensile strength (Bondeson et 
al., 2006). Cellulose has therefore, proven to be one of the finest natural fibres to be used for reinforcements.     
1.8 Applications of PHAs  
1.8.1 Tissue Engineering:  Tissue engineering is an emerging field that combines the principles of engineering and life sciences to address the issues related with the currently available therapeutic treatments. There are several restorative options available to treat the incidence of tissue loss and organ failure. The most promising ones include organ transplantation  from  a  healthy  donor,  tissue  transfer  from  the  healthy  site  to replace the diseased and the use of prosthetics or other mechanical devices such as dialysis  machine  or   a   pacemaker.  There  have   been   major   advances  in   the healthcare system since the introduction of these therapeutic treatments. However, there are several issues related with these treatments. The major issues have been the shortage of the organ donors, the lifelong dependency of the patients on immunosuppressant, organ rejection, donor-site issues, infection, lack of biocompatibility and  the  durability  of  the  mechanical devices.    In  recent  times, tissue engineering has emerged as a potential solution to these issues (Nugent and Edelman, 2003). The basic concept of tissue engineering is to facilitate the growth of the isolated cells on the scaffolds that enhance the proliferation of these cells and allows them to develop into desired tissues and organs prior to the implantation (Shieh and Vacanti, 2005). The function of the scaffold is to provide the cells with an anchorage by mimicking the biomechanical profile of the replacement tissue. There are several synthetic and non synthetic biodegradable polymers that have been used for the development of scaffolds. Characteristics of an ideal scaffold used for tissue regeneration include biocompatibility,  controllable  degradation  rate,   microstructural  and   material 




  properties that enhance cell growth, proliferation and differentiation. PHAs have been used to produce scaffolds for tissue engineering due to their excellent biocompatibility and biodegradability (Shieh and Vacanti, 2005; Martina and Hutmacher, 2007; Ravichandran et al., 2012).   
1.8.2 Bone tissue engineering  Bone tissue engineering is an emerging field of research that has come forward with an idea of generating new bone tissue to be used for the treatment of diseases such as osteoarthritis, osteomyelitis, osteoporosis and spine arthrodesis. There is a huge economic and clinical impact of the success of bone tissue engineering. It is a known fact that defective bone over the critical size is unable to heal on its own, therefore, a substitute material is filled in place of the defective bone to restore normal function. The options available for the treatment of bone defects include autogenous bone grafting, use of allografts and xenotransplantation. However, they are associated with high risk of infection, donor site morbidity, toxicity and pain. Bone tissue engineering merges engineering principles with the body’s mechanism of response to tissue damage. This has led to the development of synthetic bioactive scaffolds with excellent mechanical properties, accurate architecture to promote vascularisation, biocompatibility, biodegradability and most importantly, the ability to  promote osteogenic differentiation (Nugent and  Edelman,,  2003; Vara  et al., 2005).     
1.8.3 PHAs in bone tissue engineering  As  mentioned  previously,  Poly  3-hydroxybutyrate  P(3HB)  is  one  of  the  most extensively   studied   polyhydroxyalkanoate.   P(3HB)   has   excellent   mechanical properties for bone tissue engineering, with high crystallinity and tensile strength. It is biodegradable and biocompatible in nature. In another experiment, P(3HB) composites with hydroxyapatite (HA) were synthesized and implanted for a period of 12 months. During the implantation period, it was established that P(3HB) based  materials produced constructive bone tissue adaptation response. As a result, a layer of apatite surface was formed demonstrating the bioactivity of the HA/P(3HB) composites.  There  was   no   indication  of   inflammatory  response  during  the implantation  period  (Doyle  et  al.,  1991).  Knowles  et  al.,  performed  extensive studies on composite implants composed of P(3HB)/HA in the femur of Japanese 




  white rabbits to evaluate the interaction between the tissues and the implants. Histological evidence showed an increased bone growth (Knowles et al., 1992). Similar    experiments using    copolymers of 3-hydroxybutyrate and    3- hydroxyvalerate P(3HB-co-3HV) and tricalcium phosphate (TCP) were carried out. A bone like layer of HA crystallites was formed on the implant interface after implantation, indicating bone regeneration (Shishatskaya et al., 2002). Galego et al., reported that the mechanical strength of P(3HB)/HA and P(3HB-co-3HV)/HA was equivalent to  the  human  bones and  therefore could play  a  key  role  in  fracture fixation (Galego et al., 2000). Zheng  et  al.,  reported  that  porous  composites  of  P(3HB-co-3HV)  and  sol-gel bioactive glass (SGBG) when immersed in simulated body fluid(SBF) for 12 hours indicated the      formation of  hydroxyl carbonate  apatite  layer  on  the  surface of P(3HB-co-3HV)/SGBG scaffold (Zheng et al.,  2003). Similarly,  Al-Salihi  and Samsudin in 2004, tested the composites of P(3HB) with coral powder for bone tissue engineering. They concluded that the P(3HB)/coral composites had excellent pore sizes that facilitated the vascular invasion and bone development. They also established that the materials based on P(3HB) had higher biocompatibility compared to the HA and coral (Al-Salihi and Samsudin, 2004). Misra et al.,   tested the multifunctional composite scaffold made up of P(3HB) and nanobioglass  particles  (nBG)  to  evaluate  their  bioactivity  and  biocompatibility. These P(3HB)/nBG scaffolds were implanted into the rats subcutaneously for a period of seven days. There was no evidence of inflammatory response and in addition, these composite scaffolds also demonstrated bactericidal properties when tested for the growth of Staphylococcus aureus (Misra et al., 2008). In another study, composites of P(3HB) and HA were synthesized and implanted into   the   rabbit   bone  for   a   period  of   90   days.   They  were   monitored  for osteoconduction,   osteointegration   and   biocompatibility.   The   results   of   the experiment demonstrated that there was no evidence of inflammation throughout the period of implantation, the composites were osteoconductive and they also showed signs of biodegradability (Carlo et al., 2009).  Composites of P(3HB-co-3HV) with violacein, which is an antitumor agent was synthesized and implanted in to the  femur  of  Wister  rats  for  a  period  of  60  days.  The  histological  evidence demonstrated that there was no inflammatory response and there was new bone regeneration on the implants (Rambo et al., 2012). 




  Apart from, P(3HB) and P(3HB-co-3HV), a copolymer of 3-hydroxybutyrate and 3- hydroxyhexanoate P(3HB-co-3HHx) has also been investigated for bone tissue engineering applications. P(3HB-co-3HHx) scaffold was found to be an excellent biomaterial for the proliferation of bone marrow cells. The cell viability rate on the P3HB-co-3HHx scaffolds was 40% higher than on P(3HB) and 60% higher than on PLA, after an incubation period of 10 days (Wang et al., 2004). However, one of the problems associated with P(3HB-co-3HHx)     was that the incorporation of HA particles into P(3HB-co-3HHx) scaffold using salt leaching technique did not lead to the  enhancement  of  the  mechanical  properties.  By  varying  the  HHx  content  in P(3HB-co-3HHx), a range of polymer surface properties can be achieved.   Better proliferation  of  chondrocytes  was  achieved  on  the  P(3HB-co-3HHx)  /P(3HB) scaffold compared to the P(3HB) scaffold on its own (Deng et al., 2002). Results of the investigations carried out by various researchers have shown that PHAs such as P(3HB), P(3HB-co-3HV) and P(3HB-co-3HHx), their composites and blends have properties that are relevant for bone tissue engineering.    
1.8.4 Cardiovascular tissue engineering  Loss of cardiovascular function can be restored by surgical restoration, organ transplantation,   the   use   of   advanced   drugs   and   mechanical   devices.   These treatments have improved the quality of human health. However, cardiovascular dysfunction   continues   to   be   fatal.   Shortage   of   the   organ   donors   and   the compatibility issues related with transplantation has made these procedures very rare. Cardiovascular tissue engineering has emerged as a potential solution to treat the  injured  cardiac  muscle  or  a  blocked  artery  to  restore  the  cardiovascular function. Development of tissue engineered conduits, replacement heart valves and cellular  cardiomyoplasty  to  heal  the  injured  myocardium  has  been  promising. Apart from being used widely for bone tissue engineering, PHAs have also been used in several cardiovascular applications such as in the development of cardiac stents, pericardial patches, vascular grafts, artery augments and implants. The extensive range of applications of PHAs is due to diverse physical properties within the PHA family (Nerem and Seliktar, 2001; Vara et al., 2005; Grabow et al., 2007). 





1.8.5    PHAs in cardiovascular tissue engineering  P(4HB) or poly(4-hydroxybutyrate) which has elastomeric properties was one of the first PHAs to be used in cardiovascular tissue engineering for myocardial repair. However, its rapid degradation in in vivo conditions made it an unlikely choice for this   application   (Chen   and   Wu,   2005).   Another   such   PHA   to   be   used   in cardiovascular  application  was  poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or P(3HB-co-3HV). It was used along side polylactic acid and polyglycerol sebacate to form electrospun fibre materials to form a pericardial patch for myocardium repair. They were successful in making macroporous tubing to create a pericardial patch using these electrospun fibres (Kenar et al., 2010).  Stock et al., carried out a successful experiment where he implanted a P(3HO) polymer implant in the pulmonary artery of the sheep to replace the native pulmonary valve and the artery. They concluded that there was no thrombosis or stenosis at  the end of  the  experimental period of  24 weeks.  The  P(3HO) patch seeded with autologous cells had an organized cell accumulation at the end of the experiment (Stock et al., 2000). Sodian et al., designed a biocompatible and biodegradable trileaflet heart valve made up of porous P(3HO) seeded with an endothelial cell line. They utilised the salt leaching technique to synthesise these three dimensional porous scaffolds. They synthesised around ten heart valve scaffolds and seeded them with vascular cells for in vitro testing. They observed a confluent layer of cells on the scaffold. One of the unique characteristics of the P(3HO) trileaflet heart valve was that it was able to mould itself without being sutured to the conduit. They demonstrated that P(3HO) was an ideal candidate to be used for the development of heart valves (Sodian et al., 2000).  Cheng et al., carried out an experiment using a PHA scaffold for smooth muscle proliferation  to  evaluate  its  use  in  the  development  of  artificial  blood  vessels. Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) was the chosen material for the formation of elastin in rabbit blood vessel smooth muscle cells.  They concluded that poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with 20mol% 4HB showed an increase of 160% elastin compared to poly(3-hydroxybutyrate-co- hydroxyhexanoate) which  has  been  extensively studied  for  this  application  and they could be potential materials for the development of artificial blood vessels (Cheng et al., 2008). 




  Long term degrading elastomeric PHAs have been proven to be used widely in cardiovascular applications and have proven to be the best suited material due to their long term in vivo degradation property.  
1.9  Endothelial cell micropatterning  Endothelial cells form the inner lining of the blood vessel wall. They act as an interface between blood and the vessel wall. It is very crucial to maintain a healthy endothelium layer to avoid any kind of vascular dysfunction. Extensive studies have been carried out to understand the function and the behaviour of the endothelial cells. Recent studies have shown that the endothelial cells alter their morphology and  phenotype  in  response  to  the  blood  flow.  Endothelial  cells  demonstrated healthy elongated morphology under unidirectional smooth flow whereas under disturbed flow, endothelial cells exhibited thrombogenic cobblestone morphology (Uttayarat et al., 2008; Anderson and Hinds, 2011). In the last few years, micropatterning techniques have been utilised to alter the morphology of the endothelial cells under in vitro conditions. This technique involves the fabrication of the scaffold or the cell-substrate by creating definite microtopographical features on the surface that allows the cells to adhere and migrate in an aligned pattern (Thery, 2010). From literature, it is known that the surface topography determines the biocompatibility of a biomaterial. Surface topography and chemistry govern various  important   processes  such   as   protein   adsorption,  cell   adhesion  and migration (Duncan et al., 2007). The micropatterning technique creates a tissue like environment within the in vitro culture. It has made it easier for the researchers to study the interaction between cells and the surface topography which acts as the microenvironmental cue. Apart from causing a change in the morphology of the endothelial cells, micropatterning technique can also modify other cell processes such as their adhesion, proliferation, and their function. This technique has been very useful in studying the interaction between the cells and their method of proliferation. The use of this technique in the development of tissue engineered constructs is still in its initial phase (Thery, 2010; Anderson and Hinds, 2011). At present, there are several micropatterning techniques that are being utilised to understand the morphology of the cells such as microcontact printing, photopatterning and laser micropatterning. 





• Microcontact   printing:   This   is    one   of    the   most   commonly   used micropatterning technique. It utilises cytophobic and cytophilic adsorbed coatings to direct the attachment of the cells on the substrate.  Microcontact printing involves the use of polydimethylsiloxane (PDMS) with the desired surface features as a stamp. This patterned PDMS stamp is then pressed against scaffold or the cell substrate to transfer the pattern. The endothelial cells are then cultured on these patterned substrates. Even though this technique has been widely used, it has several drawbacks such as its inconsistency in the quality of the protein transfer and the requirement of an additional step of fabricating the stamp prior to the final printing step (Thery, 2010; Anderson and Hinds, 2011).   
• Photopatterning: This method uses Ultraviolet (UV) light to fabricate the surface of the scaffold used for cell culture. UV irradiation causes the polymerization or the detachment of different molecules present on the surface of the substrate.  In  order to  control the UV exposure spatially,  a photo mask is placed on top of the substrate.  This photo mask is also used to filter the UV light to prevent over exposure of the sample to UV light. This technique  is  often  very  flexible,  reproducible  and  a  large  area  of  the substrate can be fabricated at a time. However, it also has some drawbacks such as the requirement of specialized equipment which are not available readily and the requirement of photosensitisers which are highly incompatible (Thery, 2010; Anderson and Hinds, 2011).   
• Laser micropatterning: This technique has gained popularity in the recent years. It involves the use of UV light with a wavelength around 200nm from the laser source. One of the greatest advantages of this technique is that it does not require any photosensitisers and hence allows direct patterning of the biomaterials. The only disadvantage of using this technique is the requirement of  expensive  specialized equipment  (Thery,  2010;  Anderson and Hinds, 2011). 





1.9.1 Use of laser micropatterning for medical applications  Laser micropatterning is one of the well established techniques used for surface fabrication. It has been used to fabricate different vascular grafts, stents and tissue engineering scaffolds.   The use of this technique in medical research has gained momentum in the last few years due to its ease of handling, time efficiency and its ability to produce various micropatterns. Several investigations have been made to determine the role of laser micropatterning technique in understanding the cell- substrate relationship.  Li  et  al.,  used  laser  micropatterning  to  fabricate  the  thermanox  film  for  their potential application in the development of small diameter vessels.     Grooves of width 1.2 µm – 9.7 µm, groove depth and the ridge depth of 0.4 µm – 1.3 µm were created. Mouse fibroblast cell line L929 was grown on these laser modified surface. They observed that the cells exhibited elongated morphology in narrow grooves compared to the cells in wider grooves that exhibited triangular morphology. They concluded that the microstructures on the surface of the film had an effect on the morphology and the orientation of the cells (Li et al., 2003).   In another similar experiment, Rebollar et al., used KrF laser of 248 nm wavelength to fabricate the surface of polystyrene. The laser modified surface was analysed using Atomic force microscopy. They cultured Human embryonic kidney cells (HEK-293) on the modified as well as the unmodified polystyrene surface. They observed that cell adhesion on the micropatterned surface was significantly higher compared to the unmodified surface. Along with this, they also carried out an experiment on cell alignment by culturing Chinese Hamster Ovary cells (CHO-K1) as well as skeletal myoblast cells. They observed that the cells aligned themselves following the micropattern on the polystyrene surface. They concluded that the micropatterns on the cell substrate affect the adhesion, proliferation and alignment (Rebollar et al., 2008).   Mikulikova et al., carried out an experiment where they modified the surface of polytetrafluroethylene (PTFE) using a laser beam of the wavelength 172 nm. They cultured Human embryonic kidney cells (HEK) on these laser modified surfaces to study the behaviour of the cells on the micropatterned substrate. The cell proliferation was measured using the Neutral Red Assay. They observed that the cells adhered on the micropatterned surfaces and proliferated. They stated that the 




  increase in hydrophilicity of the laser modified surface resulted in an increase in the protein adsorption, hence lead to increased cell proliferation (Mikulikova et al., 2005). Yu et al., studied the interaction of the cells with a micropatterned surface. They altered the surface of the polycarbonate substrate using the Laser ablation technique. They generated two different types of the micropatterns, line micropatterns and the point micropatterns. On these micropatterned surfaces they cultured Human pulmonary fibroblast cells. They made an interesting observation that cells cultured on the line micropatterns exhibited alignment following the micropatterns  whereas  the  cells  cultured  on  the  point  micropatterns  had  no definite orientation (Yu et al., 2005).  Similar observation was made by Duncan et 
al., when they carried out an experiment where they modified the surface of PTFE disks using computer controlled cold laser KrF beam coupled with a microlithographic projection technique.  They designed parallel microgrooves of 3- -30 µm deep, 1-10 µm wide and 3-30 µm apart. They cultured Human umbilical  vein endothelial cells (HUVEC) on these laser modified PTFE surfaces to determine their potential for applications such as biosensors, tissue engineering scaffolds and vascular  grafts.  They  observed  that  the  cells  aligned  themselves  based  on  the microgrooves on the modified surface (Duncan et al., 2007).  Isenberg et al., used micropatterned polystyrene substrates to generate cell sheets with definite extracellular matrix and cellular organization. They cultured vascular smooth muscle cells on the micropatterned substrate to generate intact cell sheets. They observed that the cells demonstrated strong alignment based on the micropattern and successfully generated cell sheets (Isenberg et al., 2008).  Laser micropatterning has thus proven to be a valuable technique for various biomedical applications. This technique has not yet been fully exploited and has a great potential.  
1.10 Drug Delivery  New and innovative local  drug delivery systems have been  developed in  recent times to replace the conventional mode of drug administration. One of the major issues associated with the conventional dosage system is a requirement of higher dosage of drug to elicit a pharmacological response causing a number of side effects (Pouton and Akhtar, 1996). 




  The basic concept of a local drug delivery system includes the encapsulation of a drug or an active ingredient within a material and its delivery to the target cells or tissues within the body. This method prevents the healthy cells and tissue being exposed to the drug and also maintains lower incidence of toxicity in the plasma. An ideal drug carrier protects the drug from being degraded, delivers the drug to the site of action, reduces the toxicity and degrades away after the delivery into non toxic degradation products. Several synthetic and non synthetic biodegradable polymers have been used as drug carriers (Pouton and Akhtar, 1996).  
1.10.1 Mechanism of drug release  The  drug  encapsulated  within  the  carrier is  released via  three  different mechanisms namely:  1.   Osmosis  2.   Diffusion  3.   Degradation   
Osmotic release: This type of release occurs when the drug or the active pharmaceutical ingredient is present within the core of the carrier. The drug is released from within the core by osmosis. Osmotic release is usually appropriate for the conventional oral administration where the drug is in a tablet form and is covered by another layer of a semi-permeable membrane. This semi permeable membrane is  usually  made  up  of  cellulosic  material.  When  the  tablet  comes in contact  with  the  water,  it  absorbs  the  water  through  the  pores  building  a hydrostatic force. This force causes the drug to be released through the membrane. Burst release phenomenon is observed in this type of release which is followed by slow release (Dash and Suryanarayanan, 1992).  
Diffusion: Concentration gradient is the main force driving this kind of release. The drug present within the carrier is released in the body by dissolution which is followed by diffusion. Solubility of the drug in the aqueous environment also plays an important role. In this case hydrophilic drugs are released via burst release phenomenon whereas hydrophobic drugs or a drug with very low water solubility is not released at all (Dash and Suryanarayanan, 1992).  
Degradation: In this kind of release, the drug is released in the body when the carrier is degraded via hydrolysis. The degradation occurs in two different ways 




  such as bulk and surface erosion. Bulk degradation occurs when the rate of water absorption is faster than the rate of degradation while surface erosion occurs when the rate of degradation is faster than the rate of water absorption within the bulk of the polymer (Dash and Suryanarayanan, 1992).     
1.10.2 PHAs in drug delivery  Naturally derived polymers such as polyhydroxyalkanoates (PHAs) are attractive for the development of drug delivery systems for a number of reasons. Primarily, they are readily available and relatively inexpensive. In addition, they are biocompatible in nature (Chasin and Langer, 1990).  Akhtar and Pouton in 1996, reviewing the potential of using PHAs as drug delivery systems highlighted the possible benefits of using a biosynthetic rather than a chemically synthesised polymer. They argued that a biosynthetic PHA, devoid of chemical catalysts and initiators is more likely to make a safer pharmaceutical product than their synthetic counterparts.  Furthermore, the  involvement  of  microbial  enzymes  in  the production of PHAs is likely to result in more reliable consistent polymer, from a stereochemical point of view, thus ensuring highly reproducible physical properties (Pouton and Akhtar, 1996).  Of all the properties that make PHAs a preferred material for drug delivery systems, their slow biodegradability and high biocompatibility are the main characteristics that give them an edge over other polymers. With respect to the in vivo degradation, available data to explain this process is quite limited. Gogolewski et al., compared the  fate  of  poly-lactides  to  PHAs  such  as  P(3HB)  and  P  (3HB-co-3HV).  They recorded 50% degradation for the poly-lactides compared to less than 1.6% degradation in the PHAs over a period of 6 months. The slow degradation rate of PHAs in vivo is the basis for current exploitation of PHAs for the design of long acting  drug  formulations  (Gogolewski  et  al.,  1993).  Biocompatibility  has  been defined as  the  effects  of  the  physiological environment on  the  polymer and  the effect of the polymer on that same environment. Several studies have confirmed the toxicological  acceptability  and  biocompatibility  of  PHAs.  Lafferty  et  al., demonstrated that P(3HB) did not affect cell metabolism or growth by measuring glucose  consumption  and  lactate  production  when  compressed  P(3HB)  tablets were exposed to mice fibroblast cells in a culture (Lafferty et al., 1988). 




  The efficacy of PHAs in designing drug delivery systems would most likely be seen in parenterally administered polymeric carrier systems, where the active drug is usually  encapsulated in  or  conjugated onto  a  polymeric device. This  is  because most of the barriers to drug delivery presented by such phenomena such as poor solubility,  rapid  breakdown  of  drug  in vivo, unfavourable  pharmacokinetics and lack of selectivity for target tissues, to a large extent are surmounted when carrier delivery systems are employed (Allen and Cullis, 2004).  Another interesting aspect of PHAs as materials for drug delivery is their drug targeting potential. Yao et al., attached PhaPRe originally expressed from C. necator fused with cell specific receptor proteins to the hydrophobic surface of PHA nanoparticles for targeted drug delivery. Both in vivo and in vitro studies demonstrated a preferential uptake of drug within this delivery system by hepatocellular carcinoma cells highlighting the targeting potential of these biopolymers (Yao et al., 2008).  Besides parenterally administered drugs, PHAs could also be used to enhance the performance of other dosage forms such as oral suspensions for paediatric use. There  are  presently  many  paediatric  oral  dosage  forms  that  are  faced  with significant stability issues. An example is the artemisinin-based oral suspension which is vital for treating malaria in children (Gabriels and Plaizier-Vercammen, 2004). Oral suspensions containing drug encapsulated in PHA microspheres, when  thoroughly studied, could greatly improve the stability of these vital dosage forms.   Finally,  transdermal drug  delivery systems made  of  PHAs  is  another  area  with future potential. PHAs have been shown to provide suitable adhesiveness and drug permeation required for optimal performance of patches as drug delivery systems (Wang et al, 2003). Wang et al., suggested the possibility of exploiting interaction between active drug and various functional groups in the side chains of PHA for the construction of clinically  useful transdermal drug delivery system (TDDS). Since the production conditions such as carbon sources utilised, to a large extent determine the functional groups present in the side chains of these polymer, the prospect of clinically useful PHA patches look very promising (Wang et al., 2003). 





1.11 Coronary Artery disease (CAD)  Coronary artery disease is a type of a cardiovascular disease where the artery gets narrowed or blocked obstructing the normal blood flow. The blockage in the artery occurs due to the accumulation of lipids and cholesterol within the arterial wall. Due to this, the lumen of the artery becomes narrow restricting the blood flow to the other parts of the heart. This leads to the inadequate supply of oxygen resulting in coronary occlusion or myocardial infarction. CAD is still considered to be one of the major causes of death in the developed world. There are several treatment options that are available to restore the arterial function such as the intake of therapeutic agents coupled with lifestyle changes, invasive treatments such as coronary artery bypass graft (CABG) and minimally invasive techniques such as percutaneous transluminal coronary angioplasty (PTCA). Balloon angioplasty is the most common type of PTCA used to treat CAD. However, the main drawback of using PTCA is the renarrowing of the vessel wall. These narrowed arteries are widened by using a stent (Libby et al., 2002; Grabow et al., 2007; Basnett and Roy, 2010).   
1.11.1 Coronary stent: A stent is a scaffold that is inserted or placed within the diseased or narrowed coronary artery to restore its function. The stent is guided into the artery using a catheter. The major function of a stent is to broaden the blocked or narrowed artery so that normal blood flow is restored. The desirable properties of an ideal stent include  
• Biodegradability to avoid its lifelong presence within the body  
• Flexibility to ease the insertion into the artery  
• High tensile strength, ductility and radial strength to prevent stent recoiling after placement 
• Ability  to  encapsulate  and  release  drugs  to  prevent  restenosis  or  the reoccurrence of the blockage.  In recent years, stents have undergone a rapid evolution from the bare metal stents to polymer coated, drug eluting, biodegradable metallic stents, to the biodegradable polymeric stents. Biodegradable stents have several advantages over the commercially available metal stents. They are less obtrusive compared to the metal stents that is known to rupture the artery during its placement that later results in restenosis. As  the  name  suggests, biodegradable stents  degrade into  non  toxic 




  degradation products after completing their function and therefore do not remain in the body for a lifetime like the metal stents. Biodegradable stents have an added advantage over the metal stents, which is their ability to encapsulate and deliver drugs. However, a major disadvantage that has hindered the commercialization of these biodegradable stents is their poor mechanical properties (Basnett and Roy, 2010; Cantor et al., 2000).   
1.11.2 Biodegradable coronary stents:  Researchers have stated that a stent is no longer required within the artery after complete vascular healing is achieved. In the case of bare metal stents and the polymer coated metal stents, they remain in the body for a lifetime interfering with the patient’s wellbeing. Biodegradable stents on the other hand could be completely degraded into nontoxic degradation products after completing their function. Biodegradable stents are designed to provide support to the injured artery for a short period of time, therefore the long-term structural stability of these stents is not a huge concern. However, it is still a challenge to design a stent with an ideal geometry using complex polymeric materials. Apart from the inferior mechanical properties, the limited number of design tools available for stent design, also hinders the success of these biodegradable stents (Moore et al., 2010).  
1.11.2.1 History The development of the first biodegradable stent was reported by Stack et al., 1988 at Duke University. They constructed a self-expanding open mesh stent structure using Polylactic acid (PLA) which is a synthetic biodegradable polymer. This was designed to  withstand  high  pressure  in  order  to  prevent  the  loss  of  its  radial strength after implantation. The implantation of this stent into an animal model led to an inflammatory response. There was an evidence of minimal thrombosis and neointimal growth and no further clinical tests were carried out (Stack et al., 1988). Agrawal and Clark, 1992 successfully deployed a PLA stent into the femoral arteries of dogs. The stent was able to withstand the pressure and maintain its structural stability.  However,  there  was  evidence of  inflammatory  response (Agrawal  and Clark, 1992). Bier et al., 1992 developed a self–expanding stent made up of Type I collagen which is a naturally occurring polymer.     However, this attempt was unsuccessful  due  to  poor  stent  design,  which  failed  to  maintain  its  structural stability,   and  collapsed  upon   implantation   (Bier  et  al.,   1992).  Tamai   et  al., successfully designed a zig-zag, balloon expandable biodegradable stent made up of 








  PLA which required heat setting to install the geometry. The results of the trials conducted in animals were successful. This was the first biodegradable stent that was deployed in humans and was able to provide a substantial follow up data upon its implantation in the human coronary artery. At the end of one year, the results showed that there was 10.5% restenosis. This stent failed to commercialize due to the issues over heat setting that was required during the deployment (Tamai et al., 2000). These attempts of developing a commercially viable stent were unsuccessful  which has led to extensive research to find the ideal biodegradable stent.   
1.11.2.2 Abbot’s biodegradable vascular scaffold (BVS)   Currently, there are  several medical companies that  are  working on  the development of an ideal biodegradable polymeric stents. The most promising effort has been by the Abbot vascular, USA that developed Everolimus eluting biodegradable polymeric stent made up of polylactide called Abbot’s biodegradable vascular scaffold (BVS). Their first phase of clinical trials involved the implantation of BVS into 30 patients. The results of their 2 year follow up were encouraging even though the 6 month follow up results showed that there was 16% reduction in the size of the lumen due to stent recoil. It was claimed that the success rate of the BVS deployment into the patients was 94%. BVS was fully degraded at  the end of 2 years after implantation. Their second phase of clinical trials involved the implantation of BVS into 101 patients in Europe, Australia and New Zealand. The results of their three years follow up were positive (Moore et al., 2010). This led to their third phase of clinical trials involving 1000 patients. Abbot’s BVS was used in the UK for the first time at the Royal Brompton hospital to treat a patient with coronary artery disease in October 2012.                  
Figure 1.8: Abbot’s biodegradable vascular scaffold (BVS) (Moore et al., 2010) 









Figure 1.9: REVA stent with the unique slide and lock design (Moore et al., 2010) Researchers at the University of Texas, Arlington developed a stent impregnated with  recombinant adenovirus vectors  carrying  nuclear  localizing  βGal  reporter gene. The stent was made up of the polymer fibres. However, this stent has only been  tested in  the  animal  models and  has  not  yet  been  implanted  in  humans (Moore et al., 2010).  
1.11.2.4 PHAs in stent development  P(3HB) was used in the development of a biodegradable stent.  Unverdorben et al., developed a biodegradable P(3HB) stent and implanted it into the iliac arteries of the rabbits. The follow up results demonstrated inflammatory reactions (Unverdorben  et  al.,  2002).  Grabow  et  al.,  developed  a  laser  machined biodegradable, balloon expandable slotted tube stent. The stent was made up of a blend of Poly(L-lactide) or PLLA and P(4HB). They stated that the PLLA/P(4HB) stents exhibited high radial strength comparable to the metallic stainless steel and had the ability for rapid expansion. The physical characterisation of these PLLA/P(4HB)  stents  demonstrated  suitable  properties  for  several  peripheral 




  vascular applications. They implanted the stents into iliac arteries of the porcine model for the preliminary trials. The six week follow up results showed that there were evidence of inflammatory reaction and neointimal response.  This was caused due  to  the  presence  of  large  spaces  within  the  strut  allowing  the  tissues  to proliferate  within   the   stent   struts.   They  are   currently   working   actively   on addressing this design limitation (Grabow et al., 2007). With the ideal design and mechanical properties, PHAs could prove to be an ideal candidate to be used as the platform or the base material for the development of a drug eluting biodegradable stent.  
1.12 Other applications of PHAs  There are several other uses of PHAs apart from those discussed above. Some of these are briefly described below.  
1.12.1 Active Drug Compounds  In recent times, the demand for the use of chiral compounds as drugs has inspired research  into  industrial  production  of  enantiomerically  pure  compounds  from PHAs.  Being  a  family  of  polyesters  consisting  of  over  140  chiral  R- Hydroxycarboxylic acids (R-HAs), PHAs are considered a promising renewable source of obtaining chiral compounds that may be used in the synthesis of active drug  compounds.  P(3HB)  is  among  the  few  commercially  available  PHAs.  At present P(3HB) is known to be well tolerated due to their biocompatibility and hence  have  recently  been  employed  as  chiral  products  in  the  treatment   of traumatic injuries like haemorrhagic shock, severe burns, myocardial damage and ischemia, anoxia and cerebral hypoxia (Massieu et al.,    2003). Kashiwaya et al., further reported that these compounds were capable of reducing the death rate associated with human neuronal cell model culture for Alzheimer’s and Parkinson’s disease and also reduce apoptosis that brings about corneal epithelial erosion (Kashiwaya et al., 2000). The antimicrobial activities of R-3HB are also well documented (Sandoval et al., 2005; Chen and Wu, 2005; Shiraki et al., 2006; Ruth et 
al., 2007). 





1.12.2 Health food and Nutrition  3HB oligomers are known to have a good penetration and rapid diffusion into peripheral tissues and hence could be utilised as emergency energy substrates for injured patients (Tasaki et al., 1999). These oligomers, when evaluated in vivo were found to release ketone bodies over prolonged periods. For this reason, several potential uses of these compounds including parenteral nutrition, management of diabetes and insulin resistance states, seizure control, reduction of protein catabolism, appetite suppression and control of some metabolic diseases (Williams 
et al., 2003)  
1.12.3 Orthopaedics  Some studies have shown that scaffolds made up of PHAs result in consistent and favourable bone tissue adaptation response without any undesirable chronic inflammatory evidence after implantation periods of up to 12 months (Doyle et al., 1991). PHA compression-moulded T-plates prepared from P(3HB) reinforced with  7% carbon fibre were used to fix osteotomies of tibial diaphysis in rabbits. The implants, fixed to the tibia by absorbable sutures were compared to implants made from vicryl. After 12 weeks, better results were obtained from the reinforced PHA implants whereas implants from the vicryl plates resulted in frequent breakages and angulation (Bostman et al., 1987). The possibility of manufacturing several composite   materials   from   among   different   PHAs   and   with   other   polymers underlines the potential of designing materials with superior qualities such as suitable  mechanical strength, biocompatibility and  optimal  degradation time  for use as implants in orthopaedics (Vainionpaa et al., 1986).  
1.12.4 Uses in urology  The possibility of PHAs being used to repair a ureter was first proposed by Baptist and Ziegler in 1965. Another study in this area was carried out by Bowald and Johansson in 1990 where a vicryl tube coated with a solution of P(3HB-co-3HV) copolymer were implanted to replace the ureter in dogs. A fully functional ureter was claimed to have been formed within all model animals within a period of nine months (Baptist and Ziegler, 1965; Bowald and Johansson, 1990). 





1.12.5 Wound management  The use of PHAs in the manufacture of sutures with superior quality has been suggested as far back as 1965 (Baptist and Ziegler, 1965). The biocompatibility and biodegradability of these materials, among other suitable  qualities could explain the use of PHAs as clinical sutures. Looking into the wider context of controlled drug delivery by PHA materials, the prospects of designing wound dressings with these biological polymers to deliver such agents as antibiotics, minerals and vitamins, proteins and other wound healing mediators, in a controlled manner, would be worth considering.  
1.12.6 Dusting powders  Small particle powders from P(3HB) have been produced and have been proposed to be used as dusting powders, particularly on surgical gloves (Holmes, 1985)  Indeed, several other medical and pharmaceutical applications of PHAs have been suggested,  especially  in  recent  times.  Williams  et  al.,  have  listed  ligament  and tendon grafts, spinal fusion cages, surgical mesh and repair patches, ocular cell implants, bulking  and  filling  agents,  vein  valves and haemostats are among  the many possible medical uses of PHAs (Williams et al., 2003). 
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AIMS AND OBJECTIVES    The aim of this research project was to carry out the production of PHAs from  
Pseudomonas mendocina and use the PHAs produced for biomedical applications. 
Specific objectives of this project are: 
1. Investigation of  the use of  various  renewable non-expensive carbon  
sources such as sugarcane molasses, biodiesel waste and glycerol for 
the economical production of MCL-PHAs by P. mendocina.  The polymer produced will be characterised for their chemical properties using Gas Chromatography Mass Spectrometry (GC-MS), structural properties using Fourier Transform Infrared Spectroscopy (FTIR) and thermal properties using Differential Scanning Calorimetry (DSC).   
2. Development      of      novel,      biocompatible       and      biodegradable 
P(3HO)/bacterial cellulose composites. These composites will be characterised with respect to their mechanical properties using a Dynamic Mechanical Analyser (DMA), microstructural properties using Scanning Electron Microscopy (SEM) and thermal properties using DSC. In addition, the effect of the addition of cellulose microcrystals on the degradability of P(3HO) will be investigated, focusing on their potential use as scaffolds for tissue engineering. Biocompatibility of these P(3HO)/bacterial cellulose composites will be tested using Human   dermal microvascular endothelial cells (HMEC-1).   
3. Development of novel, biocompatible and biodegradable 
multifunctional  2D  P(3HO)/P(3HB) blend films with varying 
percentages  of  P(3HO)  and  P(3HB)  such  as  P(3HO)/P(3HB)  80:20, 
P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 20:80. These blend films will be  characterised with  respect  to  their  mechanical properties using  DMA, thermal properties using DSC and microstructural properties using SEM, White Light Interferometry and contact angle measurements. They will also be   characterised  for   their   bioactivity   using   HMEC-1   cells   and   their      
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 degradation properties to assess their suitability in the development of biodegradable stents and scaffolds in tissue engineering.   
4.  (1) Surface micropatterning of the P(3HO)/P(3HB) 50:50 blend films 
using the laser micropatterning technique. Bearing in mind, the potential application of the P(3HO)/P(3HB) 50:50 blend films as a platform material for the development of a biodegradable stent and as a tissue engineering scaffold,   HMEC-1 will be   grown on the micropatterned P(3HO)/P(3HB) 50:50 blend films to assess the influence of micropatterning on cell growth and proliferation. The effect of the laser micropatterning on the surface and mechanical properties of the P(3HO)/P(3HB) 50:50 blend films will be examined using SEM, AFM and water contact angle measurements and DMA respectively. (2) Development of micropatterned and non- 
micropatterned stent prototypes.   
5.   Investigation of the use of P(3HO)/P(3HB) 50:50 2D blend films with 
aspirin as the base material for the development of a drug eluting 
biodegradable stent and as a drug delivery vehicle for the controlled 
release of aspirin. P(3HO)/P(3HB) 50:50 blend film with aspirin will be characterised for its mechanical properties using DMA, thermal properties using DSC and surface properties using SEM, AFM and water contact angle measurements to investigate the effect of the incorporation of aspirin on the blend film. Biocompatibility of these blend films containing aspirin will be investigated using HMEC-1 and their degradation properties will also be characterised to determine the effect of drug loading. Drug release studies will be carried out using High performance Liquid Chromatography (HPLC).   
6.   Microbial production of P(3HB) and  their utilisation in the synthesis of 
microspheres and films to investigate their potential as a drug delivery 
tool for the controlled delivery of aspirin. P(3HB) microspheres and films containing aspirin will be characterised. Drug release rates from the microspheres and the films will be measured using HPLC. 




 The ultimate  aim  of  this  research project  is  to  use PHAs, their composites and blends for various biomedical applications such as scaffolds for tissue engineering, development of biodegradable stents and drug delivery. 
  
          
CHAPTER 2    
Materials and Methods 
Chapter 2: Materials and Methods  
 
 
2.1 Chemicals and Reagents  All the chemicals were purchased from Sigma-Aldrich or BDH Ltd. (Dorset, UK) or VWR  (Leicestershire, UK).  For analytical  studies, analytical  grade reagents were used. For chromatography analysis such as GC-MS and Nuclear Magnetic Resonance (NMR), chromatography grade reagents were used. Distilled and HPLC grade water were used for the experiments. Bicinchoninic acid assay kit used for protein estimation was purchased from Thermo-Scientific, UK. Aspirin (acetyl salicylic acid 
≥ 99.0% crystalline) which was used as the model drug for drug delivery studies was purchased from Sigma-Aldrich, UK. Cell culture studies were carried out using cell culture grade media and reagents from Sigma-Aldrich, UK, and Lonza, UK.  
2.2 Bacterial strains and cell line  P(3HO) was produced using the Gram-negative bacterium P.  mendocina, which was obtained from the National Collection of Industrial and Marine Bacteria (NCIMB 10542), Aberdeen, UK.  Bacterial cellulose (BC) was produced by growing 
Acetobacter xylinum (JCM10150) obtained from the culture collection, University of Westminster, UK. P(3HB) was produced using Gram-positive bacterium Bacillus 
cereus SPV which was also obtained from the culture collection, University of Westminster, UK. Human dermal microvascular endothelial cells (HMEC-1) were obtained from the University of Westminster, cell line collection.  
2.3 Media Various media compositions used during this study has been listed as follows:  
2.3.1 Seed culture medium  
Chemicals Composition (g/L) ‘Lab-Lemco’ powder 1.0 
 Yeast Extract  2.0 
 Peptone  5.0 
 Sodium chloride  5.0 
 
Table 2.1: Composition of the seed culture medium (Rai et al., 2011)          
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2.3.2 P(3HO) production media  
P. mendocina was grown in the second stage mineral salt medium (MSM) and the production stage MSM using sodium octanoate as the carbon source for the production of P(3HO).  
2.3.2.1 Composition of the second stage MSM (g/L)  
Chemicals Composition (g/L) (NH4)2SO4 0.45 
 Mg SO4  0.40 
 Na2HPO4  3.42 
 KH2PO4  2.38 
 Trace element solution 1 ml/L   
Table 2.2: Composition of the second stage MSM (Rai et al., 2011)      
2.3.2.2. Composition of the production stage MSM (g/L)   
Chemicals Composition (g/L) (NH4)2SO4 0.50 
 Mg SO4  0.40 
 Na2HPO4  3.80 
 KH2PO4  2.65 
 Trace element solution 1 ml/L   
Table 2.3: Composition of the production stage MSM (Tian et al., 2000) 





2.3.2.3 Trace element solution (TE)   
Chemicals Composition (g/L) CoCl2 0.22 FeCl3 9.70 CaCl2 7.80 NiCl3 0.12 CrCl6. H2O 0.11 CuSO4. 6H2O 0.16 
 
Table 2.4: Composition of the trace element solution (Rai et al., 2011)   Mineral salts were sterilised by autoclaving at 121oC for 15 minutes (min). Sodium octanoate and magnesium sulphate were sterilised separately. Trace element solution was prepared by dissolving all the chemicals in 1N HCL. The TE solution was filter sterilised before use. The pH of the media, sodium octanoate and magnesium sulphate was adjusted to 7.15 using 1N HCL or 1M NaOH before autoclaving.  Prior to  the inoculation, the mineral salts,  sodium octanoate, magnesium sulphate  and  the  trace  element  solution  were  mixed  together  in  a sterile condition.  
2.3.3 Bacterial cellulose production media  
A. xylinum was grown in the production media containing following nutrients:  
 
 
Table 2.5: Composition of the media for bacterial cellulose production (Kim et al., 2002).  Glucose solution were sterilised separately at 110oC for 10 min while the rest of the chemicals were autoclaved at 121oC for 15 min. Before the inoculation, pH of the production media was adjusted to 6.6, using 1N HCL and 1M NaOH. 





2.3.4 P(3HB) production media  
B. cereus SPV was  grown  in  Kannan  and  Rehacek  media for the  production of  P(3HB).   
2.3.4.1 Media composition (Kannan and Rehacek media)    
Chemicals Composition (g/L) Glucose Yeast extract Potassium chloride Ammonium sulphate Defatted soybean dialysate 
20.0   2.5   3.0   5.0   100 mL   
Table 2.6: Composition of the Kannan and Rehacek media (Valappil et al., 2007)   Kannan and Rehacek media was prepared by dissolving all the components in distilled water. Soybean dialysate was prepared by dissolving 10 g of defatted soybean flour in 1000 mL of water for 24 hours at 4oC. Soybean dialysate and the glucose solution were sterilised separately at 110oC for 10 min while the rest of the chemicals were autoclaved at 121oC for 15 min. The final pH of the production medium was adjusted to 6.8 by using 1N HCL or 1M NaOH. Prior to the inoculation, the soybean dialysate, glucose and the salts were mixed together in a sterile condition. 


















   
 




2.4 Production of P(3HO) The production of P(3HO) can be divided into four phases. These include:  
• Culturing of the P. mendocina in nutrient broth, the second stage MSM and then in the production stage MSM. 
• Harvesting the cells and their lyophilisation  
• Extraction and precipitation  
• Characterisation of the PHA produced       
Seed Culture 
(Nutrient Broth) Cultivation in the second stage MSM 
media Cultivation in the production stage MSM media     
Analysis of PHA 
produced PHA Extraction and Precipitation  Cell Harvest and Lyophilisation   
Figure   2.1:   Diagrammatic  representation  of   the   steps  involved  in   P(3HO)  production.    
2.4.1 Seed culture preparation in nutrient broth  A  single  colony of  P. mendocina was  used to  inoculate the nutrient broth.  The culture was incubated at 30oC at 200 rev/min for 24 hours.   
2.4.2 Cultivation of P. mendocina cells in the second stage and the production 
stage MSM  The seed culture that was prepared as described in section 2.3.1 was used to inoculate the second stage MSM. The cells were cultured in this medium for 18 hours at 30oC at 200 rev/min. 10% of the total volume of this culture was then used to inoculate the production stage MSM. Sodium octanoate was used as the carbon source at both the stages. The culture was grown for a period of 48 hours before being harvested (Rai et al., 2011). 





2.4.3 Extraction of PHA by chloroform/ sodium hypochlorite dispersion  After 48 hours of growth, the cells were harvested by centrifuging the cultures at  4600  rev/min for  30  min.  The  cell  pellet  obtained  was  then  lyophilised.  The polymer was then extracted using chloroform/sodium hypochlorite dispersion method. In this method, the lyophilised cell biomass was incubated in a dispersion containing 80% of sodium hypochlorite and chloroform in 1:4 ratio at 30oC, for two hours at 150 rev/min. The slurry was then subjected to centrifugation at 4600 rpm for 20 min. This resulted in the formation of three layers of which the first layer was that of the sodium hypochlorite solution, the middle layer was that of the cell debris  and  the  bottom  most  layer  was  that  of  the  chloroform  containing  the dissolved polymer. This layer of chloroform containing the dissolved polymer was then concentrated using the rotary vacuum evaporator in which the chloroform solution was evaporated, the polymer was precipitated using ten volumes of ice cold methanol under continuous stirring (Rai et al., 2011).  
2.4.4 PHA purification The   polymer   obtained   using   the   chloroform/sodium  hypochlorite  dispersion method was then subjected to purification to reduce the contaminating lipopolysaccharide (LPS). The polymer was precipitated using ice cold 50% methanol/ethanol mixture in an equal volume. The precipitated polymer was then dissolved in acetone and then precipitated using the same mixture. This procedure was repeated several times to obtain purified polymer.    
2. 5 Analytical studies 
2. 5.1 Biomass estimation  Estimation  of  the  biomass was  carried out  by  centrifuging 1  ml  of  the  culture sample at 12,000g for 10 min. The cell pellets obtained were freeze dried and weighed.   
2.5.2 Estimation of nitrogen concentration  The reagents required for this analysis was prepared as follows:  
• Phenol nitroprusside buffer: Sodium phosphate tribasic (3 g), sodium citrate (3 g) and ethylene tetraacetic acid (EDTA) (0.3 g) were dissolved in HPLC water. pH was adjusted to 12. To this, 6 g of phenol and 20 mg of sodium nitroprusside were added. 





• Alkaline hypochlorite reagent: This reagent was prepared by mixing 2.5 ml of sodium hypochlorite solution containing 4% chlorine and 40 ml of 1M sodium hydroxide solution. The   estimation   of   ammonium   in   the   medium   was   done   using   the   phenol hypochlorite  reaction  method.    The  sample  was  prepared  by  centrifuging  the culture at 12,000 g for 10 min. The supernatant obtained was used for the analysis by performing a dilution of 1:100 in Millipore water. To this, 1 ml of phenol nitroprusside buffer was added to the 2.5 ml of diluted sample and mixed by swirling. After this, 1.5 ml of the hypochlorite reagent was added rapidly and mixed by inversion. The sample was then incubated for 45 min. The absorbance was measured at 635 nm. This method was used to determine the concentration of inorganic nitrogen present in the sample (Rai et al., 2011).  
2.6 Characterization of the PHAs produced 
2.6.1 Fourier Transform Infrared Spectroscopy (FTIR)  Initial confirmation of the polymer produced was done by FTIR.   The conditions under which this analysis was performed were as follows: spectral range 4000 to 400 cm-1 ; window material, CsI: 10 scans and resolution 4 cm-1 .  Polymer sample (2 mg) was used to carry out this analysis at the Department of Biomaterials and Tissue Engineering, Eastman Dental institute, University College London, UK.   
2.6.2 Gas Chromatography – Mass spectroscopy (GC-MS)  Identification of the polymer produced was done using GC-MS analysis of the methanolysed polymer. Furrer et al., developed the method such as methanolysis used for making methyl esters of the polymer extracted from P. mendocina. Methylene chloride (2 ml) and 2–ethyl-2-hydroxybutyric acid (10 mg/ml) were added to 20 mg of polymer. This reaction mixture containing the polymer was allowed to stand at the room temperature for 1 hour. After this, 2 ml of boron trifluoride  in  methanol  (0.65M)  was  added  to  the  mixture  and  tightly  sealed followed by vigorous shaking. This reaction mixture was then refluxed for 16 hours after which the reaction tubes were cooled on ice for 5 min. HPLC (2 ml) water was added to the reaction mixture and it was vortexed thoroughly for 1 min. This led to the phase separation after which the bottom organic phase containing the polymer was  collected  and  dried using  the  mixture  of  anhydrous sodium  sulphate  and 




 sodium carbonate (Furrer et al., 2007).  This was then filtered and sent for GC-MS  analysis to the School of Chemistry, University of Southampton, U.K.    
2.6.3 Nuclear Magnetic Resonance Spectroscopy (NMR)  Structural characterisation of the polymer produced by P. mendocina was carried out using 13C and 1H NMR.   For this analysis, 20 mg of the purified polymer were dissolved in 1 ml of deuterated chloroform. These samples were sent to the Department   of   Chemistry,  University  College   London,  UK   for  NMR   analysis. Chemical shifts were referenced against the residual solvent signal (7.26 ppm and 77.0  ppm  for  1H  and  13C  respectively).  Spectra  were  analysed  using  MestRec  software package.     
2.6.4 Differential Scanning Calorimetry (DSC)  Thermal properties of the polymer sample such as melting temperature (Tm) and glass transition temperature (Tg) were measured by DSC using a Perkin Elmer Pyris Diamond (Perkin Elmer Instrument). 5 mg of the polymer sample was used for the analysis.   Prior  to   the  analysis,   these  samples   were   placed   in   the   standard aluminium pans and the tests were performed under nitrogen atmosphere. The sample was heated and then cooled and then heated again at the rate of 20 oC/min between -50oC to 200oC.   This investigation was carried out at the Department of Biomaterials and Tissue engineering, Eastman Dental Institute, University College London, UK.     
2.7 Production of bacterial cellulose 
2.7.1 Inoculum preparation  
A. xylinum was grown in a universal bottle containing 10 ml of the production medium, for 24 hours, at 27oC, under static conditions. This inoculum was used to inoculate 300 mL of production media in a 1L Erlenmeyer flask.   
2.7.2 Production of bacterial cellulose  Bacterial cellulose was produced at the flask level by inoculating the production media as described in section 2.3.3. Before the inoculation, pH of the production media was adjusted to 6.6, using 1N HCL and 1M NaOH and autoclaved separately. 




 After the inoculation, culture was grown under static conditions at 26oC for about 7 days. To preserve the integrity of the cellulose pellicles, no samplings were carried out and the culture was left undisturbed.   
2.7.3 Extraction of cellulose pellicles  After  7   days  of  incubation,  cellulose  pellicles  were  harvested,  washed  with deionised water several times and then bleached using 70% sodium hypochlorite solution for 30 min. After this, the pellicles were washed several times with water and then stored in deionised water at 4oC.   
2.7.4 Synthesis of cellulose microcrystals  Bacterial cellulose pellicles were homogenised into microcrystals using the blender and then freeze dried. After this, 1 g of freeze dried cellulose microcrystals were treated with sulphuric acid at 80oC to obtain shorter microfibrils before being subjected to the acetylation reaction. Cellulose microcrystals were recovered by centrifuging them at 4000 g for 10 min.   
2.7.5 Acetylation of the bacterial cellulose microcrystals  Before the reaction, bacterial cellulose microcrystals were soaked in anhydrous acetic acid. This was repeated three times in order to remove the water completely. After this, the microcrystals were added into a stoppered glass bottle containing a mixture of acetic acid, toluene and 60% perchloric acid. This mixture was then vigorously shaken for about 1 min. After this, acetic anhydride was added to the reaction mixture and again shaken vigorously for about 1 min. The reaction was allowed to stand overnight at the room temperature with continuous stirring. After this reaction, the cellulose microcrystals were recovered by centrifuging at 4000 g for about 10 min. They were then washed with methanol and then with deionised water (Kim et al., 2002).   
2.8 Production of P(3HB)  P(3HB)  was produced by B. cereus SPV using Kannan and Rehacek medium at pH  6.8, in shaken flasks (Valappil et al., 2007). Glucose was used as the sole carbon source at a concentration of 20 g/L. The pH of the media was adjusted to 6.8 using 1N  HCL  or  1M  NaOH  in  order  to  allow  cell  growth  and  facilitate  polymer 




 accumulation by avoiding extreme pH conditions. The production medium, which was inoculated using the 10% inoculum, was grown for 72 hours at 30○C, with a stirrer speed of 200 rev/min. The cells were harvested by centrifuging the culture at  4600 rev/min for  30  min.  The cell  pellet  obtained was  then  lyophilised. The polymer was then extracted using chloroform/sodium hypochlorite dispersion method. The  polymer  was  precipitated using  ten  volumes  of  ice  cold  methanol under continuous stirring.    
2.9 Characterization of the composites, blends and films containing aspirin  
2.9.1 Scanning Electron Microscopy (SEM)  Surface  characterisation  of  the  films  were  carried  out  using  a  JOEL  5610LV- scanning electron microscope (JOEL). The polymer samples were placed on the 8mm  diameter  aluminium  stubs  and  gold  coated  for  2  min  using  the  gold  spluttering device (EMITECH-K550). Images were then recorded at different magnifications and acceleration voltages to study the surface topography of the sample (Misra et al., 2008). The operating pressure of 7 x 10-2 bar and deposition current of 20 mA, for 2 min, was used. The SEM analysis was carried out at the department of Biomaterials and Tissue Engineering, Eastman Dental Institute, University College London, UK.   
2.9.2 White Light Interferometry  This technique was used to study the surface roughness of the film samples. This was done by measuring the surface roughness of the samples by obtaining a 3D image of the surface using the analyzer ZYGO (New view 200 OMP 0407C) at the Department of Biomaterials, Imperial College, UK.   
2.9.3 Atomic Force Microscopy (AFM)  This technique was also used to study the surface roughness of the film samples. The surface of the film exposed to air was used for analysis.  All the samples were run with scan size: 50µm x 50 µm using Cantilever type AC200TS-R3 and a spring constant of 10 N/m; AFM MFP3D; scan rate 0.50 Hz; Tapping mode. The films samples were sent to the University of Southampton, UK for this analysis. 





2.9.4 Contact Angle Study  Static contact angle study was carried out by measuring the hydrophilicity of the film samples by using KSV Cam 200 optical contact angle meter (KSV instruments Ltd) as described in Misra et al., 2008. This experiment was done at the Department of  Biomaterials  and  Tissue  Engineering,  Eastman  Dental  Institute,  University College London, UK.   
2.9.5 Dynamic Mechanical Analyser (DMA)  Mechanical  properties  of  the  films  were  carried  out  using  the  Perkin–Elmer Dynamic Mechanical Analyser (DMA) as described in Misra et al., 2008. This test was  carried  out  to  measure  the  Young’s  modulus,  tensile  strength  and  the elongation at break values.  This investigation was carried out at the Department of Biomaterials and Tissue engineering, Eastman Dental Institute, University College London, UK.   
2.9.6 Differential Scanning Calorimetry (DSC)  Thermal properties of the films such as melting temperature (Tm) and the glass transition temperature (Tg) were measured by DSC using a Perkin Elmer Pyris Diamond (Perkin Elmer Instrument). Film samples were used for the analysis. Prior to the analysis, these samples were encapsulated in the standard aluminium pans and the tests were performed under nitrogen atmosphere. The sample was heated and then cooled and then heated again at the rate of 20 oC/min between 60 oC to 200 oC.  This investigation was carried out at the Department of Biomaterials and  Tissue engineering, Eastman Dental Institute, University College London, UK.    
2.9.7 Protein adsorption Test  Protein adsorption assay was carried out by incubating 1 cm2 film samples in 400  µL of undiluted foetal bovine serum (FBS) at 370C for 24 hours. After incubation, the samples were washed three times with phosphate buffer saline (PBS). The samples were then incubated in 1 mL of 2% sodium dodecyl sulphate (SDS) in PBS to extract the adsorbed proteins on the film surface. This was done for 24 hours at room temperature under vigorous shaking. The overall protein adsorbed on the P(3HO)/P(3HB) blend  film  samples  was  quantified using  the  Bicinchoninic acid assay (Walker, 2009). The absorbance was measured spectrophotometrically at 




 562 nm against a calibration curve using bovine serum albumin. The assay was carried out in triplicates.   
2.9.8 Indirect cytotoxicity testing  Indirect cytotoxicity assessment using HMEC was carried out on the film samples to establish their biocompatibility. Prior to the assessment, the films were sterilised with UV rays using two UV lamps of 15W, separated by a distance of 3 cm, for a period of 30 min on each side. The samples were incubated in 1 mL of DMEM medium for 24 hours at 370C. Simultaneously, HMEC-1 cells (100, 000 cells/mL) were cultured for 24 hours in 24 well plates. The DMEM medium from step 1 was then added to the cells and cultured for a further 24 hours. Cell viability was measured using MTT assay (Gerlier and Thomasset, 1986). 4% hydrogen peroxide was used as the positive control.    
2.10 In vitro degradation study  Degradation  study  was  carried  out  by  incubating  film  samples  in  phosphate buffered saline solution (PBS) and Dulbeccos Modified Eagle medium (DMEM) at 370C. The choice of the media used for this study was based on the fact that DMEM is the optimum media used for the growth of HMEC-1, which was seeded on the P(3HO) neat, composite and blend film samples, to carry out the biocompatibility studies. Phosphate buffered saline (PBS) is an isotonic solution containing: NaCl 8 g/L, KCL 0.2 g/L, Na2HPO4 1.44 g/L and KH2PO4 0.24 g/L. DMEM media contained 4.5 g/L of glucose supplemented with 10% foetal calf serum, 2mM glutamine and 1%  penicillin and streptomycin. The cells were kept in the incubator at 370C in a humidified atmosphere (5% CO2) and cultured as described by Misra et al., 2008.   
2.10.1 Water uptake, weight loss  Prior to the incubation, the samples were weighed Mo  dry (Mo, the initial weight of the sample). After this, the samples were immersed in PBS as well DMEM media under static conditions, at 370C, for a period of one and four months. Fresh medium was added to these samples every four days. At the end of the incubation period, the samples were withdrawn from the media and their weight loss (%WL) and water uptake (%WA) behaviour was analysed as described in Misra et al., 2008. 




 The following equations were used to calculate water uptake and weight loss of the samples:  Water uptake (% WA) = [(Mw wet-Mt dry)/Mt dry] 100   Weight loss (% WL) = [(Mo dry-Mt dry)/Mo dry] 100   Where,   Mo dry = Mo, the initial weight of the sample.  Mw,  wet  = Mw,  the weight of the samples after the immersion in the respective media Mt, dry = Mt, the dry weight of the samples after the incubation in the respective media  followed by drying (Misra et al., 2008).    
2.10.2 In vitro biocompatibility studies  
2.10.2.1 Cell seeding on the samples  The samples were cut to a size of 1cm2 in area and were exposed to UV rays for 30 min on each side. This was done to sterilise the samples. Prior to the seeding, the samples were incubated in the DMEM media for about 12 hours at 370C. The confluent cells were subjected to trypsinisation and recovered by centrifugation at 1000 rev/min for 10 min. The fresh medium was then added to the cell pellet and then transferred to 75 cm2  tissue culture flask for further passages. Using the haemocytometer, the cells were counted. A cell density of 20,000 cells was used to seed the samples that were placed in 24 well plates. The cells were cultured by incubation at 370C in a humidified atmosphere (5% CO2) for a period of 7 days, as in complete media. Standard tissue culture plastic was used as the control for this experiment (Misra et al., 2008).   
2.10.2.2 Cell proliferation assay  Neutral Red (NR) assay was carried out for cell adhesion and cell proliferation studies. DMEM media containing 40 mg/ml of Neutral Red (NR) dye was added to the samples placed in 24 well plates. The cells were incubated for 3 hours. This was to allow the viable cells to take up the dye. At the end of the incubation period, the samples were then transferred to a new 24 well plate. Solution A (2 ml) containing 1 % CaCl2, 0.5 % formaldehyde was used to wash the sample twice. After this, 300 




 µl of solution B containing 1% acetic acid and 50% ethanol solution were added to each sample to extract the dye. The samples were then incubated at the room temperature for about 10 min. This was followed by vigorous agitation of the microtitre  plate   shaker.  The  absorbance  was  measured  at   540  nm   using   a microtitre plate from Thermomax using Softmax Pro version 4.8 software. To measure the cell viability, total Neutral Red (NR) uptake was measured since % NR is directly proportional to the number of viable cells. Therefore, the following equation was used to calculate the % cell proliferation:   % viability = Mean absorbance of samples X 100  Mean absorbance of control    DMEM medium containing the cells in the tissue culture plastic was used as the positive control, whereas samples incubated in the medium without the cells was used as the negative control. This was to measure the absorption of the NR dye by the samples on their own (Misra et al., 2008).   
2.10.2.3 Scanning Electron Microscopy (SEM)  P(3HO)/bacterial  cellulose  composite  films  with  HMEC-1  cells  were  examined using SEM  to analyse the proliferation of HMEC-1 cells on the surface. The samples were fixed in 0.1M phosphate buffer containing 4% glutaraldehyde for 12 hours at 40C.    Before  being  observed under  the  SEM,  the  samples  with  the  cells  were  subjected to dehydration in a sequence of graded ethyl alcohol such as 25%, 50%,  70%, 80%, and 100% for 10 min each. The samples were allowed to dry for 30 min in the fume hood. These dried samples containing cells were then mounted on aluminium stubs, gold coated and observed under SEM, using the conditions described in section 2.9.1   
2.11    In    vitro    release    of    aspirin    using    High    Performance    Liquid  
Chromatography (HPLC)  1 cm2 of the films with aspirin were immersed in PBS release medium in triplicates. The tubes containing films with aspirin in PBS were kept in a shaking incubator at 370C with 35 rpm. A sample volume of 1 ml was collected at predetermined time points  and  each  aliquot  was  replaced  with  fresh  buffer  throughout  the  entire release study. The drug content in the sample was analysed using  HPLC. From 




 literature, it is known that aspirin is hydrolysed into salicylic acid and acetic acid (Tang and Singh, 2008). A HPLC system containing C18 column was used to measure both salicylic acid and acetic acid. A methanol and water solution containing 0.5% (v/v) of acetic acid  was  used as  the mobile  phase at  a  flow  rate  of  1  ml/min. Samples injected into the HPLC system were detected at 240nm.   Aspirin control samples were prepared in PBS. They were also kept in a shaking incubator at 370C with 35 rpm for the same period of time as the film samples containing aspirin. These aspirin control samples were prepared in order to compare the chemical stability of the aspirin released from the blend film samples to that of free aspirin. The amount of aspirin hydrolysed was calculated using the following formula:   Hydrolysed aspirin (mg) = [salicylic acid (mg)/molecular weight of salicylic acid x molecular weight of aspirin]    
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Chapter 3: Introduction  
 
 
INTRODUCTION   Plastics are one of the most exploited materials in the modern world. Their applications range from being used in the packaging industry and in the medical industry.  These  plastics  are  mostly  used  for  short  term  applications  such  as packaging and disposable items and therefore contribute to about 15% of the domestic and industrial waste.   It has been predicted that the use of these plastics would continue to increase until the 2020 (Castilho et al., 2009). These plastics are derived from non-renewable source such as petroleum reserves. According to literature,  these  petroleum  derived  plastics  remain  in  the  environment  for  an average  of  100  years.  Due  to  the  slow  degradation  rates  in  the  landfills  and extremely high costs involved in incineration, it is challenging to find an adequate method  of  disposal  of  these  plastics.  Disposal  of  conventional  plastics  has  a negative impact on the environment and this has motivated progress in biotechnology research on biodegradable and biocompatible polymers (Akiyama et 
al., 2003). Dwindling petroleum reserves and the environmental hazard caused by the petroleum derived plastics have led to the search for a potential alternative. Biodegradable polymers  have  emerged  as  the  one  of  the  potential  alternatives. They have several advantages over the traditional plastics that are being used at present.  They  are  sustainable,  biodegradable  and  biocompatible  in  nature.  One such biodegradable polymer that has gained fresh impetus in the recent years is polyhydroxyalkanoates. Polyhydroxyalkanoates (PHAs) are polyesters of 3-, 4-, 5- and 6 hydroxyalkanoic acids produced by a variety of bacterial species, under nutrient-limiting conditions for e.g. with excess carbon source and limiting nitrogen. PHAs  are  accumulated  as  intracellular  storage  compounds  within  the  bacteria. These polymers are biodegradable, biocompatible and exhibit thermoplastic properties.  However,  they  can  be  degraded  into  carbon  dioxide  and  water  by several microorganisms producing extracellular PHA depolymerases (Valappil et al., 2007). There has been a great interest in the commercial utilization of these biodegradable polyesters for industrial as well as biomedical applications. One of the hindrances in the commercialization of PHAs is its high production costs. Statistics revealed that in Europe, biodegradable polymers constituted of only 0.1% of the total polymer market due to its high production cost (Kim et al., 2000a). Different strategies have been used to lower the PHA production costs. Some of these include the use of metabolic engineering, efficient downstream processing 




 and   fermentation  methods  such   as   two   stage   fermentation  and   the   use   of transgenic plants for PHA production. At present, PHAs are produced using pure carbon sources which contribute to a major fraction of the total production costs. The use of inexpensive renewable carbon sources such as industrial, agricultural and domestic waste reduces the costs of production as well as adds to the environmental significance by easing the disposal. This has been considered to be a potential alternative for the economical production of PHAs (Marangoni et al., 2002; Lee and Gilmore, 2005).  The main objective of this study was to produce PHAs using inexpensive renewable carbon sources such as biodiesel waste, pure glycerol and sugarcane molasses. The chosen organism used for the production of PHAs was  P. mendocina.  
3. 0 Results 
3.1 PHA production by P. mendocina using sugarcane molasses, biodiesel 
waste and glycerol as the carbon source  In order to investigate the potential of cheap renewable carbon sources such as sugarcane  molasses,  biodiesel  waste  and  pure  glycerol  as  a   replacement  of expensive carbon sources for the production of PHAs, P. mendocina was cultivated in  the  production  stage  MSM  for  48  hours  using  these  three  different  carbon sources. The samples were withdrawn every 3 hours during the fermentation process. The O.D. and the pH of the culture were measured during the course of the fermentation, whereas biomass estimation and nitrogen concentration measurements were carried out at the end of the fermentation as described in 
section 2.5. 
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Figure 3.1: Fermentation profile of P. mendocina using sugarcane molasses as the source of carbon.  As the fermentation started, the O.D.450  and the biomass values increased exponentially until 45 hours after which it decreased dramatically. The maximum O.D. value obtained was 4.1 at 45 hours. pH was not controlled during the course of the fermentation. The starting pH of the media was set to 7. The pH of media decreased slightly from its initial value of 7 reaching around 6.5 at the end of the fermentation. The nitrogen concentration decreased initially but remained constant until 23 hours after which there was a decrease. However, there was an unexpected 
63 
Chapter3: Results  
 
 increase in the nitrogen concentration at 36 hours of fermentation. This could indicate the release of a nitrogenous compound by the organism during the fermentation. The cells entered log phase within 3 hours of the fermentation, reaching stationary phase at around 45 hours. The maximum dry cell weight values observed was 9 g/L at 45 hours. The % polymer yield obtained at the end of the fermentation was 20% dcw.  
3.1.2 PHA production using biodiesel waste as the carbon source  A single colony of P. mendocina was used to inoculate the MSM media containing 20 g/L of biodiesel waste under nitrogen limiting conditions. The production was carried out in 5L shaken flasks in a batch mode. The cells were harvested at the end of the fermentation to extract the polymer produced. The growth profile of the P. 




Figure  3.2:  Fermentation profile  of  P. mendocina  using  biodiesel waste  as  the source of carbon.  As the fermentation started, the O.D.450 and the biomass values increased gradually, until the end of the fermentation. The O.D.450  values were lower compared to the cells  grown  in  sugarcane  molasses.  This  could  be  due  to  the  inability  of  the organism to utilise crude biodiesel waste easily or the presence of a toxic substance. The maximum O.D.450 value obtained was 2.9 at 48 hours. Nitrogen was used as the limiting    factor.    The    nitrogen    concentration    gradually    decreased    during 
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 the course of the fermentation.  The pH of culture medium decreased slightly from its initial value of 7 to around 6.5 at the end of the fermentation. The maximum dry cell weight (dcw) obtained was 7.4 g/L at 48 hours of cultivation. The % polymer yield obtained at the end of the fermentation was 43.2% dcw.  
3.1.3 PHA production using pure glycerol as the source of carbon   A single colony of P. mendocina was used to inoculate the MSM media containing 20 g/L of pure glycerol under a nitrogen limiting condition. This was carried out to compare the growth of P. mendocina and the production of PHAs in the biodiesel waste containing crude glycerol and pure glycerol. The production was carried out in 5L shaken flasks in a batch mode. The cells were harvested at the end of the fermentation to extract the polymer produced. The growth profile of P. mendocina using pure glycerol as the source of carbon is shown in Figure 3.3.                            
Figure 3.3: Fermentation profile of P. mendocina using pure glycerol as the source of carbon.  As the fermentation process started, the O.D.450  and the biomass values increased gradually,  within  3  hours  of  the  fermentation,  after  which  it  increased exponentially until 30 hours. The cells entered stationary phase after 30 hours. Maximum O.D.450 value obtained was 4.1 at 45 hours. Nitrogen was used as the limiting factor. The nitrogen concentration gradually decreased during the course of the fermentation and maintained the limiting condition. The pH of the culture 
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 medium decreased slightly from its initial value of 7 to around 6.3. The maximum dry cell weight value obtained was 8.6 g/L at 45 hours. The polymer yield obtained at the end of the fermentation was 10.5% dcw.  
3.2 Characterisation of the polymer produced 
3.2.1 Fourier Transform Infrared Spectroscopy (FTIR)  The polymer produced using these cheap carbon sources were characterised using FTIR as described in section 2.6.1. From literature, it is known that the absorption bands at 1720 cm-1 and 1282 cm-1 corresponding to the ester carbonyl group and – CH2 groups respectively are the principal bands found in SCL-PHAs, whereas the absorption bands at 1742 cm-1  and 1165 cm-1  corresponding to the ester carbonyl group and C-O stretching are the signature bands found in MCL-PHAs (Randriamahefa et al., 2003).  
3.2.1.1 FTIR analysis of the polymer produced using sugarcane molasses as 




Figure 3.4: FTIR spectrum of the polymer produced using sugarcane molasses as the carbon source.  The  absorption spectrum  showed the  presence of  a  peak  at  2900  cm-1 corresponding to the aliphatic –CH group of the polymer backbone. The absorption spectrum of the polymer confirmed the presence of the characteristic marker ester carbonyl band for MCL-PHAs, which occurs around 1725 cm-1 and the band at 1160 cm-1  that occurs due to C-O stretching. Preliminary characterisation using FTIR suggested that the polymer produced was an MCL-PHA. 
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3.2.1.2 FTIR analysis of the polymer produced using biodiesel waste as the 




Figure 3.5: FTIR spectrum of the polymer produced using biodiesel waste as the carbon source.  The  absorption spectrum  showed the  presence of  a  peak  at  2924  cm-1 corresponding to the aliphatic –CH group of the polymer backbone. The absorption spectrum of the polymer confirmed the presence of the characteristic marker ester carbonyl band for MCL-PHAs that occurs around 1734 cm-1  and the band at 1162 cm-1  that occurs due to C-O stretching. Preliminary characterisation using FTIR suggested that the polymer produced was an MCL-PHA.  
3.2.1.3 FTIR analysis of the polymer produced using pure glycerol as the 
carbon source.  The  absorption  spectrum  of  the  polymer  produced using  pure  glycerol  as  the carbon source is shown in Figure 3.6. 
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3.6: FTIR spectrum of the polymer produced using pure glycerol as the carbon source.  The  absorption spectrum  showed the  presence of  a  peak  at  2923  cm-1 corresponding to the aliphatic –CH group of the polymer backbone. The absorption spectrum of the polymer confirmed the presence of the characteristic marker ester carbonyl band for MCL-PHAs which occurs around 1734 cm-1 and the band at 1042 cm-1  which occurs due to C-O stretching. Preliminary characterisation using FTIR suggested that the polymer produced was an MCL-PHA. These polymers produced were further characterised using Gas chromatography Mass Spectrometry (GC-MS).  
3.2.2 Gas chromatography Mass Spectrometry (GC-MS)  
3.2.2.1 GC-MS analysis of the polymer produced using sugarcane molasses as 
the carbon source. 
 The polymer produced was further characterised using Gas chromatography-mass spectrometry. Prior to this analysis, the polymer was methanolysed to obtain a methyl ester as described in section 2.6.2. The GC-MS spectrum of the polymer is shown in Figure 3.7. 
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Figure 3.7: GC-MS analysis of the polymer produced by P. mendocina using sugarcane molasses as the carbon source. (a) A total ion gas chromatogram of the polymer   showing   peaks   at   6.64   (3HO)   and   7.34   (3HD)   min   (b)   The   MS fragmentation pattern of the GC peak at a retention time 6.64 min showing 3HO. (c) The MS fragmentation pattern of the GC peak at retention time 7.34 min showing 3HD.   2-ethyl-2-hydroxybutyric acid was used as an internal standard and showed a peak at a retention time of 4.61 min. The mass spectrum of the molecular ion related mass fragment peak at a retention time (Rt) of 6.64 min was identical to the mass spectrum of the methyl ester of 3-hydroxyoctanoate in the MS (NIST) library, confirming   that   the   polymer   produced   contained   monomer   units   of   the 3-hydroxyoctanoate.  The   mass   spectrum   of   the   molecular   ion   related   mass  fragment  peak  at  a  retention  time  (Rt)  of  7.34  min  was  identical  to  the  mass spectrum of the methyl ester of 3-hydroxydecanoate in the MS (NIST) library, confirming that the polymer produced also contained monomer units of 3- hydroxydecanoate. 3HD was the major monomer unit present in this copolymer at 87 mol% while 3HO was a minor constituent at 7 mol% approximately.   The MS fragmentation pattern of 3HO in Figure 3.7 (b) showed m/z peaks at 43.2,  71.1, 74.1 and 103.1. The peak at m/z 43.2 corresponded to the alkyl end of the molecule formed due to the cleavage between the C5 and C6 carbon atoms. The peak at m/z 71.1 represented the alkyl end of the molecule occurring due to the cleavage 
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 between C3  and C4  carbon atoms. The peak at m/z 74.1 represented the carbonyl end of the molecule occurring due to the cleavage between C3 and C4 carbon atoms. The peak at 103.1 corresponded to the hydroxyl end of the molecule occurring due to the cleavage between C3  and C4 atoms. This fragmentation pattern followed the McLafferty rearrangement (McLafferty, 1956).   The MS fragmentation pattern of 3HD in Figure 3.7 (c) showed m/z peaks at 43.2,  71.0, 74.1 and 103.2. The peak at m/z 43.2 corresponded to the alkyl end of the molecule originated due to the cleavage between C7 and C8 carbon atoms. The peak at m/z 71.1 represented the alkyl end of the molecule formed due to the cleavage between C3  and C4  carbon atoms. The peak at m/z 74.1 represented the carbonyl end of the molecule formed due to the cleavage between C3  and C4  carbon atoms. The peak at 103.2 corresponded to the hydroxyl end of the molecule occurring due to the cleavage between C3  and C4 atoms. This fragmentation pattern followed the McLafferty rearrangement (McLafferty, 1956). The fragment peaks at a retention time (Rt) of 7.52 and 8.65 min were identical to the mass spectrum of the methyl ester of dodecanoic acid and pentadecanoic acid in the MS (NIST) library. These are saturated fatty acids. The other fragment peaks at a retention time (Rt) of 8.61 and 9.11 min were identical to the mass spectrum of the methyl ester of  hexadecenoic acid  and  13-octadecenoic acid,  also  known  as oleic acid respectively in the MS (NIST) library. These are monounsaturated fatty acids. They could be removed by the further purification of the polymer (Rai et al., 2011). 
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3.2.2.2 GC-MS analysis of the polymer produced using biodiesel waste as the 








Figure  3.8:  GC-MS  analysis  of  the  polymer  produced  by  P.  mendocina  using biodiesel waste as the carbon source. (a) A total ion gas chromatogram of the 
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 polymer produced showing peaks at 7.34 min. (b) The MS fragmentation pattern of the GC peak at a retention time of 7.34 min showing 3HD.  The mass spectrum of the peak at a retention time (Rt) of 7.34 min was identical to that of the methyl ester of 3-hydroxydecanoic acid in the MS (NIST) library, confirming that the polymer produced was the polymer of 3-hydroxydecanoate. 3HD   was   the   main   monomer   unit   at   33   mol%   approximately.   2-ethyl-2-  hydroxybutyric acid was used as an internal standard and was represented by the peak at a retention time of 5.20 min.  The MS fragmentation pattern of 3HD in Figure 3.8 (b) showed m/z peaks at 43.2,  71.0, 74.1 and 103.2. The peak at m/z 43.2 corresponded to the alkyl end of the molecule formed due to the cleavage between C7  and C8 carbon atoms. The peak at m/z 71.1 represented the alkyl end of the molecule formed due to the cleavage between C3  and C4  carbon atoms. The peak at m/z 74.1 represented the carbonyl end of the molecule formed due to the cleavage between C3  and C4  carbon atoms. The peak at 103.2 corresponded to the hydroxyl end of the molecule occurring due to the cleavage between C3  and C4 atoms. This fragmentation pattern followed the McLafferty rearrangement (McLafferty, 1956). Apart from the above mentioned peaks, there were other fragment peaks that were detected during this analysis. The peak at a retention time (Rt) of 8.65 was identical to the mass spectrum of the methyl ester of pentadecanoic acid in the MS (NIST) library. The peaks at 9.52, 9.74 and 10.36 min were identical to the mass spectrum of heptacosane in the MS (NIST) library. Another peak at 9.94 min was identical to the mass spectrum of pentacosane in the MS (NIST) library. Other peaks at 10.59, 10.84 and 11.13 min were identical to the mass spectrum of octacosone in the MS (NIST)  library.  Heptacosane,  octacosone  and  pentacosane  belong  to  the hydrocarbon family of alkanes and are known to form major constituents of diesel and aviation fuel. By further purification of the polymer, these non-relevant compounds can be removed. 
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3.2.2.3 GC-MS analysis of the polymer produced using pure glycerol as the 
carbon source. 
 GC-MS result of the methanolysed polymer produced using pure glycerol as the carbon source is shown in Figure 3.9.  
 
 
(a)          
Methyl ester of 3- 
hydroxydecanoate                 
m/z  
(b)   
Figure 3.9: GC-MS analysis of the polymer produced by P. mendocina using glycerol as the carbon source. (a) A total ion gas chromatogram of the polymer produced 
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 showing peaks at 7.34 min. (b)The MS fragmentation pattern of the GC peak at a retention time 7.36 min showing 3HD.  The mass spectrum of the peak at a retention time (Rt) of 7.36 min was identical to that of the methyl ester of 3-hydroxydecanoic acid in the MS (NIST) library, confirming that the polymer produced was the polymer of 3-hydroxydecanoate. 2- ethyl-2-hydroxybutyric acid  was  used as  an  internal  standard and  showed as  a peak at a retention time of 4.59 min.  The MS fragmentation pattern of 3HD in Figure 3.9 (b) showed m/z peaks at 43.2,  71.0, 74.1 and 103.2. The peak at m/z 43.2 corresponded to the alkyl end of the molecule originated due to the cleavage between C7 and C8 carbon atoms. The peak at m/z 71.1 represented the alkyl end of the molecule occurring due to the cleavage between C3  and C4  carbon atoms. The peak at m/z 74.1 represented the carbonyl end of the molecule occurring due to the cleavage between C3 and C4 carbon atoms. The peak at 103.2 corresponded to the hydroxyl end of the molecule occurring due to the cleavage between C3  and C4 atoms. This fragmentation pattern followed the McLafferty rearrangement.  There were other fragment peaks that were detected during this analysis peak at a retention time (Rt) of 8.65 and 10.04 min that were identical to the mass spectrum of the methyl ester of hexadecanoic acid and octadecanoic acid in the MS (NIST) library. These are saturated fatty acids. The polymer produced can be further purified by solvent extraction to remove these impurities.   
3.2.3 Molecular weight analysis  The  weight  average  molecular  weight  (Mw)  of  the  polymer  produced  by  P. 
mendocina using sugarcane molasses, biodiesel waste and pure glycerol was determined using gel permeation chromatography (GPC). Two Polar Gel-M columns (30 cm) in series (Varian Inc) were calibrated to 380994 – 590 Da using narrow molecular weight polystyrene standards. Tetrahydrofuran was the eluent used in this analysis and the flow rate was adjusted to be 1 ml/min. The polymer that was eluted was detected using a differential refractometer. Viscotek ‘Trisec 2000’ and ‘Trisec 3.0’ software was then used to collect and analyse the data. This analysis  was carried out at the Department of Chemistry, University of Nottingham, UK. 
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 According to literature it is known that the relative Mw (weight average molecular weight) of the MCL-PHAs fall within the range of 60,000 and 412,000. Similarly, the Mw of the SCL-PHAs fall within the range of 5,30,000 to 1,100,000 (Valappil et al., 2007).  The  GPC  analysis  of  the  polymer  produced  by  P.  mendocina  using  sugarcane molasses was carried out. The weight average molecular weight of the Poly(3- hydroxydecanoate-3-hydroxyoctanoate) was found to be 1.4 x 105. Polydispersity index  (PDI),  which  is  a  measure  of  the  distribution  of  molecular  masses  in  a polymer, was calculated to be 1.9, indicating that the molecular mass distribution of the  polymer  sample  was  within  a  small  range,  a  desirable  property.  The  GPC analysis of the polymer produced by P. mendocina using biodiesel waste was also carried out. The weight average molecular weight of the Poly(3-hydroxydecanoate) was found to be 6.5 x 104. The PDI was calculated to be 2.0. The GPC analysis of the polymer produced by P. mendocina using pure glycerol was carried out.  The weight average molecular weight of Poly(3-hydroxydecanoate) was found to be 4.6 x 104. The PDI was calculated to be 2.6.   
3.2.4 Thermal characterisation  Thermal  characterisation  of   the   polymer  was   carried  out   using   Differential Scanning Calorimetry (DSC) as described in section 2.6.4. DSC was used to determine the melting temperature (Tm) and the glass transition temperature (Tg) of the polymer produced using cheap carbon sources. The results of the thermal analyses are summarised in Table 3.1.    
Samples Tm (°C) Tg (°C) 
Sugarcane molasses 53.9 ± 0.2 -37.9 ± 0.4 
Biodiesel waste 42.3 ± 0.7 -29.8 ± 0.3 
Pure glycerol 44.5 ± 1.0 -22.8 ± 0.7 
Table 3.1: Thermal analysis of the polymer produced using cheap carbon sources    




 respectively. The FTIR and the GC-MS results have confirmed that the polymer produced is a  copolymer of P(3HD-co-3HO) which is a  type  of a  medium chain length (MCL) PHA. According to the literature, it is known that MCL-PHAs have a low  melting  temperature  and  glass  transition  temperature.  The  melting temperature ranges within 40 – 60oC and the glass transition temperature ranges within -50 and -25oC (Rai et al., 2011). The thermal properties of this polymer produced using sugarcane molasses falls within this range.  
Biodiesel Waste: The Tm and the Tg of the polymer produced using biodiesel waste as the carbon source were found to be 42.3 ± 0.7 oC and -29.8 ± 0.3 oC respectively. The FTIR and the GC-MS results have confirmed that the polymer produced is P(3HD) which is a type of a medium chain length (MCL) PHA containing 10 carbon atoms within a monomer unit. The thermal properties of this polymer produced using biodiesel waste also falls within the range of the thermal properties of the MCL-PHAs (Rai et al., 2011).  
Pure Glycerol:  The Tm  and the Tg  of the polymer produced using pure glycerol as the carbon source were found to be 44.5 ± 1 and -22.8 ± 0.7 oC respectively. The FTIR and the GC-MS results have confirmed that the polymer produced is a P(3HD) which is a type of a medium chain length (MCL) PHA containing 10 carbon atoms within a monomer unit. Thermal properties of this polymer produced using pure glycerol   falls within the   range thermal properties of the MCL-PHAs (Rai et al., 2011).   
Discussion   Recent  studies  have  shown  that  the  production  of  PHAs  could  become commercially viable with the utilisation of cheap and renewable carbon sources. This could bring down the cost of production of PHAs by about 50% (Chaudhry et 
al., 2011). Therefore, in this study, the production of PHAs by P. mendocina using cheap  carbon  sources  such  as  sugarcane  molasses,  biodiesel  waste  and  pure glycerol have been investigated. The results of these studies have been discussed in detail.  P. mendocina was  the  chosen organism used for the  production of  PHAs during this study. P. mendocina is a Gram negative bacteria which was first isolated from the soil and water samples by N.J. Palleroni in 1970 (Palleroni et al., 1970). They belong to the rRNA homology group I and are known to produce MCL-PHAs from  both  structurally  related  and  unrelated  carbon  sources,  under  nutrient 
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 limiting conditions (Tian et al., 2000; Rai et al., 2011). P. mendocina was grown in MSM  medium  containing  20  g/L  of  the  cheap  renewable  carbon  source  in  5L shaken flasks.  Sugarcane  molasses  is  rich  in  sugar  such  as  sucrose,  stachyose,  raffinose  and vitamins such as thiamine, riboflavin, pyridoxine and niacinamide, therefore sugarcane molasses has been widely used as the energy source for the production of  PHAs.  Previous  studies  have  shown  that  sugarcane  molasses  enhances  the growth of the organism and also causes the accumulation of PHAs within the cells (Gouda et al., 2001; Chaudhry et al., 2011; Akaraonye et al., 2012). In this study, an MCL copolymer containing 3HO and 3HD monomer units were produced by P. 
mendocina using sugarcane molasses as the carbon source. This was confirmed by carrying out FTIR and GC-MS analysis. A similar experiment was carried out by Solaiman et al., where they screened and identified P. corrugata as the organism that was able to utilise 5% of soy molasses and produce 0.6 g/L of the MCL-PHAs containing  repeating  units  of  3HDD,  3HO  and  3-hydroxytetradodecanoate (Solaiman et al., 2006). However, in an experiment carried out by Jiang et al., 2008, they observed that P. fluorescens when cultured in sugarcane liquor produced P(3HB). The P(3HB) yield obtained was around 70% dcw. This proved that P. 
fluorescens, which is commonly known to be an MCL-PHA producer was able to synthesize P(3HB) (Jiang et al., 2008a). In this work, the maximum dry cell weight obtained using sugarcane molasses as the sole carbon source was 9 g/L at 45 hours. However, the PHA yield at 48 hours was 20% dcw which was low in comparison to the amount of the biomass obtained. This suggested that under the specific conditions used, maximum energy was utilised in growth instead of PHA biosynthesis. The finding of this study was in agreement with the results obtained by Gouda et al., 2001 where they cultivated Bacillus megaterium in a medium containing sugarcane molasses as the carbon source. They stated that PHA yield is not  dependent  on  cell  growth  (Gouda  et  al.,  2001).  Nitrogen  was  the  limiting nutrient in this study. The concentration of nitrogen decreased gradually. However, there was an unexpected increase in the concentration of nitrogen at 36 hours.  The cells  had  a  prolonged  log  phase  and  entered  stationary  phase  at  45  hours. According to literature, the presence of nitrogen is crucial for cell growth. It is also known that  the depletion of the nitrogen concentration in the media guides the cells into the stationary phase and causes the accumulation of PHA (Lageveen et al., 
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 1988; Kim et al., 1994; Wang and Lee, 1997; Choi and Lee, 1999). In another experiment carried out by Tian et al., 2000, they cultivated P. mendocina strain 0806 in glucose media. They observed that the ratio of carbon source to nitrogen  source (C/N) affected the accumulation of PHA. They concluded that nitrogen limitation was a major factor for the triggering of the polymer synthesis (Tian et al., 2000). Sugarcane molasses have been used widely for the production of SCL-PHAs such as P(3HB) by various organisms such as Bacillus spp JMa5, R. picketti, B. 
megaterium and B. cereus SPV (Gouda et al., 2001; Bonatto et al., 2004; Akaraonye 
et al., 2012). However, sugarcane molasses remain fairly unexplored for the production of MCL-PHAs.  The waste product generated during the production of biodiesel is rich in glycerol, fatty acids and fatty acid methyl esters. Under appropriate conditions, they can be used as the feedstock for various industrial processes (Ashby et al., 2004). In this study,  an  MCL  polymer  containing  3HD  monomer  units  were  produced  by  P. 
mendocina using biodiesel waste as the sole carbon source. This was confirmed by carrying out FTIR and GC-MS analysis. Maximum dry cell weight obtained was 7.4 g/L at 48 hours. The polymer yield at 48 hours was 43.2% of the dry cell weight which was the highest yield obtained in this study. In an experiment carried out by Ashby et al., 2004, they cultivated P. corrugata in a medium containing 1 to 5 % of the biodiesel waste that was rich in glycerol, free fatty acids and fatty acid methyl esters. They observed that the increase in the concentration of the biodiesel waste in the production media had a negative effect on the growth of the cells.  Maximum cell growth was attained when the biodiesel waste concentration was 1% in the medium. In this study, the concentration of the biodiesel waste in the media was 20% which is much higher compared to 5% used in the study carried out by Ashby et al., 2004.  Poor  growth  of  P. mendocina  in  this  study  could  be  due  to  a  very  high  concentration of biodiesel waste in the media. Highest PHA yield obtained by Ashby 
et al., 2004 was 42% of the dry cell weight when the concentration of biodiesel waste was 3% in the media. GC-MS analysis confirmed that the polymer produced contained 3-hydroxyoctanoic acid, 3-hydroxydecanoic acid and 3- hydroxytetradodecanoic acid as monomers (Ashby et al., 2004).  These results were in agreement with the outcome of this study that the crude biodiesel waste could be utilized as the carbon source for the production of PHAs. In the same experiment, Ashby et al.,  cultivated another Pseudomonas strain such as P. oleovorans NRRL 
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 B14682 in a medium containing 5% biodiesel waste. They observed the production of a homopolymer of P(3HB) (Ashby et al., 2004). This suggested that the type of the polymer produced using the biodiesel waste as the carbon source is dependent on the type of the organism used. They also added that the growth of  P. oleovorans was not affected by the increase in the concentration of the biodiesel waste in the media. This indicated that the effect of the biodiesel waste on the growth of the organism  was  dependant  on  the  type  of  organism  (Ashby  et  al.,  2004).  The maximum P(3HB) yield obtained was 27% dcw at 5% of biodiesel waste concentration (Ashby et al., 2004).  Future studies involving cultivation of P. mendocina in various concentrations of biodiesel waste could shed light on the effect of the biodiesel waste on cell growth and  PHA  accumulation  within  the  P.  mendocina cells.  In  a  similar  experiment carried out by Koller et al., 2004, they cultivated an osmophilic wild strain of bacteria, in a medium containing biodiesel waste rich in glycerol content. They observed the production of poly(3-hydroxybutyrate-co-hydroxyvalerate) (Koller et 
al., 2005). Organisms such as Methylobacterium rhodesianum and C. necator have been reported to have utilised glycerol rich biodiesel waste for the production of P(3HB) (Bormann and Roth, 1999).  In  this  study,  P.  mendocina  was  also  cultivated  in  a  medium  containing  pure glycerol for the production of PHAs. The results obtained were compared to that of the glycerol rich biodiesel waste. In this study, MCL polymer containing 3HD units were produced by P. mendocina using pure glycerol as the sole carbon source. This was confirmed by carrying out FTIR and GCMS analysis. The maximum dry cell weight obtained was 8.6 g/L at 45 hours. This showed that cell growth was better in the medium containing glycerol compared to the biodiesel waste. However, the polymer yield at 48 hours was 10.5% of the dry cell weight which was much lower compared to the polymer yield in the biodiesel waste. In an experiment carried out by Ashby et al., 2005, a mixed culture containing P(3HB) producing P. oleovorans NRRL  B14682  and  the  MCL-PHA  producing  P.  corrugata  was  cultivated  in  a medium containing pure glycerol as the carbon source. They observed that P. 
corrugata  was  not  capable  of  producing  MCL-PHAs  when  the  glycerol concentration was higher than 3% whereas P. oleovorans NRRL B14682 was able to accumulate P(3HB) at 5% glycerol concentration in the media. P. oleovorans NRRL B14682 produced a homopolymer of P(3HB) while P. corrugata produced the MCL 
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 copolymer containing 3HD and 3HDD monomer units at 2% glycerol concentration (Ashby et al., 2005). Ashby et al., 2005 obtained maximum P(3HB) yield of 40% dcw by P. oleovorans NRRL B14682 and a maximum MCL-PHA yield of 20% dcw by 
P. corrugata. The MCL-PHA yield was lower in the pure glycerol medium compared to  the  medium  containing  biodiesel  waste  (Ashby  et  al.,  2005).  As  mentioned earlier, nitrogen limitation  triggers the  accumulation  of  PHAs  (Lageveen et al., 1988). Nitrogen was the limiting nutrient in both biodiesel waste and the pure glycerol containing media. The concentration of the nitrogen in the biodiesel waste medium decreased during the early hours of fermentation maintaining a nitrogen limiting condition throughout the course of the fermentation. In  the case of the pure glycerol, there was an unexpected increase in the concentration of nitrogen at 36 hours. This could most likely be a nitrogenous compound which forms the part of the chemical composition of the carbon source. These results suggested that P. 
mendocina was capable of utilising both crude as well as pure glycerol as the sole carbon  source  for  the   production  of  PHAs.   However,  in   future,   analysis  to determine PHA yield at  regular  intervals during the course of the fermentation would point towards an optimum time for the polymer extraction. It would also determine the degradation of the accumulated PHA. Apart from this, the estimation of the carbon in the media would give an understanding of the utilization of the carbon source by P. mendocina. Depending on the percentage of the unused carbon in the media at the end of the fermentation, one would be able to determine the optimum carbon concentration for the increased PHA production.  GPC analysis was carried out to determine the molecular weight of the polymers produced.  The molecular weight of the PHAs produced using sugarcane molasses, biodiesel waste and pure glycerol were within the known range for the MCL-PHAs which is 60,000 – 412,000. However, P(3HD) produced using pure glycerol as the carbon source has a  lower molecular weight compared to  the P(3HD) produced using  biodiesel  waste  as  the  carbon  source.  PHAs  are  produced  intracellularly within the organism (Rai et al., 2011). In this study, the polymer produced within the  cells  was  extracted  using  chloroform  and  hypochlorite  dispersion  method. Furrer et al., 2007 stated that the sodium hypochlorite used for the extraction of the polymer is responsible for the degradation of the polymer by causing chain scission. This was confirmed by carrying out GPC analysis (Furrer et al., 2007). Previous studies have shown that hypochlorite degradation can cause upto 50% 
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 decrease in the molecular weight of the polymer produced (Yasotha et al., 2006). Apart from this, it has also been reported that the polymer is degraded due to the repeated washing after the hypochlorite extraction (Rai et al., 2011).  This could be one  of  the  reasons  for  the  decrease  in  the  molecular  weight  of  the  polymer produced. The effect of the hypochlorite on the molecular weight of the polymer depends on the type of the organism used. There was a 75% reduction in the molecular weight of the polymer produced by A. eutrophus due to the chain scission caused by hypochlorite, whereas there was 15% reduction in the molecular weight of the polymer produced by recombinant E. coli (Rai et al., 2011). The decrease in molecular weight of the polymer produced using glycerol rich biodiesel waste and the pure glycerol have been previously observed by Koller et al., 2005, Ashby et 
al.,2004  and Ashby et al., 2005. Koller et al., stated that the presence of glycerol in the medium terminated the chain elongation by covalently binding to the carboxyl end of the PHA (Koller et al., 2005). Ashby et al., reported that there was 72% decrease in the molecular weight of the MCL-PHAs produced by P. corrugata using pure glycerol. However, they stated that there was no evidence of the termination of chain propagation. They speculated that this decrease in the molecular weight of the MCL-PHAs could be due to osmotic stress caused by the increase in the concentration of glycerol in the media resulting in low biomass yield, low polymer synthesis and molecular weight (Ashby et al., 2005).  Thermal properties of the polymer were studied using DSC. The results have been summarised in Table 3.1. The Tm and the Tg   values of the polymer produced corresponded to the Tm of MCL-PHAs which ranges between 40oC and 60oC and the Tg values which ranges between -50 and -25oC (Rai et al., 2011). MCL-PHAs in general, have a low melting and glass transition temperature. According to the literature, they have a low crystallinity and therefore exhibit poor mechanical properties. However, their elastomeric nature makes them highly suitable for biomedical applications such as soft tissue engineering (Rai et al., 2011).  In conclusion, this study has demonstrated the utilization of cheap carbon sources such as the sugarcane molasses, glycerol rich biodiesel waste and pure glycerol by 
P. mendocina for the production of PHAs. MCL-PHAs were produced and characterised. A maximum PHA yield of 43.2% dcw was obtained in the media containing biodiesel waste. Utilisation of these inexpensive carbon sources for the 
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INTRODUCTION Medium   chain   length   PHAs   (MCL-PHAs)   are   structurally   diverse   and   their properties can be tailored for specific applications (Philip et al., 2007). Due to their elastomeric properties, MCL-PHAs have been explored for their application in soft tissue engineering, biological implants such as the heart valves, cartilage tissue engineering and in wound healing (Kim et al., 2007). P(3HO) is a type of MCL-PHA which has a % elongation at break value of  278. It has a low melting temperature (Tm) and a low glass transition temperature (Tg) of 30-50˚C and -35 to -36˚C respectively. P(3HO) has relatively low tensile strength and Young’s Modulus value of  around  1.8  and  11.4  MPa  respectively (Rai  et al., 2011).  However,  previous studies have shown that the MCL-PHAs can be modified to obtain optimum properties such as high mechanical strength by making composites and blends with inorganic and organic additives (Kim et al., 2007).  In recent times, there has been a great interest in using natural fibres as reinforcement agents to enhance the mechanical properties of biodegradable polymers. One of the most commonly used reinforcing element is cellulose. It is a major component of the plant biomass and an extracellular polymer in microorganisms belonging  to  the  genera  Acetobacter, Rhizobium, Agrobacterium, and Sarcina. The major difference between plant and bacterial cellulose is the absence  of  hemicelluloses  and  lignin  residues  in  the  latter  which  makes  them highly pure compared to the plant cellulose (Soykeabkaew et al., 2009). Bacterial cellulose has excellent mechanical properties such as a Young’s modulus value of 16.9 GPa and tensile strength of 256 MPa. It is highly hydrophilic in nature. Due to its excellent mechanical properties and hydrophilic nature, bacterial cellulose has been widely used as a reinforcement material in the synthesis of novel composite materials (Klemm et al., 2001).  Therefore in this study, P(3HO), a type of MCL-PHA produced by P. mendocina, a Gram negative bacteria was reinforced using bacterial cellulose to produce P(3HO)/bacterial cellulose composite film. It is a known fact that bacterial cellulose is  extremely  hydrophilic  in  nature  with  a  very  high  water  retention  capacity whereas P(3HO) is very hydrophobic in nature. In order to achieve a significant level    of   compatibility   between    bacterial   cellulose   and   P(3HO),   bacterial 








  cellulose was chemically modified using an acetylation reaction in which the water retaining cellulose hydroxyl groups were replaced by acetyl groups. This would decrease the hydrophilic properties of bacterial cellulose and hence make them compatible with the P(3HO) matrix. P(3HO)/5% bacterial cellulose, P(3HO)/15% bacterial cellulose and P(3HO)/25% bacterial cellulose composite films were characterised with respect to their mechanical, thermal and microstructural properties. In addition, the effect of the addition of cellulose microcrystals on the degradability as well as biocompatibility of P(3HO) were also  investigated.  
4.0 Results  
4.1 P(3HO) Production P(3HO) production by P. mendocina using sodium octanoate as the sole carbon source was carried out   as described in section 2.4. The carbon to nitrogen (C/N) ratio used in this study was 15:1. The fermentation profile is shown in Figure 4.1.                              
Figure 4.1: The fermentation profile for P(3HO) production by P. mendocina using sodium octanoate as the sole carbon source. The O.D.450 and the dry cell weight (dcw) values increased exponentially reaching a value of 4.8 and 1.6 g/L respectively, at 48 hours, showing a steady growth of the organism throughout the 48 hour fermentation period. The nitrogen concentration reduced rapidly through the fermentation process, indicating usage of nitrogen by the organism. After about 32 hours, nitrogen concentration had reduced from its initial value of 0.5 mg/ml to 0.1 mg/ml, becoming a limiting condition. The % DOT 
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  values  also  reduced  from  its  initial  value  of  100%,  through  the  fermentation, reaching a value of 0%.  After 48 hours of fermentation, the P. mendocina cells were harvested  for  the  extraction  of  the  polymer.  In  this  study,  NaOCl/chloroform mixture was used to rupture the cells followed by dissolution of the PHA inclusions in the chloroform solution as described in section 2.4.3. A polymer yield of 45.3% dcw was observed at 48 hours while 9% dcw polymer yield was observed at 36 hours of the fermentation. Polymer produced was purified using the method described in section 2.4.4. Elbahloul and Steinbϋchel, 2009 were able to achieve 95% (wt/wt) of 99% pure polymer from the freeze dried cells using this method. This was followed by an additional purification step using acetone as the polymer has a higher solubility in acetone than the lipolysaccharide (an endotoxin present on the cell  wall  of the Gram negative bacteria such as in  Pseudomonas species) (Elbahloul and Steinbuchel, 2009). Therefore, in this study, this procedure was repeated several times to ensure that the polymer produced were of high purity. This purified polymer was then further characterised.    
4.2 Characterisation of the polymer produced 
4.2.1 Fourier Transform Infrared Spectroscopy (FTIR)   The polymer produced was characterised using FTIR as described in section 2.6.1. The  absorption  spectrum  of  the  polymer  confirmed the  presence of  the characteristic marker ester carbonyl  band  for  MCL-PHAs which occurs  around 1742  cm-1   and  the  band  at  1162  cm-1    which  occurs  due  to  C-O  stretching  (Randriamahefa et al., 2003) as shown in Figure 4.2. 
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Figure 4.2:   FTIR spectrum of the polymer indicating the presence of absorption peak at 1740 cm-1 and 1162 cm-1.  Preliminary characterisation using FTIR suggested that the polymer produced was an MCL-PHA.  
4.2.2 Gas Chromatography Mass Spectrometry (GC-MS)   The polymer produced was further characterised using Gas chromatography mass spectrometry.  Prior  to  this  analysis,  the  polymer  was  methanolysed  to  obtain methyl esters as described in section 2.6.2. 
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Figure 4.3: GC-MS analysis of the polymer produced by P. mendocina using sodium octanoate  as  the  sole carbon  source. (a)  A  total  ion  gas  chromatogram of  the 
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  polymer  produced  using  sodium  octanoate  as  the  carbon  source.  (b)  The  MS  fragmentation pattern of the GC peak at a retention time 10.63 min.   The mass spectrum of the peak at a retention time (Rt) of 10.63 min was identical to that of the methyl ester of 3-hydroxyoctanoate (Mw = 174) in the MS (NIST) library, confirming that the polymer produced was Poly(3-hydroxyoctanoic acid). 2-ethyl-2-hydroxybutyric acid was used as an internal standard and showed as a  peak at a retention time of 7.86 min as shown in Figure 4.3.     
4.2.3 Nuclear Magnetic resonance (NMR)   Final characterisation of the polymer produced by P. mendocina was carried out using 13C and 1H NMR as described in section 2.6.3. 1H and 13C spectra of the polymer are represented in Figure 4.4 (A) and (B).     
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Figure  4.4:  NMR  spectrum  of  polymer  produced  by  P.  mendocina  using  using sodium octanoate as the sole carbon source (A) 1H spectrum; (B) 13C spectrum.   In the 13C spectrum, eight peaks have been observed. This corresponds to the eight different environments for the carbon in the molecule. The chemical shift at 169.53 ppm  corresponds to  C1 (C=O  group),  70.94  ppm  to  C3 (-CH),  39.18  ppm  to  C2 (-CH2), 23 – 35 ppm to C4, C5, C6, C7 (-CH2) and 13.93 ppm to C8 (-CH3). Similarly, in 1H  spectrum,  five  different  peaks  were  observed  owing  to  the  five  different  environments for the proton in the molecule. The chemical shifts of 2.5, 5.1, 1.5, 1.2 and 0.8 ppm demonstrated the presence of protons bonded to C2 (-CH2), C3 (-CH), C4 (-CH2),  C5,    C6,   C7 (-CH2) and  C8 (-CH3) respectively. Hence,  the  13C  and  1H  NMR analysis further confirmed the GC-MS result, i.e. that the polymer produced by P. 
mendocina, using sodium octanoate as the sole carbon source, is the homopolymer of 3-hydroxyoctanoic acid.  
4.3 Production of cellulose from Acetobacter xylinum and its chemical 
modification. In this study, bacterial cellulose was used as a reinforcing agent to improve the mechanical properties of P(3HO). It was produced by A. xylinum at the conical flask level as described in section 2.7.2. In this study, A. xylinum was cultured in a static mode and the bacterial cellulose was produced in the form of a gel like pellicle as shown in Figure 4.5 
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Figure 4.5: A bacterial cellulose pellicle produced by Acetobacter xylinum in a hydrated state. These bacterial cellulose pellicles were then washed with 2% sodium hydroxide at  96oC for an hour. They were then subjected to homogenisation followed by acid hydrolysis as described in section 2.7.4. This was carried out to generate shorter microfibrils referred to as cellulose microcrystals as shown in Figure 4.6                         
Figure 4.6: Freeze dried acetylated bacterial cellulose microcrystals used for composite production. The bacterial cellulose microcrystals were then subjected to an acetylation reaction as described in section 2.7.5. This was carried out to increase the compatibility of the hydrophilic bacterial cellulose with the hydrophobic P(3HO). Acetic anhydride was used as the catalyst for this acetylation reaction as shown in Figure 4.8. 
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Figure  4.7:  Chemical  reaction  of  the  bacterial  cellulose  with  acetic  anhydride  (Jonoobi et al., 2010).    
4.4 Characterisation of the acetylated cellulose microcrystals using FTIR  After the acetylation reaction, bacterial cellulose microcrystals were characterised using FTIR in order to confirm their chemical modification as described in section 
2.6.1. The FTIR spectrum of the acetylated bacterial cellulose microcrystals was  compared with the spectrum of the native cellulose as shown in Figure 4.8.    
 
 
Figure 4.8: The FTIR analysis showing the acetylated bacterial cellulose versus the non-acetylated bacterial cellulose.   A sharp peak at 3400 cm-1  corresponding to hydroxyl groups was observed in the FTIR spectrum of the native bacterial cellulose. As expected there was a decrease in the   intensity   of   this   absorption   peak   in   the   acetylated   bacterial   cellulose 
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  microcrystals. This decrease in the absorption intensity confirmed the substitution of the hydroxyl groups by the acetyl groups. The acetylation of the cellulose was further confirmed by the presence of the absorption band at 1737 cm-1 corresponding  to   C=O   ester   stretching,  at   1208   cm-1   corresponding  to   C-O stretching of the acetyl group and 1367 cm-1 corresponding to the CH3 group, which were not present in the spectrum of native bacterial cellulose.    
4.5 X-Ray Diffraction  To investigate the effect of acetylation on the crystallinity of the bacterial cellulose, XRD studies were carried out. This test was carried out on the acetylated and the non-acetylated  bacterial  cellulose.  The  cellulose  samples  were  analysed  on  a Brüker D8 Advance diffractometer in flat plate geometry, using Ni filtered Cu Ka, radiation. Data was collected from 10 to 100° with a primary beam slit size of 0.6 mm. A Brüker Lynx Eye silicon strip detector was used and a step size of 0.02° and a count time of 0.1 s per step. The XRD pattern of the acetylated bacterial cellulose was compared with the non-acetylated bacterial cellulose microcrystals as shown in Figure 4.9.                            
Figure  4.9:  XRD  patterns  of  the  acetylated  bacterial  cellulose  and  the  non- acetylated bacterial cellulose. 
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  There was a decrease in the intensity of the absorption peaks of the acetylated bacterial cellulose compared to the non-acetylated bacterial cellulose indicating a decrease in the crystallinity.   
4.6 Preparation of neat P(3HO) and P(3HO)/5% bacterial cellulose, P(3HO)/ 
15% bacterial cellulose and P(3HO)/25% bacterial cellulose composite 
films using the solvent cast method.  Acetylated bacterial cellulose microcrystals were incorporated into the P(3HO) matrix to produce 2D composite films containing 5%, 15%, 25% of acetylated bacterial cellulose microcrystals using the solvent casting method.  This was done by dissolving the P(3HO) polymer and acetylated cellulose microcrystals in chloroform, casting the solution onto a glass petri dish. The film was then air dried for one week before being freeze dried for another two weeks.    
4.7 Characterisation of the P(3HO)/bacterial cellulose composite films 
4.7.1 Mechanical properties  The  mechanical properties of  the  neat  and  the  composite films  were  measured using  the  Perkin–Elmer  Dynamic  Mechanical  Analyser  (DMA)  as  described  in 
section 2.9.5. This was carried out in order to investigate the effect of the bacterial cellulose microcrystals on the mechanical properties of the composite films. The results are summarised in Table 4.1. 
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P(3HO) 1.5 ± 0.1 1.8 ± 0.5 204.0 ± 0.2 P(3HO)/5% 
 cellulose 7.0 ± 0.1 5.0 ± 0.8 145.0 ± 0.3 P(3HO)/15% 
 cellulose 11.3 ± 0.9 4.3 ± 1.0 65.0 ± 0.7 P(3HO)/25% 
 cellulose 18.4 ± 0.7 4.2 ± 0.9 35.0 ± 3.0 
Table 4.1: Mechanical properties of the neat P(3HO) as well as P(3HO)/ bacterial  cellulose composite films (n = 3).  The Young’s modulus value, which is a measure of the stiffness of the materials was higher  for  the  composite  films  compared  to  the  neat  P(3HO)  film.  With  the increasing concentration of modified cellulose microcrystals in the P(3HO), there was an increase in the ‘E’ values of the composite films. The tensile strength of the P(3HO)/ bacterial cellulose composite films  were also higher than the neat P(3HO) films. However, there was a decrease in the tensile strength of the P(3HO)/cellulose composite films with the increase in the concentration of the bacterial cellulose microcrystals in the P(3HO) film. Therefore, the composite production method needed improvement in order to suitably exploit the properties of the acetylated bacterial cellulose microcrystals for enhancement of the tensile strength of the composites. From the literature, it is established that the % elongation at break values for MCL- PHAs range between 6.5 to 350 % (Asrar et al., 2002). The values obtained in this study were within this range. There was a decrease in the elastomeric properties with the increase in the concentration of modified cellulose microcrystals in the films indicating that the presence of bacterial cellulose microcrystals had a significant effect on the elastomeric properties of the composite films. 
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4.7.2 Thermal Characterisation Thermal characterisations were carried out to investigate the thermal stability of the composite films as a function of the temperature, as described in section 2.9.6. The results of the thermal analysis are summarised in Table 4.2.   
Samples Tg (°C) Tm (°C) 
P(3HO) -34.0 ± 0.8 51.8 ± 0.2 




-31.4 ± 1.0 
 
46.3 ± 0.7 




-33.8 ± 1.2 
 
44.3 ± 0.9 
 
Table 4.2: Thermal analysis of the neat P(3HO) and P(3HO)/bacterial cellulose composite films (n = 3). There was a decrease in the melting temperature (Tm) of the P(3HO)/bacterial  cellulose composite films compared to the neat P(3HO) film due to the addition of the modified bacterial cellulose microcrystals. On the other hand, there was an increase  in  the  glass  transition  temperature  (Tg) on  addition  of  the modified cellulose microcrystals to the P(3HO) matrix.   
4.7.3 Contact Angle Study  Static contact angle measurement was carried out in order to determine the effect of bacterial cellulose microcrystals on the hydrophilicity or wettability of P(3HO)/bacterial cellulose  composite  films  as  described in  section  2.9.4. According to the literature, it is known that the polymer film with the contact angle (θ) values less than 70○ are considered to be hydrophilic whereas θ values greater than 70○ are considered to be hydrophobic in nature (Peschel et al., 2008). Static contact angle measurements of the P(3HO) neat and P(3HO)/bacterial cellulose composites films are shown in Figure 4.10. 
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Figure 4.10: Static water contact angle measurement of the neat P(3HO) and P(3HO)/ bacterial cellulose composite films (n = 3). The data were compared using ANOVA and the difference were considered significant when *p<0. 05.   P(3HO)/5% and P(3HO)/25% bacterial cellulose composite films had a more hydrophilic  surface  compared  to   the   neat   P(3HO)   film.   While   P(3HO)/15% cellulose composite film had a more hydrophobic surface compared to the neat P(3HO) neat film.   Based on these preliminary data, P(3HO)/25% bacterial cellulose composite films with  the  highest  Young’s  modulus  value  and  a  relatively  higher  hydrophilicity, known to favour cell adhesion, was chosen for further characterisation.  
4.8 Microstructural studies of the neat P(3HO) and P(3HO)/25% bacterial 
cellulose film.  
4.8.1 Scanning Electron Microscopy (SEM)  Surface topography of the P(3HO)/25% bacterial cellulose film was studied using SEM as described in section 2.9.1  in order to study the effect of bacterial cellulose on the surface properties of the composite film. The surface topography of the P(3HO)/25% bacterial cellulose composite film  was compared to the neat P(3HO) film as shown in Figure 4.11. 
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(a) (b) 
Figure 4.11: SEM images of the neat P(3HO) and P(3HO)/ 25% bacterial cellulose  composite films. (a) Surface of the neat P(3HO) film (b) Surface of the P(3HO)/25%  bacterial cellulose composite film.  A new topography was introduced when modified bacterial cellulose microcrystals were included within the P(3HO) matrix. This change in the surface topography of the composite film was further confirmed using White Light Interferometry.   
4.8.2 White Light interferometry  Surface   roughness   of   the   neat   P(3HO)   and   P(3HO)/25%  bacterial   cellulose composite films was measured using White light interferometer as described in 
section 2.9.2. As shown in Figure 4.12, the root mean square (RMS) roughness of the (a) neat P(3HO)   film was calculated to be 0.272 µm (b) whereas the RMS roughness of the P(3HO)/25wt% bacterial cellulose composite film was found to be 0.884 µm.                    
(a) (b)  
Figure 4.12: Surface scans of the (a) P(3HO) neat and (b) P(3HO)/25% bacterial cellulose composite films using White Light Interferometry. 
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  Hence, the addition of modified bacterial cellulose microcrystals to the neat P(3HO) film resulted in a rougher topography. Surface roughness of the P(3HO)/25% bacterial cellulose composite film was 226% higher compared to the neat P(3HO) film.   
4.8.3 Protein Adsorption Test  Previous results in this study have shown that the presence of acetylated cellulose within the P(3HO) matrix resulted in the change of surface topography as well as the water contact angle. In order to evaluate the effect of these changes on the total protein adsorption on the composite film, an assay was carried to quantify the total protein adsorption as described in section 2.9.7. The results of the total protein adsorption is shown in Figure 4.13.    
 
 
Figure 4.13: Protein adsorption of the neat P(3HO) and P(3HO)/25% cellulose composite film (n = 3). The data were compared using t-test and the difference were considered significant when *p<0. 05.   The overall protein adsorbed on the neat P(3HO) film was 318±1.0 µg/cm2 which was lower as expected, compared to the total protein adsorbed on the surface of the P(3HO)/25% bacterial cellulose which was 580±1.6 µg/cm2. The protein adsorption was significantly higher in the composite film in comparison to the neat P(3HO) film (*p<0. 05). 
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4.8.4  In vitro degradation study in DMEM and PBS media  A short, one month, in vitro degradation study was carried out using phosphate buffered saline solution (PBS) and Dulbeccos Modified Eagle Medium (DMEM) to investigate the effect of bacterial cellulose microcrystals on the degradation behaviour of the composite film, as described in section 2.10.   
4.8.4.1 Water uptake, weight loss and pH measurements   Percentage of water absorbed (%WA) and weight loss (%WL) during the degradation of the neat as well as the composite film were measured and are presented in Figure 4.14 (a), (b), (c) and (d).                     
(a) (b)                     
(c) (d)  
Figure 4.14: Water absorption by the neat P(3HO) and P(3HO)/25% bacterial cellulose composite films during the degradation study in (a) DMEM media and (b) PBS media. Weight loss by the degrading neat P(3HO) and P(3HO)/25% bacterial 




  cellulose composite film during the degradation study in (c) DMEM media and (d) PBS media (n = 3).   The data were compared using t-test and the difference were considered significant when *p<0. 05.   Water absorption (%WA) was significantly higher in the composite film compared to the neat film both in DMEM and PBS media (*p<0.05). The %WA by the neat P(3HO) film in DMEM media during this one month study  was 4.6±2.5%,  whereas it  was  12.5±0.1%  in  the  P(3H0)/25%  bacterial  cellulose.  In  the  PBS  media, the %WA in the neat P(3HO) film was 14.4±0.7% compared to 28.1±1.0% in the P(3HO)/25% bacterial cellulose respectively. The weight loss by the composite film was significantly higher compared to the neat film in both DMEM and PBS media (*p<0. 05). The % weight loss (%WL) by the neat P(3HO) film in DMEM media during this one month study  was 7.5±0.2% whereas it was 14.2±1.0% for P(3H0)/25% bacterial cellulose. Similarly, in the PBS media, the %WL in the neat P(3HO) film was 3.3±0.6% compared to 5.8±1.0% in P(3H0)/25% bacterial cellulose. Hence, the P(3HO)/25% cellulose composite film had increased water absorption and weight loss  in comparison to the neat P(3HO) film.  
4.8.4.2 pH measurements  During the study, the neat P(3HO) and P(3HO)/25% bacterial cellulose composite film were incubated in DMEM and PBS media for a period of 30 days as described in 
section 2.10.  pH  measurements were carried out  to  analyse  any change in  the media due to the degradation of the film. There was an increase in the pH of both DMEM and PBS media after the completion of the study. The pH value of the DMEM media increased from a value of 7 to 8.4. Similarly, there was an increase in the pH of PBS media from 7.4 to 8.1.   
4.8.4.3 Mechanical characterisation of the degrading film  At the end of the incubation period of the film samples in DMEM and PBS media, the Young’s moduli of the degrading samples were measured to investigate the effect of degradation on the mechanical properties of the neat as well as the composite film. The Young’s modulus values of the degrading samples had increased in both DMEM and PBS media as compared to the non-degraded samples. The ‘E’ values of the neat P(3HO) film incubated in the DMEM increased from 1.5±1.0 MPa to 7.3±0.8 MPa. A 















  similar trend was observed in the P(3HO)/25% bacterial cellulose composite film with an increase in the ‘E’ values of  P(3HO)/25% bacterial cellulose composite film from 18.4±0.4 MPa to 25.1±0.3 MPa, upon incubation in the DMEM media, for a period of one month. Similar increase in the ‘E’ values of the neat P(3HO) and P(3HO)/bacterial cellulose composite film was observed in the PBS where the ‘E’ values of the neat P(3HO) film incubated in the PBS increased from 1.5±0.2 MPa to 1.8±0.5 MPa and the ‘E’ values of   P(3HO)/25% bacterial cellulose composite film from 18.4±1.2 MPa to 27.1±2.0 MPa.    
4.9  In vitro biocompatibility study  Preliminary in  vitro  cell  culture  studies  were  carried  out  on  neat  P(3HO)  and P(3HO)/25% bacterial cellulose composite film using Human dermal microvascular endothelial cell line (HMEC-1) as described in section 2.10.2. HMEC-1, which is an endothelial cell line, was chosen for this study due to the potential application of these novel P(3HO)/bacterial cellulose microcrystal composites for tissue engineering  applications.  The  Neutral  red  (NR)  assay  was  carried  out  for  cell adhesion and cell  proliferation studies. Attachment and proliferation of HMEC-1 cells on the film were analysed over a period of 1, 4 and 7 days. The standard tissue culture plate was used as the positive control for this experiment. The results of these biocompatibility tests have been summarised in Figure 4.15.    
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Figure 4.15: Cell proliferation study of the seeded HMEC-1 cells on the neat P(3HO) and P(3HO)/25% bacterial cellulose composite film on (a) day 1, (b) 4 and (c) 7 using Neutral Red assay. The data were compared using t-test and the difference were considered significant when *p<0.05. All the tested samples were measured relative to the untreated cells on the tissue culture plate. Untreated cells were set to 100% control (n = 3).    There was a better growth and proliferation of the cells on the composite film as compared to the neat film. At the end of the 1st day, the growth of the cells on the neat P(3HO) film and the P(3HO)/25% bacterial cellulose composite film was comparable. The growth of HMEC-1 on the P(3HO)/25% bacterial cellulose film 











  and  P(3HO) neat  film  was  40±1.8% and  41±1.6% respectively as  compared to tissue culture plastic. However, there was a significant increase in the growth of the cells on the P(3HO)/25% bacterial cellulose composite film as compared to the P(3HO) neat film when analysed at the end of the 4th  day (*p<0.05). The growth of HMEC-1 cells on the P(3HO)/ 25% bacterial cellulose film was 87±1.5% respectively as compared to the neat  P(3HO) film which had 66±2.4 % growth.  At the end of the 7th  day, there was a further significant increase in the growth of the cells on the P(3HO)/ bacterial cellulose composite film as opposed to the cells on the neat P(3HO) film (*p<0.05). The growth of HMEC-1 cells on the P(3HO)/25% bacterial cellulose film was measured to be 104±1.1% as compared to the 71±0.9% of cell growth on the neat P(3HO) film. The cell growth and proliferation on the composite film was 33% higher compared to the neat P(3HO) film at day 7.   
4.10  Scanning Electron Microscopy (SEM)  In this study, the HMEC-1 cells seeded onto the P(3HO)/25% bacterial cellulose composite film was analysed using SEM  as described in  section 2.11.9.4.     The HMEC-1 cells fixed on the composite film at day 4 and 7 are shown in Figure 5.12.   
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Figure 4.16: SEM images of the HMEC-1 cells on P(3HO)/25% bacterial cellulose composite film on day 1 (A1-A2), day 4(A3-A4) and day 7(A5).   The SEM images revealed the adhesion and proliferation of HMEC-1 cells on the surface of P(3HO)/25% bacterial cellulose composite film. 
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Discussion  MCL-PHA  was  produced  by  P.  mendocina, using  sodium  octanoate  as  the  sole carbon source. The %PHA yield at 48 hours obtained in this study was 45.3% which was about 10% higher than the 35% yield reported in the literature (Rai et al., 2011). Higher PHA yield of 62% was achieved by Kim et al., (2002) when P. 
oleovorans was grown on octanoic acid in a fed batch mode versus the batch mode of fermentation used in this study. This finding suggested that the mode of fermentation played a very important role in PHA accumulation (Kim et al., 20007). Organisms are capable of utilising the PHAs produced during carbon limiting conditions in order to sustain growth. This occurs usually in the batch mode when carbon in the media is insufficient unlike the fed batch or continuous fermentation where the media is continually replenished (Rai et al., 2011). Extraction of the polymer from the cells plays a very important role in determining the yield as well as  the  purity  of  the  polymer  (Rai  et  al.,  2011).  Studies  on  different  extraction methods and their effect on the yield and purity of the PHA produced were carried out by Rai et al., which revealed that the dispersion method utilising 80% sodium hypochlorite solution (NaOCl) and chloroform solution (CHCl3) was the most effective in the efficient recovery of the polymer (Rai et al., 2011). PHA produced in this study was confirmed to be P(3HO), which is a homopolymer of 3- hydroxyoctanoic acid using GC-MS and NMR analysis. Bacterial cellulose was also successfully produced by culturing A. xylinum in a static mode. It is known from the literature that the morphology and the mechanical properties of bacterial cellulose is highly dependent on the mode of culturing. Bacterial cellulose pellicles produced via static mode exhibited better mechanical properties compared to that produced using agitated cultures (Ciechanska, 2004). Therefore, in this study, cellulose pellicles were produced on the surface of the production media via static culturing. The bacterial cellulose pellicles were homogenised and subjected to the acetylation reaction   to   increase  its   compatibility   with   the   hydrophobic  P(3HO)   matrix. Previous studies have shown that the modification of bacterial cellulose pellicles by carrying out acetylation reaction makes it increasingly compatible with the other hydrophobic   materials.   During   acetylation,   the   hydrophilic   hydroxyl   groups present in the bacterial cellulose are replaced by the hydrophobic acetyl groups (Kim et al., 2002). Usually, acetyl chloride along with a solvent such as acetic acid is 
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  used in the presence of a catalyst to speed up the acetylation reaction, as reported by Bledzki et al., 2008. In this study, acetic anhydride was added in the presence of acetic  acid  and  perchloric  acid  as  the  catalyst.  Chemical  modification  of  the bacterial cellulose microcrystals using acetic anhydride was chosen for this study due to the ease of the methodology. There are several other methods that can be employed to modify natural fibres which include physical methods such as electric discharge method, mercerization and chemical methods such propionylation, treatment  with  isocyanates  and  the  use  of  organosilanes  as  coupling  agents (Bledzki and Gassan, 1999). The FTIR analysis was used to confirm the acetylation reaction was successful. The  hydroxyl groups in bacterial cellulose were replaced with the acetyl groups. The X ray   diffraction  patterns  indicated  that   there  was  a   decrease  in   the  overall crystallinity of the bacterial cellulose microcrystals due to the acetylation reaction. It is known from literature that chemical modification of bacterial cellulose leads to the disruption of the crystalline regions causing degradation as well as a decrease in the crystallinity (Barud et al., 2008).   Mechanical  characterisation  of  the  P(3HO)/bacterial  cellulose  composite  films were done to investigate the effect of acetylated bacterial cellulose microcrystals on the mechanical properties of the composite films. Previous studies have shown that MCL-PHAs exhibited Young’s modulus values in a range of 3.6 MPa to 600 MPa depending upon the thickness and the monomeric composition of the polymer film (Rai et al., 2011). The ‘E’ values of the neat P(3HO) film obtained in this study were within this range. With the increasing concentration of modified cellulose microcrystals in the P(3HO), there was an in increase in the ‘E’ values of the composite  films.  However,  the  increase  was  not  very  high  indicating  that  the stiffness  enhancement  properties  of  cellulose  were  not  fully  exploited. Soykeabkaew   et   al.,   demonstrated  that     the   incorporation   of   the   cellulose microfibrils within the polymer matrix increased the stiffness of the composite material (Soykeabkaew et al., 2009). This increase would be due to the restricted mobility  of  the  polymer  in  the  presence of  modified  bacterial  cellulose microcrystals (Shumigin et al.,  2011).    Polycaprolactone  (PCL) when  reinforced with 3% of modified microfibrilliated cellulose (MFC) exhibited an increase in the Young’s modulus value up to 60%. The authors attributed this drastic increase to the excellent interaction between the polymer matrix and the cellulose fibrils at 3% 
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  concentration of MFC (Siqueiria et al., 2010). Cheng et al., demonstrated that there was  an  increase  in  the  Young’s  modulus  of  the  polyvinyl  alcohol  (PVA)  and propylene when reinforced with fibril aggregates isolated from cellulose fibres. However, the increase was not very high. They hypothesized that this could be due to several factors such as poor adhesion between the fibrils and the polymer matrix, poor dispersion of the fibrils in the matrix or the aspect ratio of the polymer (Cheng 
et al., 2007). There was an increase in the tensile strength of the P(3HO)/bacterial cellulose composite films compared to the neat P(3HO) film. However, the increase was  not  as  high  as  expected.  Therefore,  it  can  be  concluded  that  the  tensile properties  of   the   acetylated   bacterial   cellulose   microcrystals  were   not   fully exploited in the composites. This could be due to the heterogeneous dispersion of the modified bacterial cellulose microcrystals in the P(3HO) matrix which led to the formation of weak points (Siqueiria et al., 2010). This may be improved in future, by better modification of the bacterial cellulose microcrystals to achieve uniform dispersion of the bacterial cellulose within the P(3HO) matrix.    Shumigin et al., demonstrated that there was a decrease in the tensile strength of the PLA/cellulose composites with the increase in the concentration of bacterial cellulose within the composite film. They stated that this decrease in the tensile strength was due to the irregular aligning of the cellulose composites in the PLA matrix and poor adhesion between the filler and the matrix leading to formation of numerous microflaws in the composite structure, thereby causing inefficient stress transfer between the matrix and the cellulose fillers (Shumigin et al., 2011). Similarly when styrene– butadiene rubber (SBR)/α-cellulose composite were tested for their mechanical properties, there was a decrease in the tensile strength with increase in the filler concentration (Haghighat et al., 2005). These results indicate that the filler-polymer interaction is crucial to achieve good mechanical properties in composites. This can be achieved by good processing methodology. According to the literature, it is known that the % elongation at break values for  MCL-PHAs range between 6.5 to 350% (Asrar et al., 2002). The value obtained for the neat P(3HO) film in this study was within this range. The elongation at break values of the P(3HO)/bacterial cellulose composites were lower compared to the neat P(3HO) film.  Hence, as expected, there was a  decrease in  the elastomeric properties of the composite film due to the addition of the acetylated cellulose microcrystals. There was a similar decrease in the % elongation at break value of the PCL/modified cellulose nanocrystals composite film with the addition of 12 wt% 
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  of modified cellulose nanocrystals within the PCL matrix (Siqueiria et al., 2010). Another study also similarly demonstrated a decrease in the % elongation at break values of the poly(styrene-co-butyl acrylate)/MFC composites with the addition of MFC as a reinforcing agent. The authors attributed this decrease to the filler/filler entanglement causing poor dispersion of the filler in the polymer matrix (Dalmas et 
al., 2006). Hence, overall, the results in the context of mechanical properties suggested that the interaction of the acetylated bacterial cellulose microcrystals with P(3HO) has led  to  some  improvement in  mechanical properties but  in  future,  further work would be needed to achieve even better improved mechanical properties by modification of the processing methodology and ensuring higher degree of acetylation of the cellulose. Thermal characterisation was carried out on the P(3HO)/bacterial cellulose composite films as well as on the neat P(3HO) film to determine the effect of the acetylated bacterial cellulose microcrystals on the thermal properties of the composite film. There was a decrease in the Tm values of the composite films compared to the neat P(3HO) film. This decrease in the Tm could also be due to the disruption of the crystalline region of the polymer by the acetylated bacterial cellulose microcrystals (Siqueiria et al., 2010). There was an increase in the Tg values of the of the composite films compared to  the neat P(3HO) film. The increase was not statistically significant. However, the presence of the acetylated bacterial cellulose microcrystals would restrict the mobility of the amorphous region in the polymer increasing the Tg values. A similar observation was made when modified fibrillated cellulose nanoparticles were used to reinforce PCL. The authors stated that this increase in the Tg occurred when the molecular mobility of the amorphous region of the polymer matrix was restricted due to the addition of the fillers (Siqueiria et al., 2010). Water contact angle studies were carried out to investigate the effect of acetylated bacterial  cellulose  microcrystals on  the  wettability  of  the  composite  films.  The presence of acetylated bacterial cellulose microcrystals lowered the contact angle of the P(3HO)/5% cellulose  and P(3HO)/25% cellulose composite films compared to  the  neat  P(3HO)  film.  Also,  the  higher  hydrophobicity  of  the  P(3HO)/15% cellulose  composite film  as  compared to  the  neat  P(3HO)  film was quite  an unusual result. This was possibly due to the fact that at this specific concentration (15%), the cellulose remains within the interior of the 2D-film as compared to the 5% 
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  and 25% cellulose composites, resulting in higher hydrophobicity of the surface of the 2D film. Based on these preliminary data, P(3HO)/25% bacterial cellulose composite films with  the  highest  Young’s  modulus  value  and  a  relatively  higher  hydrophilicity, known to favour cell adhesion, was chosen for further characterisation. Microstructural  studies  were  carried  out  to  investigate  the  effect  of  bacterial cellulose  microcrystals  on  the  surface  topography  of  the  composite  film.  SEM studies  revealed  a  rough  topography  of  the  P(3HO)/25%  bacterial  cellulose composite film compared to the smooth surface of the neat P(3HO) film. This could be most likely due to the presence of acetylated bacterial cellulose microcrystals dispersed on the surface of the P(3HO) film. It is known from literature that the arrangement  of  the  crystalline  and  amorphous  domain  on  the  surface  of  the composite film determines its morphology (Luo et al., 2009). Rai et al., demonstrated that there was a change in the surface topography of the P(3HO)/n-BG  composite  film  due  to  the  addition  nanobioactive  glass  (n-BG) particles within the P(3HO) matrix. The authors attributed the rough topography of the P(3HO)/n-BG composite film to the presence of  n-BG particles on the film-air interface (Rai et al., 2011). In order to confirm the change in the surface topography, the surface roughness of  the composite film were measured using the White Light Interferometry. The result was compared with the surface roughness values of the neat P(3HO) film. The increase in the surface roughness of the composite film was due to the presence of acetylated bacterial cellulose microcrystals on the surface. This could be due to the exposure  of  the  modified cellulose  microcrystals on  the  surface  of  the  P(3HO) matrix due to heterogeneous distribution of the former within the P(3HO) matrix. The finding of this study is supported by the results demonstrated in the previous studies. Siqueiria et al., observed that there was no change in the surface roughness of the cellulose/polycaprolactone composite film when modified cellulose whiskers were uniformly or homogenously dispersed within the polycaprolactone matrix, (Siqueiria et al., 2010). Previous studies have shown that surface roughness, hydrophilicity and total protein adsorption, which is crucial for cell adhesion, are interrelated. Therefore, surface roughness is known to play a significant role in cell adhesion and proliferation process (Hao and Lawrence, 2004). The increase in the surface  roughness  of  the  P(3HO)/25%  bacterial  cellulose  composite  film  is 




  therefore  an  encouraging  result  for  the  use  of  the  composite  films  as  tissue engineering scaffolds. Another characterisation that was carried out on the composite as well as the neat P(3HO) film were total protein adsorption assay. This was carried out in order to assess  the  effect  of  the  bacterial  cellulose  microcrystals  on  the  total  protein adsorption. The increase in protein adsorption on the composite film compared to the neat P(3HO) film could be due to the increase in the surface roughness  of the composite  film.  Previous  studies  have  shown  that  there  is  increased  protein adsorption on a rough surface compared to the smooth, flat surface (Chen et al., 2009). Protein adsorption plays a key role in determining the biocompatibility of a  biological implant. Failure of protein adsorption on the implant could lead to inflammatory responses (Das et al., 2007). Therefore, this increase in the total protein adsorption on the P(3HO)/25% bacterial cellulose composite film would make these film highly suitable for biomedical applications.   Cell culture studies were carried out to determine the effect of the presence of the acetylated cellulose microcrystals on  the  adhesion and  the  proliferation of  the HMEC-1 cells on the P(3HO)/25% bacterial cellulose composite film compared to the neat P(3HO) film.   According to literature, it is known that increased protein adsorption enhances cell adhesion and proliferation processes (Das et al., 2007). Gentile et al., demonstrated an increase in the cell growth when grown on rough topography compared to the smooth surface. This could also be another reason for the increased cell proliferation in the P(3HO)/25% bacterial cellulose microcrystals composite as  compared to  the  neat  P(3HO) film  (Gentile  et al.,  2010). Similar observations were made by other researchers where there was an increased cell proliferation on the P(3HO)/n-BG and P(3HB)/n-BG composites respectively, in comparison to the neat polymer film. The authors attributed this increase in the % cell proliferation on the composite film to the increase in the surface roughness (Rai  et  al.,  2010;  Misra  et  al.,  2008;  Gentile  et  al.,  2010).  Hence,  the  rough topography  followed  by  increased  protein  adsorption  due  to  the  addition  of bacterial  cellulose  resulted  in  enhanced  biocompatibility  of  the  P(3HO)/25% bacterial cellulose composites. SEM images of the HMEC-1 cells on the P(3HO)/25% bacterial   cellulose   composite   film   confirmed   the   biocompatibility   of   these composite film. These results suggested the fact that these P(3HO)/25% bacterial cellulose composites were suited for biomedical applications. 




  Another important characterisation that was carried out on the composite film was the in vitro degradation study. Biodegradability is considered to be a significant feature of a biomaterial with potential medical application (Li and Shimizu, 2007). It was found that the inclusion of the acetylated bacterial cellulose microcrystals in the P(3HO) film increased the degradation rate of the composite film in comparison to the neat P(3HO) film in both PBS and DMEM media. Previous studies have shown that there is a correlation between the water absorption and the progressive degradation of the polymer film (Holland et al., 1987). This was in agreement with the finding in this study where highest %WL in the P(3HO)/25% cellulose microcrystals had the highest % WA  compared to  the neat P(3HO) film  in  both DMEM and in the PBS media. Rai et al., demonstrated an increase in the %WL for the P(3HO)/nBG composite film compared to the neat P(3HO) film due to the addition of nBG particles within the matrix at the end of 4 month degradation study. Considering the fact that these composite as well as the neat P(3HO) film were incubated in the non- enzymatic media, the degradation occurred via hydrolysis. It is known from the literature that during hydrolytic degradation, water molecules initially attack the amorphous region of the polymer followed by the crystalline regions of the polymer which then gets degraded forming monomers and dimers (Volova and Volova, 2004). This was confirmed by measuring the pH of the DMEM and the PBS at the end of the one month degradation study. There was an increase in the pH which could possibly be due to the degradation of the amorphous regions of the P(3HO) resulting in the production of 3-hydroxyoctanoic acid or 3- hydroxyoctanoate. The pKa for 3-hydroxyoctanoic acid, which is the degradation product of the P(3HO) is 4.89 which is lower than the pH of DMEM and PBS media (pH 7.0), therefore 3-hydroxyoctanoic acid exists as 3-hydroxyoctanoate in these media, which is a base, causing an increase in the pH of the media (Rai et al., 2011). These  results  indicated  that  the  weight  loss  of  the  samples  was  due  to  the hydrolytic degradation of the amorphous region of P(3HO). The mechanical characterisation of the degrading composite film was carried out to investigate the effect of the degradation on their mechanical properties. The results were quite unexpected. The Young’s modulus values of the degrading samples were higher than the non-degraded samples. This was possibly due to the ageing process of   the   PHAs   during  which  the   amorphous  region  of   the   polymer  becomes crystallised thereby causing an increase in the E values or the stiffness of the degrading film (Hutchinson et al., 1995). 




  In conclusion, P(3HO)/bacterial cellulose composites with improved mechanical microstructural and  biodegradability properties were  successfully produced. Further improvement in the method of fabrication of this composite film, better mechanical properties can  be achieved. The cell culture data obtained from this study revealed promising results by demonstrating good cell growth and proliferation on the composites making them suitable for medical applications such as scaffolds for tissue engineering. 
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INTRODUCTION  Cardiovascular disease is responsible for a significant number of deaths in the developed world (Kurowska-Nouyrigat and Szumbarski, 2009).   According to the estimates of the World Health Organization (WHO), cardiovascular disease will be responsible for the highest rate of morbidity and death by the year 2020 (Bogaert and Dymarkowski, 2005). Coronary artery disease (CAD) is a type of cardiovascular disease  where  a  coronary  artery  is  blocked  or  narrowed  due  to  the  plaque formation within the vessel affecting the normal blood flow. This in turn causes inadequate supply of oxygen to other parts of the heart leading to heart attack (Kurowska-Nouyrigat  and  Szumbarski,  2009).  Percutaneous  Transluminal Coronary Angioplasty (PTCA) has been widely used to treat the patients suffering from CAD (Kastrati et al., 2000). PTCA is a minimally invasive procedure where a catheter mounted with a balloon at its tip is directed into the blocked artery. The balloon is inflated at the site of blockage to widen the narrowed artery (Basnett and Roy, 2010). A major breakthrough was achieved with the use of coronary stent in 1986 to address the limitations of conventional PTCA such as vessel renarrowing (Kastrati et al., 2000). A stent is an implant that is guided using a catheter into the diseased or narrowed coronary artery to restore its function. In the recent years, stents have undergone a rapid evolution from the bare metal stents to polymer coated, drug eluting, biodegradable metallic stents, to the fully biodegradable polymeric stents.  Studies have shown that biodegradable stents are less obtrusive compared to metal stents that are known to cause injury to the artery during its placement that later result in restenosis. Restenosis is the reoccurrence of the blockage after the stent is placed  within the artery. Three factors that  lead  to  restenosis include (a) stent injury which could occur during the implantation (b) incompatibility of the stent material with the blood components causing inflammatory response followed by a cascade of events leading to neointimal thickening and (c) smooth muscle cell proliferation caused due to local wall shear stress (Basnett and Roy, 2010). Biodegradable stents  have  several  advantages  compared to  these  metal  stents. They are made up of biocompatible polymers which degrade in to non-toxic degradation products. However, a major disadvantage that has hindered the commercialization of  these  biodegradable stents  is  their  poor  mechanical properties (Basnett and Roy, 2010; Cantor et al., 2000). 




  PHAs are attractive materials for biomedical applications because of their natural origin, enhanced biocompatibility and biodegradability. They can be classified as short chain length (SCL) and medium chain length (MCL) PHAs depending on the total number of carbon atoms present in their monomeric units. Their properties vary depending on the type. SCL-PHAs are brittle, have high melting temperature and crystallinity whereas MCL-PHAs are elastomeric in  nature  and have a  low melting  temperature and low  crystallinity (Valappil  et al., 2007). Based on  the nature of the application, desired characteristics can be attained by making blends of PHAs and composites with various organic and inorganic additives (Kim et al., 2007). It is known that polymer blends are developed to tailor the bulk as well as  the surface properties of the individual polymers based on the desired application (Zhang, 1999). Blending has several advantages over co-polymerization techniques. The main advantage of the blending approach is the ease of the processability, reduced costs and optimum properties (Ha and Cho, 2002).  This study is divided into three parts. In the first part of this study, P(3HB) was successfully produced by B. cereus using Kannan and Rehacek media. P(3HO) and P(3HB)  blends  with  intermediate properties were  developed and  characterised. The production of these novel blends with tailored desirable properties was aimed for their use as a base material in the development of a biodegradable coronary stent. These blend films were characterised with respect to their mechanical, thermal, surface and microstructural properties. Degradation and biocompatibility studies were carried out on the blend films containing various ratios of P(3HO) and P(3HB)  In the second part of this study, surface micropatterning of the P(3HO)/P(3HB)  50:50 blend film using Laser microcutting technique was carried out. Surface topography of a biomaterial plays an important role in their biocompatibility. It strongly affects the nature of the interaction between the biomaterial and the biological host. Surface topography dictates cell adhesion, differentiation and cell morphology. From literature, it is known that medical applications require a biomaterial to have a positive interaction with the cells. Therefore, biodegradable stents would require the chosen biomaterials to be compatible with the vascular endothelial cells (Li et al., 2001; Duncan et al., 2007; Anderson and Hinds, 2011). Endothelial cells form the inner lining of the blood vessel wall. They act as an interface between the components of blood and the vessel wall. Endothelial cell 




  dysfunction leads to vascular diseases such as atherosclerosis (Kidd et al., 2003). Previous studies have shown that the shape and the orientation of the endothelial cells within the artery were regulated by blood flow. It was observed that the endothelial cells within the arteries were aligned along the axis of the vessel maintaining  their function  (Langille  and  Adamson,  1981).  It  is  known  that  the shape and the alignment of the endothelial cells play a key role in the occurrence of artherosclerotic lesions. The development of artherosclerotic lesions occurs in the arterial region where the endothelial cells display a round morphology. No such occurrence was recorded in the arterial region with elongated and aligned endothelial cells. It is known that the function of endothelial cells is regulated by the cell shape (Gray et al., 2002). Endothelial cells, when cultured in a static mode or in an environment with a multi directional or disturbed flow reveal cobblestone morphology which is attributed to a thrombogenic phenotype. On the contrary, the endothelial cells when cultured under oriented or unidirectional flow exhibit elongated morphology with a healthy phenotype (Anderson and Hinds, 2011).   In order to improve biocompatibility, it is crucial for the cells to grow in an oriented manner to form tissues of specific architecture (Li et al., 2001). Therefore, surface modification or fabrication of the biomaterials to encourage the cells to grow in an aligned manner has been investigated for several years.  One of the most promising technologies used in the surface fabrication of the biomaterials is micropatterning. Most commonly used micropatterning techniques include microcontact printing, photo patterning and most recently laser micropatterning (Thery, 2010).  Micropatterning allows the cells to be exposed to a physiologically relevant environment compared to the traditional cell culture conditions. It also makes it possible to interfere or control cell behaviour in the absence of the flow which is a great step forward in regenerative medicine. The response of the cells to the engineered surface of the biomaterial enables one to understand cell behaviour during its growth and differentiation. Using micropatterning, one could guide the attachment, proliferation and alignment, thereby controlling the phenotypic characteristics of the cells (Anderson and Hinds, 2011).  Bearing  in  mind,  the  potential  application  of  the  P(3HO)/P(3HB) 50:50 blend films as a platform material for the development of biodegradable stents, Human  microvascular  endothelial  cells  (HMEC-1)  were  grown  on  the micropatterned P(3HO)/P(3HB) 50:50 blend  films  under  static  conditions. The 




  influence of the laser micropatterning on the microstructural and the mechanical properties of the P(3HO)/P(3HB) 50:50 blend films were examined. The % cell proliferation and the orientation of the HMEC-1 cells on the micropatterned P(3HO)/P(3HB)  50:50  blend  films  were  compared  with  that  on  plain P(3HO)/P(3HB) 50:50 blend films.  In the final part of this study, the potential of the P(3HO)/P(3HB) 50:50 blend films as the base material for the development of drug eluting biodegradable stents with controlled delivery of aspirin was investigated. One of the most desirable characteristics of an ideal biodegradable stent is its ability to deliver drugs (Moore 
et al., 2010). Numerous attempts have been made to develop an efficient drug delivery system to prevent restenosis (Faxon, 2002). One of the major difficulties in developing an efficient pharmacotherapeutic regime to prevent restenosis via systemic administration is their inability to deliver a drug concentration that triggers a pharmacological response. Local drug delivery has been considered to be key in addressing the limitations of systemic drug administration. With local drug delivery, there would be no systemic toxicity and the drug would be delivered locally at a concentration to evoke a pharmacological response combined with drug release kinetics required for the vascular healing process (Basnett and Roy, 2010). For  this  particular  study,  aspirin  was  chosen  as  the  model  drug.  Aspirin  is  commonly used to achieve relief from pain and fever. However, the most significant property of aspirin is its antithrombotic activity. Previous studies have shown that thrombus formation plays an important role in the initial stages of neointimal thickening leading to restenosis (Basnett and Roy, 2010). The principle behind the anti-thrombotic effect of aspirin is that it inhibits thrombooxygenase A2, a strong inducer of thrombus formation, thereby reducing platelet aggregation. Because of its anti-thrombotic property, aspirin is an important drug used to prevent cardiovascular   events   such   as   myocardial   infarction.   One   of   the   problems associated with the conventional oral dosage of aspirin is that it has a poor oral bioavailability. This makes it extremely challenging to deliver a concentration that triggers a pharmacological response. Studies have shown that the prolonged use of aspirin in the form of oral dosage leads to a number of side effects such as gastrointestinal  (GI)  mucosa  ulcer  and  GI   haemorrhage.  Clinical  trials  have 




  established that a low dose local delivery of aspirin would strongly improve the therapeutic efficacy of the drug (Tang and Singh, 2008). Therefore, the main focus of this part of the study was to investigate the potential of the P(3HO)/P(3HB) 50:50 blend films as the base material for the development of drug eluting biodegradable stents with controlled delivery of aspirin. 
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Part I   
Production of  P(3HO)/P(3HB) blends for the development of biodegradable 
stents    
5.0 RESULTS  
5.1 Production of P(3HB)   P(3HB) production was carried out using  B. cereus SPV in Kannan and Rehacek media,  as  described  in  section  2.8.  Analytical  studies  such  as  O.D.  and  pH measurements,   nitrogen   and   biomass   estimation   were   done   using   samples withdrawn at an interval of 3 hours, as described in section 2.5. The growth profile of Bacillus cereus SPV in Kannan and Rehacek media for the production of P(3HB) is shown in Figure 5.1.     
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Figure 5.1: The fermentation profile of P(3HB) production using Bacillus cereus  SPV in Kannan and Rehacek media.   Optical density (O.D.), pH, nitrogen concentration and biomass estimation was carried out for the samples withdrawn at intervals of every 3 hours. From the O.D. values measured at 600 nm, there was a steady increase in cell growth from the initial hours of fermentation indicating that there was no lag phase. The O.D. values increased exponentially, reaching a value of 8.9 at 60 hours of fermentation. This 
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  was considered to be the log phase. After this, the cells entered stationary phase where  there  was  no  further  increase  in  the  O.D.  Dry  cell  weight  of  the  cells increased progressively reaching a maximum value of 9 g/L at 60 hours after which there was no further increase. This could be explained in relation to the O.D. values which increased until 60 hours after which there was no increase as the cells had entered stationary phase. Nitrogen concentration decreased throughout the fermentation reaching a value of 0.0009 g/L at 57 hours.   pH was not controlled during fermentation and the values were observed to decrease progressively from the 6th   hour of fermentation reaching a pH value of 4.9 at the end of the fermentation. A maximum PHA yield of 48% dry cell weight was obtained at 72 hours. In this study, P(3HB) production was carried out in a nitrogen limiting condition. The decrease in pH, reaching acidic levels, during P(3HB) production has been previously observed by Philip et al., 2007. This acidic pH is known to protect the degradation of P(3HB). Since, P(3HB) is degraded to 3-hydroxybutyric acid, its degradation under acidic pH conditions is inhibited according to the law of mass action. Apart from preventing the degradation of P(3HB), this low pH environment also prevents spore formation in B. cereus (Kominek and Halvorson, 1965). According to a study conducted by Browne and Dowds, 2002, B. cereus cells in their log phase are more sensitive to the acidic stress and become increasingly resistant as they enter stationary phase. Hence, the pH adjusted to 6.8 at the start of the fermentation promotes cell growth during log phase, when the cells are sensitive to acidic stress. The polymer produced during fermentation was analysed using FTIR and Gas Chromatography.    
5.2 Characterisation of the polymer produced  
5.2.1 Fourier Transform Infrared Spectroscopy (FTIR)  The polymer that was produced by B. cereus SPV using Kannan and Rehacek media was characterised using FTIR, as described in section2.6.1. The IR spectrum of the polymer produced is shown in Figure 5.2. 







Figure 5.2: FTIR spectrum of the polymer produced by Bacillus cereus SPV using  Kannan and Rehacek media.   The IR spectrum of the polymer showed the presence of two characteristic absorption peaks present in the SCL-PHAs such as 1719 cm-1 corresponding to the ester carbonyl group and the absorption peak at 1282 cm-1 corresponding to the –CH2 group. This confirmed that the polymer produced was a type of SCL-PHA. The  polymer was further characterised using GC.   
5.2.2 Gas Chromatography (GC)  The SCL-PHA produced was further analysed using the Gas chromatography. The polymer was methanolysed to obtain methyl esters as described in section 2.6.2. The gas chromatogram of the methanolysed polymer is shown in Figure 5.3.  
 
 
Figure 5.3: The Gas chromatogram of the methyl esters of 3-hydroxybutyric acid. 




  A peak with the retention time (Rt) of 5.47 corresponded to the methyl ester of  3-hydroxybutyric acid (3HB) while the peak with retention time (Rt) of 9.9 corresponded to methyl benzoate which was added as the internal standard (Rai et 
al., 2011). This confirmed that the polymer produced by B. cereus SPV using Kannan and Rehacek media was P(3HB).  
5.3 Synthesis of the novel P(3HO)/P(3HB) blends  P(3HO)/P(3HB) blends with varying compositions such as 20:80, 50:50, 80:20 and neat P(3HB) films were synthesized using the solvent cast technique. P(3HO) and P(3HB) were dissolved in chloroform in order to obtain a polymer concentration of 5wt% in ratios of 80:20, 50:50 and 20:80. The polymer solution was mixed well by  sonication and then cast in a glass petri dish. The film was air dried for one week. Films of 0.18mm thickness were produced. The surface of the film exposed to air was used for analysis. These blend films were then characterised with respect to their microstructural, thermal and mechanical properties and compared with the properties of the neat P(3HO) film.    
Characterisation of the P(3HO)/P(3HB) blend films 
5.4 Scanning Electron Microscopy:  Microstructural studies of these P(3HO)/P(3HB) blend films were carried out using SEM as described in section 2.9.1. This study was carried out to investigate the effect of the varying proportions of P(3HB) on the  surface properties of the blend films.  The  surface  properties  of  these  blend  films  were  then  compared to  the surface of the neat P(3HO) film as shown in Figure 5.4. 
































Figure 5.4: SEM images of the P(3HO)/P(3HB) blend films revealing a change in their surface topography with the addition of P(3HB) in comparison to the neat P(3HO) film. (a) neat P(3HO) film, (b) P(3HO)/P(3HB) 20:80 (c)  P(3HO)/P(3HB) 50:50 (d) P(3HO)/P(3HB) 80:20 blend films (e) P(3HB) film. Scale bars = 60 µm.  The surface properties of the blend film changed with the varying proportions of P(3HB). The SEM images of the  neat P(3HO) film revealed a smooth surface while the  blend   films  with  increasing  concentration  of  P(3HB)  revealed  a   rough 










  topography.  P(3HO)/P(3HB) 80:20 blend film which had the highest concentation of P(3HO) and the P(3HO)/P(3HB) 50:50 blend film appeared to have a relatively smoother surface whereas P(3HO)/P(3HB) 20:80 blend which had the highest concentration of P(3HB) appeared to have a rough topography.   Overall, the SEM images revealed that a new level of surface topography was introduced with the incorporation of P(3HB) in the P(3HO) matrix. These blend films were further characterised using Atomic Force Microscopy (AFM).  
5.5 Atomic Force Microscopy (AFM)  To evaluate the effect of varying proportions of P(3HB) on the surface roughness of the blend films, AFM was used to measure their surface roughness values as described in section 2.9.3. The surface roughness of these blend films were then compared with the neat P(3HO) film. Typical root mean square (rms) values were calculated to determine the surface roughness of these blend films as shown in 
Figure 5.5.                 
(a) (b)                
(c)  
Figure 5.5: The AFM images of the (a) P(3HO)/P(3HB) 80:20 (b) P(3HO)/P(3HB)  50:50 blend film and (c) neat P(3HB) film. Scan size: 50 µm. The surface of the film exposed to air was used for the analysis. 






  AFM images of the P(3HO)/P(3HB) blend films confirm the increase in the surface roughness with the increase in the P(3HB) content. From previous studies, it has been found that the roughness value of the neat P(3HO) film is 0.272 µm. The rms value of the P(3HB) film was calculated to be 0.24 ± 0.10 µm. The rms values of the P(3HO)/P(3HB) 50:50 blend were found  to be 0.59 ± 0.02 µm and the rms values of P(3HO)/P(3HB) 80:20 blend were found to be 0.58 ± 0.04 µm. The surface roughness  of  the  P(3HO)/P(3HB) 50:50  and  P(3HO)/P(3HB) 80:20  blend  films were  found  to  be  118%  and  114%  higher  respectively  compared  to  the  neat P(3HO) film. Due to highly increased roughness of the P(3HO)/P(3HB) 20:80 blend film, it was not feasible to measure its roughness values using the AFM. In future, White Light Interferometry studies could be carried out to measure its surface roughness. These results confirmed that there was an increase in the surface roughness of the blend films compared to the neat P(3HO) film.  
5.6 Water contact angle  Water contact angle studies were carried out to study the effect of the different concentrations of P(3HB) on the wettability of the blend films as described in 
section 2.9.4. The results were compared to the wettability properties of the neat P(3HO) films are shown in Figure 5.6.                             
Figure     5.6:     Static     water     contact     angle     measurements    of     the     neat  P(3HO),P(3HO)/P(3HB) blend films and neat P(3HB) film(n = 3; error bars = ± SD). 




  The data were compared using ANOVA and the difference were considered significant when *p<0.05.   Hydrophobicity was significantly decreased in P(3HO)/P(3HB) blend films in comparison to the neat P(3HO) film (*p<0.05). The water contact angle of the P(3HO)/P(3HB) 80:20,    P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 20:80 blend films were 88.9±0.3, 89.5±0.8, and 81.1±1.5 respectively compared to the water contact angle of the neat P(3HO) film which was measured to be 92.0±1.0. The neat P(3HO) film   as well as the blend films were hydrophobic in nature. There was a decrease in the hydrophobicity of the blend films with the increase in the concentration of the P(3HB) within the film. However, there was a surprising result where P(3HO)/P(3HB) 50:50 had a higher contact angle compared to the P(3HO)/P(3HB) 80:20. The results confirmed that the blend films were comparatively hydrophilic cpompared to the neat P(3HO) film.   
5.7 Protein Adsorption Test  Surface characterisation of these blend films confirmed the change in the surface topography, roughness and the wettability properties due to the addition of varying proportions of P(3HB) in the film. In order to evaluate the effect of these changes on the total protein adsorption on the blend films, an assay was carried out to quantify the total protein adsorption as described in section2.9.7. The results of the total protein adsorption is shown in Figure 5.7. 






                             
Figure  5.7:  Protein adsorption of  the neat  P(3HO), P(3HO)/P(3HB) blend  films and neat P(3HB) film (n = 3; error bars = ± SD). P(3HO)/P(3HB) 20:80 which has the highest P(3HB) content exhibits highest protein adsorption compared to the neat P(3HO) film. The data were compared using ANOVA and the difference were considered significant when *p<0. 05.  The overall protein adsorbed on to the neat P(3HO) film was 318 ± 1.0 µg/cm2  which was lower compared to the total protein adsorbed on to the P(3HO)/P(3HB)  80:20,  P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 20:80 blend films which were  527±2 µg/cm2, 400±1 µg/cm2  and 650±4 µg/cm2  respectively. Protein adsorption on the neat P(3HB) film was 414±3 µg/cm2 . The protein adsorption was 65%, 25% and 104% higher in the P(3HO)/P(3HB) 80:20, P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 20:80 blend films respectively in comparison to the neat P(3HO) film. The increase in protein adsorption was statistically significant (*p<0. 05)  
5.8 Indirect Cytotoxicity Assessment  To investigate the effect of the substances released from the blend films on the HMEC-1 cells, indirect cytotoxicity assessment was carried out as described in 
section 2.9.8. Bearing in mind, the potential application of these P(3HO)/P(3HB) blend films as the base material for the development of biodegradable stents, an endothelial cell line was selected for this study. The negative control for this experiment  was  the  cells  grown  in  DMEM  in  the  absence  of  polymer  and  the positive control was the cells grown in the presence of 4% hydrogen peroxide, 






  which     is     known     to     induce     cell     death     as     shown     in     Figure     5.8.                               
Figure 5.8: Indirect toxicity assessment of P(3HB)/P(3HO) blend films (n = 3; error bars = ± SD). All the tested samples were measured relative to the untreated cells on the tissue culture plate and the untreated were set to 100%.    The data were compared using ANOVA and the difference were considered significant when *p<0. 05.   The % cell viability observed in the P(3HO)/P(3HB) 80:20,   P(HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 20:80 blend films were 111.1±1.3%, 98.9±1.5%, 133.3±0.9% compared to the % cell viability of 55.5±3.1% in the neat P(3HO) film The % cell viability in the positive control was    8±1.6% and in the neat P(3HB) film was 96.6±0.8%. The highest percentage of cell viability was observed with the P(3HO)/P(3HB) 20:80 blend film containing the highest amount of P(3HB). The increase in the % cell viability in the  P(3HO)/P(3HB) compared to the neat P(3HO) film were statistically significant (*p<0. 05). The assessment suggested that no cytotoxic degradation products were released from the blend films.  
5.9 Thermal properties  Thermal characterisations of the blend films were carried out to investigate the thermal stability of the blend films as a function of the temperature. Thermal properties such as melting temperature (Tm), glass transition temperature (Tg) and crystallization   temperature   (Tc)   were   measured  using   Differential  Scanning 




  Calorimetry (DSC) as described in section 2.9.6. The results of the thermal analysis  are summarised in Table 5.1.    
Samples Tm (°C) Tg (°C) Tc (°C) P(3HO) 51.8 ± 0.2 -34.0 ± 0.8 - P(3HB)/P(3HO) 
 20:80 150.3 ± 0.1 -13.3 ± 0.3 61.0 ± 0.1 P(3HB)/P(3HO) 
 50:50 159.5 ± 0.1 11.9 ± 0.1 98.5 ± 0.3 P(3HB)/P(3HO) 
 
 80:20 166.4 ± 0.3 16.3 ± 0.1 102.7 ± 0.3 P(3HB) 170.3 ± 0.0 10.0 ± 0.0 109.5 ± 0.0 
 
 
Table 5.1: Thermal Analysis of the neat P(3HO), P(3HO)/P(3HB) blend films and neat P(3HB) film (n = 3).  There was an increase in the glass transition temperature (Tg) with the increase in the  amount  of  P(3HB) in  the  blend  films.  A  similar  trend was  observed in  the melting temperature (Tm) of the blend films. There was an increase in the Tm of the blend films with the increase in the amount of P(3HB) in the blend film. The crystallization temperature (Tc) also increased with increasing P(3HB) content in the film. P(3HB)/P(3HO)   80:20 blend film with the highest amount of P(3HB) concentration had the highest value of Tg, Tm and Tc. The results demonstrated that the presence of P(3HB) increased the thermal stability of the blend films.   
5.10 Dynamic Mechanical Analysis  Mechanical properties of the blend films such as tensile strength, Young’s modulus (E   values)   and   elongation   at   break   values   were   measured   using   Dynamic Mechanical Analysis (DMA) as described in section 2.9.5. 













P(3HO) 1.50 ± 0.01 1.80 ± 0.05 204.05 ± 0.02 P(3HB)/P(3HO) 
 20:80 28.03 ± 0.75 6.01 ± 0.01 58.70 ± 0.15 P(3HB)/P(3HO) 
 50:50 78.50 ± 0.01 7.80 ± 0.03 22.90 ± 0.05 P(3HB)/P(3HO) 
 80:20 84.60 ± 0.40 7.50 ± 0.03 10.10 ± 0.01 
Table 5.2: Mechanical analysis of the neat P(3HO) and P(3HO)/P(3HB) blend films  (n = 3).   This  was  carried  out  to  understand  the  effect  of  P(3HB)  on  the  mechanical properties of the blend films. The results have been summarised in Table 5.2. The Young’s Modulus values increased with the increase in the concentration of P(3HB) in the blend film. The E values of the blend films were higher than the E values of the  neat  P(3HO) which  is  1.5  MPa.  The  Young’s  modulus  value  of  the P(3HB)/P(3HO) 80:20 blend film which has the highest concentration of P(3HB) was 5540% higher compared to  the neat  P(3HO) film.  The Young’s  Modulus of values of the other blend films such as P(3HB)/P(3HO) 50:50 and P(3HB)/P(3HO) 20:80 were 5133% and 1766% higher compared to the neat P(3HO) film.   The tensile strength of the P(3HO)/P(3HB) blend films were higher compared to the neat P(3HO) film. The tensile strength of blend films such as P(3HB)/P(3HO) 20:80 blend film, P(3HB)/P(3HO) 50:50 and P(3HB)/P(3HO) 80:20 were 300%,  420%  and  400%  higher  than  the  neat  P(3HO)  film  respectively.  However,  the tensile strength of the P(3HB)/P(3HO) 80:20 blend film which has the highest concentration of the P(3HB) content was slightly lower compared to the P(3HO)/P(3HB) 50:50 blend film. Elongation at break value, which is the measure of  the  elastomeric  properties of  the  films  was  also  measured  using  DMA.  The results  obtained  showed,  as  expected,  a  drastic  decrease  in  the  elastomeric 








  properties of the blend films with an increase in the concentration of P(3HB) when compared  to   the  neat   P(3HO)  film.   The  elongation  at   break  value   of  the P(3HB)/P(3HO) 80:20 blend film which has the highest concentration of the P(3HB) content was 95% lower compared to the neat P(3HO) film. The elongation at break values of the other blend films such as P(3HB)/P(3HO) 50:50 and P(3HB)/P(3HO) 20:80 were 88% and 71% lower than the elongation at break value of the neat  P(3HO)  film.  The  mechanical  properties  of  the  neat  P(3HB)  film  could  not  be measured using DMA due to its high Young’s Modulus value which  
5.11 In vitro degradation study  The film samples incubated in DMEM  and PBS were characterised as described below to find out the changes that occurred during degradation.  
5.11.1 Water absorption and weight loss measurements  Percentage of water absorbed (%WA) and weight loss (%WL) during the degradation of the films were measured for one and four months as described in 
section 2.10. The result of the one month study is presented in Figure 5.9 (a), (b), (c) and (d).                      
(a) (b) 








                      
(c) (d)   
Figure 5.9:  Water absorption by the neat P(3HO) and P(3HO)/P(3HB) blend  films during  the  in vitro  degradation study  in  (a)  DMEM  media  and  (b)  PBS  media. Weight loss by the degrading neat P(3HO) and P(3HO)/P(3HB) blend films during one month in vitro degradation study in (c)  DMEM media and (c) PBS media (n = 3). The  data   were  compared  using   ANOVA  and  the  difference  were  considered significant when *p<0. 05.  The water absorption was higher in the blend films compared to the neat P(3HO) film in both DMEM and PBS medium. The percentage water absorption (% WA) by the neat P(3HO) film in DMEM media was measured to be 4.5±0.1%  at the end of a one  month  degradation  study  as  compared  to  the  blend  films  which  were 17.4±0.8%,   12.3±0.6%   and   4.6±0.3%   in   P(3HO)/P(3HB)   20:80   blend   film,  P(3HO)/P(3HB)  50:50  blend  film  and  P(3HO)/P(3HB)  80:20  blend  film respectively. The water absorption was significantly   higher in P(3HO)/P(3HB) 20:80 and P(3HO)/P(3HB) 50:50 blend films compared to the neat P(3HO) film  (*p<0. 05).   Similarly in the PBS media, the % WA by the neat P(3HO) film was  9.1±0.2% in comparison to the 19.6±0.4%, 16.3±0.7% and 10.2±0.5% in P(3HO)/P(3HB) 20:80, P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB)   80:20   blend films respectively. It was also found that the weight loss was significantly greater in P(3HO)/P(3HB)  20:80 and P(3HO)/P(3HB) 50:50  blend films compared to the neat P(3HO) films in both DMEM and PBS media (*p<0. 05).  The % WL in the neat P(3HO) film in DMEM was 3.1±0.3% at the end of one month degradation study as compared to the blend films which was 26.5±0.8%, 18.1±0.4% and 3.8±0.9% in the P(3HO)/P(3HB) 20:80, 












  P(3HO)/P(3HB) 50:50  and  P(3HO)/P(3HB) 80:20  blend  films  respectively. Similarly, in the PBS media, the % WL in the neat P(3HO) film was 3.3±0.5% in comparison to 16.4±0.7%, 9.1±0.4% and 7.2±1.0% in P(3HO)/P(3HB) 20:80, P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 80:20 blend films respectively. The result of the four month study is presented in Figure 5.10 (a), (b), (c) and (d).                      
(a) (b)                      
(c) (d)  
Figure  5.10:  Water  absorption  by  the  neat  P(3HO)  and  P(3HO)/P(3HB) blend films during the in vitro degradation study in (a) DMEM media and (b) PBS media. Weight loss by the degrading neat P(3HO) and P(3HO)/ P(3HB) blend films during the in vitro degradation study in (c) DMEM media and (d) PBS media (n = 3). The data were compared using ANOVA and the difference were considered significant when *p<0. 05.  The  water  absorption  was  significantly  higher  in  P(3HO)/P(3HB)  20:80  and  P(3HO)/P(3HB) 50:50 blend films compared to the neat P(3HO) film in both DMEM 




  and PBS medium at the end of the four month study (*p<0. 05). The percentage water absorption (% WA) by the neat P(3HO) film in DMEM media was measured to be 9.8±0.8% at the end of a four month degradation study as compared to the blend films which were 18.2±1.5%, 16.2±0.4% and 10.5±0.9% in P(3HO)/P(3HB) 20:80  blend  film,  P(3HO)/P(3HB) 50:50  blend  film  and  P(3HO)/P(3HB)  80:20  blend film respectively. Similarly in the PBS media, %WA by the neat P(3HO) film was 11±0.3% in comparison to 21.6±0.5%, 20.2±1.1% and 12.5±0.7% in P(3HO)/P(3HB) 20:80, P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB)   80:20   blend films respectively. It was also found that the weight loss was significantly greater in P(3HO)/P(3HB)  20:80 and P(3HO)/P(3HB) 50:50 blend films compared to the neat P(3HO) film in both DMEM and PBS medium at the end of the four month study (*p<0. 05). The % WL for the neat P(3HO) film in DMEM   was 4.4±1.3% at the end of one month degradation  study   as   compared  to   the   blend   films   which  was   28.6±2.1%, 22.5±1.5% and 5.0±0.9% in the P(3HO)/P(3HB) 20:80, P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 80:20 blend films respectively. Similarly, in the PBS media, %WL in the neat P(3HO) film was 7.3±0.5% in comparison to 17.1±0.7%, 14.5±1.4% and 8.0±2.0% in  P(3HO)/P(3HB) 20:80, P(3HO)/P(3HB) 50:50 and  P(3HO)/P(3HB)  80:20 blend films respectively.   
5.12 Surface studies of the degrading films   At the end of the one month degradation study, the neat P(3HO) film and P(3HO)/P(3HB) blend films were rinsed in HPLC grade water. The surface morphology of  the  degrading films  were  studied using  Scanning  electron microscopy (SEM) as described in section 2.9.1. SEM images confirmed that there was  higher level of degradation in the P(3HO)/P(3HB) blend films as compared to the neat (P3HO) film (Figure 5.11).  Biodegradability of the blend films is affected by various factors such as the blend composition and the surface properties of the blend components. 











Figure 5.11: SEM images of the P(3HB)/P(3HO) blend films after of one month of incubation exhibiting different states of degradation: (a) neat P(3HO) film, (b) P(3HO)/P(3HB) 80:20 (c) P(3HO)/P(3HB) 50:50 (d) P(3HO)/P(3HB) 20:80 blend film in DMEM. Scale bars = 100µm.  The  degradation  rate  was  higher  in  the  all  the  P(3HO)/P(3HB)  blend  films compared to the neat P(3HO) film. The highest percentage of degradability was found to be associated with the P(3HO)/P(3HB) 20:80 blend film as confirmed by SEM. The SEM image showed the degraded surface of the the P(3HO)/P(3HB) 20:80 film compared to the relatively non-degraded neat P(3HO) film. Based on these results, P(3HO)/P(3HB) 50:50 blend with intermediate properties  were chosen for further studies. 






Surface micropatterning of the P(3HO)/P(3HB) 50:50 blend films using laser 
micropatterning technique. This work was led by Dr. Iban Quintana at Tekniker Institute in Bilbao, Spain.    
5.13 Picosecond pulse laser technology  A pico-second pulse Nd:YVO4 laser (RAPID: Lumera Laser) integrated in a micromachining workstation by a 3D-Micromac was used to micropattern P(3HO)/P(3HB) 50:50  blend  films.  The  laser source delivered 10  ps  pulses  at 1064nm wavelength with energy of 12 µJ operating at a maximum repetition rate of 1 MHz. In addition to the fundamental mode, the laser emitted at second and third harmonic wavelengths of 532 and 355 nm, with maximum energies of approximately 22.5 and 17.5 µJ respectively and at a repetition rate of 200 kHz. The laser beam was focused over the sample by a focusing lens placed in the air that has a focal length of 100mm for light of 532 and 1064 nm wavelength, and of 103 mm for light of 355 nm wavelength. Spot sizes (beam radius at 1/e2) of 30 µm and 20.5 µm were obtained at energy of 0.2 µJ for wavelengths of 532 nm and 355 nm, respectively, by selecting optional fixed beam expanders. Sample position was selected by a XY stage with lateral resolution in the µm-range and a Z positioning system with a vertical resolution of roughly 10 nm. By means of pulse overlapping we obtained different microstructures, whose width and depth could be controlled by appropriately selecting the laser power, frequency and mark speed, making it possible to obtain almost any desired topography and geometry. After an optimization process of the laser ablation parameters, varying the wavelength (λ), frequency (f), speed (v) and power level  (P),  the suitable  laser configuration to carry out the material micropatterning was obtained which is as follows:  
λ = 355 nm, f = 250 kHz, v = 600 mm/s   P(3HO)/P(3HB) 50:50  blend  films  were  micropatterned by  creating  grooves  of width  (w)  =  12  μm  (P  =  30%), interline  distance or  the  distance between  the grooves = 10 μm and the depth of the groove (d) = 6 μm. 









5.14 Characterization of the micropatterned (3HO)/P(3HB) 50:50 blend film 
5.14.1 Scanning Electron Microscopy (SEM)  Microgrooves were  created  on  the  P(3HO)/P(3HB) 50:50  blend  films  using  the Laser  micropatterning method as  described in  section 5.13.  This  was  done  to guide the attachment and proliferation of the endothelial cells in an aligned manner. Microstructural properties of the micropatterned P(3HO)/P(3HB) 50:50 blend film were studied using SEM as described in section 2.9.1. The surface topography of the laser micropatterned P(3HO)/P(3HB) 50:50 blend film was compared to the topography of the plain P(3HO)/P(3HB) 50:50 blend film as shown in Figure 5.12.                     
(a) (b)  
Figure 5.12: SEM images of the (a) plain P(3HO)/P(3HB) 50:50 blend film (b)  surface micropatterned P(3HO)/P(3HB) 50:50 blend film.  The microgrooves created on the blend films were of width (12µm) and depth (6  µm). The interline distance or the distance between the grooves was 10 µm. The SEM   images   confirmed  that   P(3HO)/P(3HB)  50:50   blend   film   with   a   new topography had been  successfully created using  the  laser micropatterning technique. The fabricated blend films were further characterised using the Atomic force microscopy (AFM).  
5.14.2 Atomic Force Microscopy (AFM)  In order to evaluate the effect of surface micropatterning on the surface roughness of the blend films, AFM was used to measure the surface roughness values of the fabricated blend films as described in section 2.9.3. Typical root mean square (rms) values were calculated to determine the roughness value of the micropatterned 

































Plain blend film Micropatterned blend film  
Figure 5.13: Surface roughness of the plain P(3HO)/P(3HB) 50:50 blend film and micropatterned blend film measured using AFM (n = 3).  The change in the topography of the P(3HO)/P(3HB) 50:50 blend films due to the micropatterning was confirmed by AFM.  The laser micropatterned blend films had a 217% higher surface roughness value compared to the plain blend film indicating that laser micropatterning had increased the surface roughness of the blend films.    
5.14.3 Contact Angle Study  Static contact angle experiments were carried out on the micropatterned blend film samples to study the effect of the surface micropatterning on the wettability of the fabricated blend films as described in section 2.9.4. Contact angle measurement of the micropatterned P(3HO)/P(3HB) 50:50 blend film was compared with the plain blend film as shown in Figure 5.14 






                              
Figure 5.14: Static water contact angle measurements of the plain P(3HO)/P(3HB)  50:50 blend film and micropatterned blend film  (n = 3; error bars = ± SD). The data were compared using t-test and the difference were considered significant when *p<0. 05.   The water contact angle of the micropatterned blend film was 62.9±2 that demonstrated hydrophilic characteristics compared to the plain blend film that had a contact angle of 88.8±1.0 (*p<0. 05). The surface micropatterning of the blend films by laser micropatterning lowered the water contact angle, making the films more hydrophilic compared to the plain blend film.  
5.14.4 Protein Adsorption Test  The creation of the microgrooves on the blend films by laser micropatterning increased their surface area.  Protein adsorption assay was  done to  quantify the total  amount  of  Bovine  serum  albumin  (BSA)  adsorbed by  the  micropatterned blend film as described in section 2.9.7. The results were compared to the protein adsorption on the plain blend films as shown in Figure 5.15. 






                              
Figure 5.15: Total protein adsorption on  the plain  P(3HO)/P(3HB) 50:50 blend film and the micropatterned blend film (n = 3). The data were compared using t- test and the difference were considered significant when *p<0. 05.  The overall protein adsorbed by the plain blend film was 400±0.2 µg/cm2 that was lower compared to  the total protein adsorbed by the micropatterned blend film that was 507.3±0.9 µg/cm2. This increase in the protein adsorption in the micropatterned blend film was significantly higher than the plain blend film (*p<0. 05).   
5.14.5 Dynamic Mechanical Analysis  In order to evaluate the effect of the surface micropatterning on the blend film samples, detailed mechanical characterisation of the films were carried out as described in section 2.9.5. This was compared to the mechanical properties of the plain blend film. The results of the mechanical analyses are summarised in Table 
5.3. 















Plain P(3HO)/P(3HB) 50:50 78.50 ± 0.01 7.80 ± 0.03 22.90 ± 0.05 Micropatterned blend film 74.50 ± 0.70 7.30 ± 0.30 25.40 ± 1.01 
Table 5.3: Mechanical characterisation of  the plain P(3HO)/P(3HB) 50:50 and the  micropatterned blend films using Dynamic Mechanical Analysis (n = 3).   There was a decrease in the tensile strength and the Young’s modulus (a measure of stiffness) of the micropatterned blend films compared to the plain blend films. However, there was an increase in the % elongation at break values.  
5.14.6 In vitro biocompatibility studies  The effect of the surface micropatterning on the attachment and the proliferation of the  Human   microvascular  endothelial  cells   (HMEC-1)  cells   was  analysed  by culturing the cells on the plain blend film as well as the micropatterned blend film samples. Preliminary in vitro cell culture studies were carried out as described in 
section 2.10.2.     Neutral red (NR) assay was used for obtaining a quantitative measure of the cell adhesion and cell proliferation studies. Attachment and proliferation of HMEC-1 cells on the films were analysed over a period of 1, 4 and 7 days. The results of these biocompatibility tests have been summarised in Figure 
5.16.  There was better growth and proliferation of the cells on the micropatterned blend films compared to the plain blend film samples. 










                      
(a)                     
(b)                     
(c)   
Figure 5.16:     Cell proliferation study of the seeded HMEC-1 cells on the plain P(3HO)/P(3HB) 50:50 blend film and micropatterned blend film on (a) Day 1, (b) Day 4 and(c) Day 7. The data were compared using ANOVA and the difference were 











  considered significant when the *p<0. 05. All the tested samples were relative to the control and the control was set to 100%.  At the end of the 1st day, the growth of HMEC-1 cells on the plain blend film and the micropatterned film was 26.6±1% and 48.2±1% respectively, as compared to the tissue culture plastic. Cell attachment on the micropatterned films was much higher compared to the plain blend film. The cells continued to grow on all the samples.  At the end of the 4th day, the growth of HMEC-1 cells on the micropatterned blend film was 68.5±2.3% as compared to the plain blend film which had 48.1±1.8% growth on the 4th  day. At the end of the 7th  day, there was a significant increase in the growth of the cells on the micropatterned blend film samples as opposed to the cells on the plain blend film samples (*p<0.05). The growth of HMEC-1 cells on the micropatterned blend  film was 94.0±0.9% as compared to the 64.0±1.6% of cell growth on the plain blend film samples.    
5.14.7 Scanning electron microscopy (SEM)   In this study, the HMEC-1 cells seeded onto the surface micropatterned blend film and the plain blend films were analysed using SEM as described in section 2.9.1. This was done to study the effect of micropatterning on the morphology and alignment of the HMEC-1 cells as shown in Figure 5.17.                    
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Figure 5.17: SEM images of the HMEC-1 cells on the (A1-A2) plain P(3HO)/P(3HB)  50:50 blend film on day 7. The SEM images of the HMEC-1 cells (A3-A4) dividing within the groove on the micropatterned blend film on day 1. The SEM image demonstrating the migration of the elongated HMEC-1 cells along the groove (A5- A6) on day 4. Images (A7-A10) showing HMEC-1 cells proliferating along the microgrooves in an aligned manner on day 7.    














Figure 5.18: Dimensions of a laser cut film for stent prototype development   These laser cut films were wound to a mandrel to obtain a helical structure as shown in Figure 5.19. 








                 
Figure 5.19: A stent prototype made up of P(3HO)/P(3HB) 50:50 blend film.   The  inner  wall  of  these  stent  prototypes  was  micropatterned  using  laser  to promote endothelialisation. Due to time constraint, the characterisation of these stent prototypes could not be completed and will be carried out in future. However, the stent prototypes were successfully developed. 





PART III    
Incorporation of aspirin within the P(3HO)/P(3HB) blend film and their 
characterisation  
Preparation of P(3HO)/P(3HB) 50:50 blend film containing aspirin   The P(3HO)/P(3HB) 50:50 blend film containing aspirin was prepared using the solvent casting  method. P(3HO) and P(3HB) were dissolved in  dichloromethane with a polymer concentration of 5wt% in a ratio of 50:50. Aspirin was dissolved in dichloromethane and mixed with the polymer solution to achieve a drug loading of 15 wt%. The polymer solution containing aspirin was mixed well by sonication and then cast into a glass petri dish immediately to achieve a uniform distribution of aspirin  within  the  polymer  matrix.  P(3HO)/P(3HB)  50:50  blend  film  without aspirin was also prepared to investigate the effect of drug loading on the properties of the blend film. The film was air dried for one week. Films of 0.18 mm thickness were produced.    
Characterisation of the P(3HO)/P(3HB) 50:50 blend film with aspirin  
5.14.9 Fourier Transform Infrared Spectroscopy (FTIR)  FTIR spectroscopy was performed on the blend film with aspirin as well as on the commercial aspirin sample using the method described in section.  2.6.1. This was done to establish that the aspirin had been absorbed within the matrix of the P(3HO)/P(3HB) 50:50 blend   film. The IR Spectrum of (a) commercial aspirin (-) and (b) blend film with aspirin (-) is shown in Figure 5.20. 







Figure 5.20: FTIR spectra of the (a) commericial aspirin (-) and (b) P(3HO)/P(3HB)  50:50 blend film with aspirin (-).  Three characteristic absorption peaks at 1680, 1605 and a broad peak in the range  2500 - 3500 cm-1  present in the commercial aspirin sample and were also present in the blend film with aspirin indicating that aspirin had been absorbed within the P(3HO)/P(3HB) 50:50 matrix. The broad absorption peak at 2800 cm-1 represented the carboxylic acid group present in aspirin. The peak at 1605 cm-1 occurred due to the benzene ring whereas the absorption peak at 1680cm-1  represented the two carbonyl groups found in aspirin (Li et al., 1999).   
5.14.10 Scanning electron microscopy (SEM)  Surface properties of P(3HO)/P(3HB) 50:50 blend film samples with aspirin were measured by SEM using the method described in section 2.9.1. The surface topography of the P(3HO)/P(3HB) 50:50 blend film with aspirin was compared to the topography of the blend  film without aspirin as shown in Figure 5.21. This was done to examine the effect of aspirin loading on the surface properties of the film. 








                        
(a) (b)  
Figure  5.21:.SEM  images  of  the  (a)  P(3HO)/P(3HB) 50:50  blend  film  without aspirin and (b) P(3HO)/P(3HB) 50:50 blend film with aspirin. Scale bars = 50 µm.   The SEM results revealed that aspirin was uniformly distributed within the blend film. A new surface topography was introduced due to the incorporation of aspirin within the matrix of the P(3HO)/P(3HB) 50:50 blend film. The surface of the P(3HO)/P(3HB)  50:50  blend   film   with   aspirin  appeared  to   have   a   uniform roughness. The  films  were  further characterised using  the  Atomic Force Microscopy (AFM).   
5.14.11  Atomic Force Microscopy (AFM)  The  change  in  surface properties of  the  blend  film  due  to  the  incorporation of aspirin within their matrix was further investigated using AFM. This was done to compare the surface roughness of the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin.   AFM analysis was carried out according to the method described in  section 2.9.3  and  the  results  obtained are shown  in  Figure  5.22. From our previous studies, it was established that the rms values of the P(3HO)/P(3HB) 50:50 blend film was 0.59±0.02 µm. 
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Figure  5.22:  Surface  roughness  of  P(3HO)/P(3HB)  50:50  blend  film  without aspirin (b) P(3HO)/P(3HB) 50:50 blend film with aspirin.   The surface roughness values of the P(3HO)/P(3HB) 50:50 blend film with aspirin was 6% lower compared to the P(3HO)/P(3HB) 50:50 blend film without aspirin. This confirmed that aspirin was homogeneously distributed within the matrix of the blend film making the surface of the blend film slightly smoother and more uniform compared to the P(3HO)/P(3HB) 50:50 blend film without aspirin (Zilberman and Persson, 2002).  
5.14.12 Contact Angle Study  Static contact angle measurement were done to determine the hydrophilicity of the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin as described in 
section 2.9.4. Contact angle measurements of the P(3HO)/P(3HB) 50:50 blend film with and without aspirin is shown in Figure 5.23. 






                                
Figure  5.23:  Static  water  contact  angle  measurements  of  the  P(3HO)/P(3HB)  50:50  blend  film  samples  with  and  without  aspirin  (n  =  3).  The  data  were compared using t-test and the difference were considered significant when *p<0. 05.   The water contact angle of the P(3HO)/P(3HB) 50:50 blend and the blend films with aspirin were  89.5 ± 0.8 and 72.7 ± 1.3 respectively. The results indicate that the water contact angle of the blend films with aspirin is significantly lower compared to the blend film without aspirin (*p<0. 05). Hence, the blend film containing aspirin was comparatively more hydrophilic in nature.  
5.14.13 Protein adsorption Test  Protein adsorption assay was done to quantify the total amount of protein on the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin as described in 
section 2.9.7. The test was carried out to determine the effect of aspirin loading on the protein adsorption on the P(3HO)/P(3HB) 50:50 blend film. The results of the protein adsorption assays have been summarised in Figure 5.24. 






                                 
Figure 5.24: Protein adsorption on the P(3HO)/P(3HB) 50:50 blend   film samples with and without aspirin (n = 3). The data were compared using t-test and the difference were considered significant when *p<0. 05.  Protein adsorption on the P(3HO)/P(3HB) 50:50   blend film samples with aspirin was 811 ± 1 µg/cm2  while the protein adsorption on the P(3HO)/P(3HB) 50:50 blend   film without aspirin was 400 ± 0.2 µg/cm2. Hence, there was a significant increase of 102% in the P(3HO)/P(3HB) 50:50  blend films with aspirin compared to  the  P(3HO)/P(3HB)  50:50  blend  film  samples  without  aspirin  due  to  the presence of hydrophilic aspirin within the matrix of the blend film (*p<0. 05).   
5.14.14 Indirect cytoxicity testing  Indirect cytotoxicity testing was carried out as described in section 2.9.8 to study the effect of the degradation products of the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin on the HMEC-1 cells. The results have been summarised in Figure 5.25. 






                                  
Figure  5.25:  Indirect  toxicity  testing  of  the  P(3HO)/P(3HB)  50:50  blend  film samples with and without aspirin(n = 3). Cells grown in DMEM, in the absence of polymer were taken as untreated and the cells grown in the presence of 4% hydrogen peroxide were taken as the positive control. The data were compared using t-test and the difference were considered significant when *p<0. 05.  P(3HO)/P(3HB) 50:50 blend film samples with aspirin showed the highest cell viability percentage of  108.3 ± 0.6%  followed by percentage cell viability of 100% when the HMEC-1 cells were grown in DMEM without any polymer. P(3HO)/P(3HB) 50:50 blend film samples without aspirin showed a percentage cell viability of 98.8  ± 1.0% while the  lowest percentage cell viability of 8.0 ± 0.0% was observed when the HMEC-1 cells were grown in the presence of 4% hydrogen peroxide, a chemical that is known to induce cell death. These results, therefore, confirmed that no toxic by-products were released from the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin. 





5.14.15 Thermal characterisation   Thermal properties such as the melting temperature (Tm), glass transition temperature (Tg) and the  crystallization temperature(Tc) of P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin  were studied using DSC as described in section 2.9.6. The results have been summarised in Table 5.4.   
Samples Tm (°C) Tg (°C) Tc (°C) P(3HO)/P(3HB) 50:50 159.5 ± 0.1 11.9 ± 0.1 98.5 ± 0.3 P(3HO)/P(3HB) 
 50:50 aspirin 152.4 ± 1.0, 123.1 ± 0.0 10.0 ± 0.1 71.1 ± 9.0 
Table  5.4: Thermal properties of the P(3HO)/P(3HB) 50:50 blend  film  samples  with and without aspirin (n = 3).   The melting temperature (Tm), glass transition temperature (Tg) and the crystallization  temperature(Tc) of  the  P(3HO)/P(3HB) 50:50  blend  film  samples with aspirin were lower compared to the P(3HO)/P(3HB) 50:50 blend film samples without aspirin. A sharp peak at 123.1 °C was observed during the heating of the blend film with aspirin. It is known that the melting temperature of aspirin is 136°C. Hence, a shift in the melting temperature of aspirin to a lower value of 123.1°C was observed.  
5.14.16 Dynamic Mechanical Analysis  Mechanical properties of the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin were carried out as described in section 2.9.5.  The results of the mechanical analyses are summarised in Table 5.5 



















P(3HO)/P(3HB) 50:50 78.50 ± 0.01 7.80 ± 0.03 22.90 ± 0.05 P(3HO)/P(3HB)50:50Aspirin 40.01 ± 0.70 3.03 ± 0.40 46.30 ± 5.10 
Table  5.5: Mechanical characterisation of the P(3HO)/P(3HB) 50: 50 blend film  samples with and without aspirin using Dynamic Mechanical Analysis (n = 3). Incorporation of  aspirin  within  the  P(3HO)/P(3HB) 50:50  blend  film  led  to  a significant  change  in  their  mechanical  properties.  The  tensile  strength  of  the P(3HO)/P(3HB) 50:50  blend  film  samples  with  aspirin  had  decreased by  61% compared to the blend film without aspirin while the Young’s modulus (a measure of stiffness) of the P(3HO)/P(3HB) 50:50 blend film samples with aspirin was 49% lower compared to the blend film without aspirin. However, there was an increase in the % elongation at break values.  
5.15 In vitro degradation study in PBS  
5.15.1 Water absorption and weight loss  The percentage of water absorbed (%WA) and weight loss (%WL) by the P(3HO)/P(3HB)  50:50   blend   film   samples   with   and   without   aspirin,   when incubated in the PBS media for a period of 30 days were measured as described in 
section 2.10 and presented in Figure 5.26 (a)and (b).                      
(a) (b) 












Figure 5.26: (a) Water absorption (%WA) by the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin in PBS media (b) Weight loss (%WL) of the P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin in PBS media ( n=3). The data were compared using t-test and the difference were considered significant when *p<0. 05.  Water absorption in the P(3HO)/P(3HB) 50:50 blend film containing aspirin was  44.8±1% which was significantly higher compared to the   water absorption in the P(3HO)/P(3HB) 50:50 blend film samples without aspirin which was 16.3±0.7% (*p<0. 05). Similarly, the weight loss in the P(3HO)/P(3HB) 50:50 blend film with aspirin was 29.1±10.4% which was significantly greater compared to the   water absorption in the P(3HO)/P(3HB) 50:50 blend film samples without aspirin which was 9.0±0.3% (*p<0. 05).   
5.15.2 Scanning Electron microscopy (SEM)  At the end of the degradation study, P(3HO)/P(3HB) 50:50 blend film samples with and without aspirin were rinsed in HPLC grade water . The degrading films were studied using SEM as described in section 2.9.1. This was done to study the microstructural properties of the degrading films.    SEM images of the degrading films are shown in Figure 5.27.                         
(a) (b)  
Figure 5.27: SEM images of the (a) P(3HO)/P(3HB) 50:50 blend films and the (b) P(3HO)/P(3HB) 50:50 blend films with aspirin, after being immersed in PBS for one month. 















  The SEM images thus confirmed that there was an increased degradation of the P(3HO)/P(3HB) 50:50 blend film samples with aspirin as compared to the P(3HO)/P(3HB) 50:50 blend film samples. Surface properties of the P(3HO)/P(3HB) 50:50 blend film samples without aspirin after degradation indicated homogenous surface erosion where a rougher topography was observed. In the P(3HO)/P(3HB) 50:50 blend film samples with aspirin, a rough surface with a visible mass loss was observed suggesting an accelerated   surface erosion due to the increased water uptake through the water channels formed by the diffused drug. Also, aspirin being hydrophilic would interact more with water than the blend film, hence enhancing the rate of hydrolytic degradation of the sample.    
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Figure 5.28: In vitro release profile of aspirin from P(3HO)/P(3HB) 50:50 blend film for a period of 30 days Aspirin was released slowly at a constant rate throughout the period of release. There  was  a  an  initial  burst  release  of  only  9±1.5%  on  day  1.  In  this  study, cumulative release of 96.6% occurred within a period of 25 days and aspirin was released in  two  stages.  In  the first stage,  the  aspirin was  released slowly,  this 






  occurred  until  the 7th  day of release. In the second stage, the rate of drug release increased until the 25th day of release.   It  is known that aspirin upon hydrolysis loses its therapeutic activity. Therefore, it is very crucial to release aspirin in its chemically stable form (Aubrey-Medendorp 
et al., 2008).  The amount of chemically stable aspirin  in the released samples and in the control aspirin solution in PBS is shown in Figure 5.29                            
Figure 5.29: In vitro release profile of chemically stable aspirinP(3HB) 50:50 blend film(a) and control aspirin standard (b) for a period of 30 days.   The  percentage of  chemically stable  aspirin released from  the  P(3HO)/P(3HB)  50:50  blend  film  containing  aspirin  was  significantly  higher  compared  to  the control aspirin solution. This was in agreement with the results obtained by Tang and Singh, where the percentage of chemically stable aspirin was much higher in the PLGA based drug delivery compared to the  free aspirin (Tang and Singh, 2008). Other studies on the controlled release of aspirin from polymer implants have not confirmed the release of chemically stable aspirin into the media. 






Part I  In this part of the study, P(3HB) was produced by B. cereus SPV using Kannan and Rehacek media, in a batch mode. The polymer produced was characterised using FTIR. The IR spectrum of the polymer showed the presence of two characteristic absorption peaks present in the SCL-PHAs, such as 1719 cm-1 , corresponding to the ester carbonyl group and the absorption peak at 1282 cm-1 , corresponding to the –CH2 group (Valappil et al., 2007). This confirmed that the polymer produced was a  type of SCL-PHA. The polymer was further characterised using GC. This confirmed that the polymer produced by B. cereus SPV using Kannan and Rehacek media was P(3HB). P(3HO)/P(3HB) blend films were prepared using solvent casting method.  One of the potential applications of P(3HO)/P(3HB) blends developed in this work would possibly be in the area of biodegradable stents. According to the literature, the most desirable features of an ideal biodegradable stent include biocompatibility, tailorable biodegradability and excellent mechanical properties to provide support to the injured artery to facilitate its healing. Thermal stability is another characteristic which is essential for the processing of these blends. One of the major concerns  regarding  the  implantation  of  these  biodegradable  stents  within  the artery is in stent restenosis.   Therefore, a first requirement of the biodegradable polymers to be used in stent development is biocompatibility with the surrounding tissues to prevent any inflammatory response leading to neointimal thickening. Previous works have shown that other biodegradable polymers tested to be used in stent development have demonstrated tissue incompatibility leading to in stent restenosis (Regar et al., 2001). Thus, it is very crucial to establish the compatibility of the biomaterial with the endothelial cells which forms the inner lining of the blood vessel. The major advantage of the PHAs over the other biodegradable polymers such as Poly-L-Lactic acid (PLLA),Poly-D-Lactic acid (PDLA), Polylactic- co-glycolic acid  (PLGA) is  that  it  yields  degradation products  which are  weaker acids compared to the highly acidic degradation products generated by the other biodegradable polymers (Mani  et al.,  2007; Liu  et al.,  2006; Cordewener et al., 2000).   In this study, P(3HO)/P(3HB) blend films of varying compositions were developed using solvent casting method. These blend films were characterised with respect to 




 their microstructural, mechanical and thermal characteristics. Degradation studies and biocompatibility studies were also carried out on the blend films.  Microstructural  studies  of  these  blend  films  were  carried  out  using  SEM.  It  is known from literature that the polymer blending leads to a change in their microstructural properties as  well  as  their bulk  properties (Zhang et al.,  1998). SEM images revealed a rough topography for all the  blend films compared to the smooth surface of the neat P(3HO) film. However, the morphologies were different for all the blend films. The formation of  spherulites on the surface of the blend film containing  highest  amount  of  P(3HB)  represented  a  predominantly  crystalline matrix with the highly crystalline P(3HB) at the air-polymer interface. A relatively smoother surface was observed for the blend P(3HO)/P(3HB) 20:80 which had the highest concentation of P(3HO) representing a predominantly amorphous matrix. This is possibly due to the presence of P(3HO) on the air-polymer interface which has a low crystallinity (Chen et al., 2002; Ha and Cho, 2002; Luo et al., 2009). The surface of the P(3HO)/P(3HB) 50:50 blend film represented an intermediate morphology comprising of both crystalline and amorphous domains. The presence of tiny pores on the surface of this particular blend film could be due to the rapid evaporation of the solvent from the film during solvent casting. The solvent evaporation during the synthesis of the blend film is hugely affected by the arrangement of the amorphous and the crystallline regions of the film (Luo et al., 2009). Kai et al., observed  that the surface of the P(3HB)/P(3HB-co-3HHx) blend films with increased concentration of P(3HB) revealed a rough topography with the formation of protusions. This was due to the high crystallization rate of P(3HB) causing it to crystallize simultaneously during solvent evaporation. The blend films with increased concentration of     P(3HB-co-HHX) which has a low crystallinity revealed a smoother and continous surface without protusions. This was due to the low  crystallization rate  of  P(3HB-co-3HHx) allowing  the molecules to  rearrange (Kai et al., 2003). Another  study  demonstrated  that  the  surface  topography  of  the  hydrophobic  poly(vinylidene)  fluoride  (PVDF)  and  hydrophilic  poly(vinylpyrrolidone)(PVP)  blend films varied depending on the concentrazhang  tion of PVP in the blend. With 10% PVP in the blend film, a spherulitic phase was revealed.   This   spherulitic   phase   was   changed   to   an   intermediate   structure containing both spherulitic and plain domains, when the concentration of PVP was 
  
Chapter 5: Results  50%. At 80% concentration of PVP, the surface of the blend film appeared to have no characteristic morphology (Chen and Hong, 2002). Similar results were obtained when acetylated bacterial   cellulose crystals were incorporated into P(3HO) matrix. SEM images revealed rougher surface topography of the composite films with the acetylated cellulose microcrystals compared to the neat P(3HO) matrix (Basnett et al., 2012). Another study demonstrated that  the surface topography of the blend films of P(3HB-co-3HHx) and P(3HB-co-4HB) were much rougher compared to the neat P(3HB-co-4HB)  and the P(3HB-co-HHx) films (Luo et al., 2009). Surface roughness of these blend films were measured using AFM. The results were compared with the surface roughness values of the neat P(3HO) film to confirm the increase in the surface roughness of the blend film due to the presence of P(3HB). The  increase in  the  surface roughness with  the  increase in  the  P(3HB) concentration is most likely due to the presence of the highly crystalline P(3HB) on the  surface  of  the  film.  The  AFM  results  were  in  agreement  with  the  images produced by SEM which depicted the change in the surface topography of the blend films depending on the concentration of P(3HB) within the film. It is known that the arrangement of the amorphous and the crystallline regions at the polymer air interface affects the surface topography of the film (Luo et al., 2009). Surface roughness of a biomaterial plays a crucial role in its biocompatibility (Das et al., 2007).  Surface  roughness  has  been   asociated  with   the  protein  adsorption  and  cell adhesion behaviour. Chen et al., demonstrated that there was an increase in the adsorption of fibrinogen on the patterned surface of the poly(dimethylsiloxane) compared to flat, smooth surface (Chen et al., 2009). Previous studies have shown that surface roughness enhances the cell adhesion process by changing the surface energy of the biomaterial (Das et al., 2007; Lampin et al., 1997). Therefore, this increase in the surface roughness of the blend films was considered to be a encouraging result. In future, surface energy of the blend films could be measured to gain a better understanding. Water contact angle studies were carried out to measure the hydrophilicity/hydrophobicity of the blend films. The results highlighted the role of P(3HB) in increasing the hydrophilicity of the blend films. It is a known fact that P(3HB) in which the monomer is composed of only four carbon atoms is more    
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 hydrophilic in nature compared to P(3HO) in which the monomer is made up of eight carbon atoms (Rai et al., 2011). Hence, with the increase in the amount of P(3HB) incorporation, the resulting blends exhibited increased hydrophilicity compared to  the neat P(3HO) films.  Similar results were observed by Rai  et al., when the P(3HO) matrix was modified by the incorporation of hydrophilic n-BG (bioglass). There was a decrease in the water contact angle  resulting in increased hydrophilicity of the composite film compared to neat P(3HO)( Rai et al., 2011). In another study,     there was an increase in the hydrophilicity of the P(3HB)/PVA (Polyvinyl alcohol) blend    films compared to the neat P(3HB) films due to the incorporation of hydrophilic PVA. The water contact angle values were very close to the water contact angle values of the hydrophilic PVA (Ikejima et al., 1998). Chen 
et al., demonstrated that the presence of hydrophilic PVP within the hydrophobic PVDF dominated film lowered the water contact angle of the resulting PVP/PVDF blend films (Chen and Hong, 2002). Hydrophilicity is another important characteristic that plays a crucial role in the  biocompatibility of the material. According to literature, a low water contact angle which means increased hydrophilicity results in an increase in the surface energy of the material. This results in increased cell adhesion, thereby improving the biocompatibility of the material (Das et al., 2007). It  has been demonstrated by Bruil et al.,  that the number of cells adhering to the polyurethane surface increased with the increase in the surface hydrophilicity (Bruil et al., 1994). Another study demonstrated that there was an increase in the number of Human umbilical vein endothelial   cells   (HUVECs)   adhering   to   the   surface   of   the   self   assembled monolayers when  there was  a  decrease in  the  water  contact  angle  (Arima  and Iwata, 2007). Previous studies have also shown that there is a strong correlation between  the  surface roughness,  hydrophilicity and  the  total  protein  adsorption (Hao and Lawrence, 2006b). Another characterisation that was done on these blend films was the total protein adsorption test. According to literature, it is known that the mammalian cells are anchorage dependent. They require a protein rich surface for their attachment and elongation. When a biological implant is placed within the body, water and a layer of adsorbed protein is formed on the surface of the biomaterial depending upon its 




 surface properties.. This is considered to be the initiation of the healing process (Kurella and Dahotre, 2005). The cells then adhere to these protein rich surfaces. Therefore, protein adsorption plays a key role in evaluating the biocompatibilty of the biomaterial for tissue engineering applications (Rai et al., 2011). In this study, there was an increase in the total protein adsorption on the blend films compared to the neat P(3HO) film. This increase in the protein adsorption in the P(3HO)/P(3HB) blends is most likely due to the incorporation of P(3HB) within the P(3HO)  matrix  which  in  turn  has  increased  the  surface  roughness  and hydrophilicity, hence changing the surface properties of the blend films (Hao and Lawrence, 2006a). Misra et al.,     demonstrated an increase in the total protein adsorption on the P(3HB)/BioglassTM composite films compared to the neat P(3HB) film. The authors stated that this increase in the protein adsorption was due to the change in the surface topography and surface wettability of the composite films owing to the presence of hydrophilic bioglass within the P(3HB) matrix (Misra et 
al., 2010). In another study, there was an increase in the adsorption of fibrinogen and fibronectin adsorption on the patterned poly(dimethylsiloxane) film compared to the smooth, flat surface. This increase was due to the increase in the surface roughness of the patterned PDMS film (Chen et al., 2009). Hao and Lawrence in 2006, observed a strong corelation between surface roughness, surface hydrophilicity and protein adsorption on the material. They stated that surface roughness and hydrophilicity were predominant factors that dictated the total protein adsorption (Hao and Lawrence, 2006a). This increase in the protein adsorption in the blend films was an encouraging result, bearing in mind their potential medical applications.  Another characterisation done on these blend films was the indirect cytoxicity assay. This was done to investigate the effect of the substances released from the blend films on the growth of Human dermal microvascular endothelial cells (HMEC-1) by MTT assay. It is a known fact that the endothelial cells form the lining of the blood vessel wall and therefore play a significant role in retaining the vascular homeostasis. During stent placement, the injury caused to the vessel wall or the incompatibility of the stent material with the blood components could lead to the development of neointimal hyperplasia causing stent restenosis. Therefore, accelerating the endothelialisation of the stent could speed up the natural healing process, thereby avoiding in stent restenosis (Ong et 
al., 2005). The assessment proved that no cytotoxic degradation products were 




 released from the blend as well as neat P(3HO) films, however % cell viability was higher for the blend films compared to the     neat P(3HO) films. According to literature, P(3HB) and its derivatives are present in human blood and tissues as endogenous metabolites. They are non-toxic in nature (Volova and Volova, 2004). Also,  P(3HB)  used  in  this  study  was  produced  by  Bacillus cereus SPV,  a  Gram positive bacteria which is free of lipopolysaccharides (LPS), a known endotoxin found in the Gram negative bacteria. However, the P(3HO) that was used in the synthesis of the blend films were produced by  Pseudomonas mendocina, a  Gram negative bacteria, which is known to have lipopolysaccharide (Rai et al., 2011). P(3HO) used in this study was thoroughly purified, however it      might have contained traces of LPS leading to relatively lower cell viability. One of the major requirements of a successful stent implantation is its rapid endothelialisation to prevent inflammatory response. This aspect could be verified further using surface cell proliferation and animal studies.  Thermal characterisation of  the  blend  films  were  carried out  to  investigate the effect of P(3HB) on the thermal stability of the blend films. There was an increase in the glass transition temperature (Tg) of the blend films with the increase in the amount of P(3HB) compared to the Tg of neat P(3HO) film.  The increase in the Tg of the blend films with increasing P(3HB) content could be due to the presence of the crystalline P(3HB) within the P(3HO) matrix, hence restricting the mobility of the amorphous phase comprising mainly of P(3HO) (Qiu et al., 2005). As summarised in Table 5.1, only one Tg values was obtained for all the blends indicating that the blends were miscible (Kai et al., 2003; Luo et al., 2009). Luo et al., demonstrated the increase  in  the  Tg   of  the blend  films  of  P(3HB-co-HHx)  and  P(3HB-co-4HB) compared to the Tg  of the neat P(3HB-co-4HB). The authors also stated that only one Tg value  was obtained indicating complete miscibility of the P(3HB-co-HHx) and P(3HB-co-4HB) blends (Luo et al., 2009). Similar results were obtained in another study,  where there was an increase in the Tg value of  polylactic acid (PLA) and polyurethane (PU) blend films compared to the Tg value of PU films with a low crystallinity compared to PLA (Li and Shimizu, 2007).  Similar trends were observed in the melting temperature (Tm) of the blend films. There was an increase in the Tm  of the blend films with the increase in the amount of P(3HB) in the blend film compared to the neat P(3HO) film. The results indicated 
  
Chapter 5: Results  that there was increase in the thermal stability of the blend films. This is due to the increase  in  the  crystallinity  of  the  blend  film  owing  to  the  presence  of  the crystalline P(3HB) polymer. According to literature, the increase in melting temperature occurs when the mobility of the amorphous region is restricted due to presence of composites or fillers of crystalline nature (Qiu et al., 2005). The crystallization temperature (Tc) also increased with increasing P(3HB) content in the film. The crystallization of the polymer occurred during the cooling run from 200°C  to   -50°C.  The  blend   films  with  the   higher  concentration  of  P(3HB)  crystallized rapidly at a higher temperature during the cooling whereas the crystallization occurred at a slightly lower temperature in the blend    films with increasing amount of P(3HO. This is possibly due to the positive effect of the presence of P(3HB) which accelerates the nucleation process of P(3HO) spherulites (Qiu et al., 2005). Similar results were obtained where there was a decrease in the crystallization rate of the P(3HB)/P(3HB-co-3HHx) blend films with the increase in the concentration of P(3HB-co-3HHx) which has a low crystallinity compared to the highly crystalline P(3HB) (Kai et al., 2003).  Mechanical characterisation of these blend films were carried out  to understand the  effect  on  the  P(3HB) on  the  mechanical  properties of  the  blend  films.  The Young’s Modulus values (E values) which is the measure of the stiffness increased with the increase in the concentration of P(3HB) in the blend film. This increase in stiffness of the blends with  increased P(3HB) content is  most  likely  due  to  the increase  in  the  crystallinity  of  the  blend  films  with  increased  incorporation  of crystalline  P(3HB). From literature, it  has been  established that  the  increase in crystallinity enhances the stiffness of the material whereas their ductility is highly reduced (Rai et al., 2011). These DMA results were in agreement with the thermal characterisation results, demonstrating an increase in the crystallinity of the blend films. It has also been shown in our previous studies that the presence of bacterial cellulose microcrystals in the P(3HO) matrix  increased the Young’s modulus of the P(3HO)/bacterial cellulose composite film compared to the neat P(3HO). This was due to the presence of highly crystalline cellulose microcrystals within the P(3HO) matrix (Basnett et al., 2012). Another study demonstrated similar  results where there was an increase in the E values of polylactic acid (PLA)/MCL-PHA blend films with an increase in the concentration of crystalline PLA within the film (Martelli et 
al., 2012).   
165 




 The tensile strength of all blend films also increased compared to the neat P(3HO) film. However, the tensile strength of the P(3HO)/P(3HB) 20:80 blend film which has the highest concentration of the P(3HB) content was slightly lower compared to the    P(3HO)/P(3HB) 50:50 blend film. Similar results were observed in our previous study when P(3HO) films were reinforced using bacterial cellulose. A low value of tensile strength was measured for the P(3HO) film containing the highest concentration of bacterial cellulose microcrystals. This could be due to the increase in the stiffness causing P(3HO)/P(3HB) 20:80 blend film to be brittle (Basnett et al., 2012). Kai et al., observed higher tensile strength values with higher concentration of P(3HB) within the P(3HB)/P(3HB-co-3HHx) blends. This increase in tensile strength was  due  to  the  higher crystallinity of P(3HB) compared to  P(3HB-co- 3HHx) (Kai et al., 2003). Li and Shimizu, 2007 also demonstrated high values of Young’s modulus and tensile strength vlaues for PLA/PU blends observed with high concentrations of crystalline PLA within the film (Li and Shimizu, 2007).  The elongation at break values of the blend films were lower compared to the neat P(3HO) film. This is possibly due to the lack of adhesion of the two phases, i.e., P(3HO) and P(3HB) in certain regions form weak points in the films causing them to be brittle in nature. Similar results were obtained in a study where there was a decrease in the elongation at break values of the PLA/PU blends with the increase in the PLA concentration within the film. An investigation was carried out to understand the mechanism causing a change in the elongation at break values of the blend films. They observed the tensile tested specimen under the SEM to study the  morphology of  different necking  regions.  They  concluded  that  the  PLA/PU blend films were a partially miscible system bearing two different morphologies. This was in disagreement with their DSC results that showed only one Tg value for all the blends indicating complete miscibility (Li and Shimizu, 2007). However, the Young’s modulus and tensile strength values need to be be further improved by reinforcing these blend films with fibres or fillers. The standard reference for the mechanical properties desired for a stent development is SS316L stainless steel. It is the most commonly used material for the development of vascular stents. It has a tensile strength, Young’s modulus value and % elongation at break value of 490 MPa, 193 GPa and 40% respectively. It has a radial strength value of 135 KPa. Radial strength is key in determining the success of the stent after its implantation within the body. In order to meet the clinical 




 requirements, the radial strength value should be in a range of 80-120 KPa (Feng et 
al., 2011).    With significant improvement in mechanical properties, these novel blends could be used for the development of biodegradable stents. Feng et al.., demonstrated a  significant increase in  the radial strength of the poly-p-dioxane stent with a novel sliding lock architecture compared to the poly-p-dioxane stent with a  basic net tube  structure. They concluded that  the stent architecture also plays an important role in improving the mechanical properties of the stents (Feng 
et al.,  2011).  These  blend  films  developed in  this  study  could  also  be  used  as scaffolds for tissue engineering applications. Another important characterisation that was carried out on these blend films was the in vitro degradation study. Biodegradability is considered to be a significant feature of a biomaterial with potential medical application (Li and Shimizu, 2007). Previous studies have shown that biodegradability of a polymer blend system is dependent on factors such as the surface blend composition, phase structure or the miscibility of the blend  components and the  blend  composition (Ikejima  et al., 1998).   The blend film P(3HO)/P(3HB) 20:80 had the highest percentage of water absorption and highest percentage of weight loss in both DMEM and PBS media. It is known that P(3HB) is known to be more hydrophilic than P(3HO) due to the presence of a relatively shorter hydrophobic side chain, therefore, this was an expected result.    Previous studies have also shown that there is an association between water uptake and progressive degradation and hence weight loss of the samples. Hydrophilicity of the biomaterial plays a very important role in the hydrolytic degradation of the biodegradable polymer (Renard et al., 2004). During this study, the film samples were incubated in enzyme free media and hence, degradation in the films would have occurred solely due to hydrolysis. Hydrolytic degradation would have occured in two stages. Initially, the water molecules would have  begun  to   cleave  the  amorphous  part  of  the  polymer  followed  by  the degradation of crystalline part of the polymer (Volova and Volova, 2004). The presence of P(3HB) on the surface of the blend films would have made the blend films more hydrophilic compared to the hydrophobic surface of the P(3HO) film. (Ikejima et al., 1998). This would have lead to an increased water uptake resulting in an increase in hydrolytic degradation. 




 Therefore, surface composition of the blend films plays a crucial role during the initial stages of degradation. It is a known fact that the degradation of the PHAs occurs via surface erosion as opposed to the bulk degradation observed in the case of PLA. This would lead to highly controlled degradation, maintaining the core structure, a highly desirable property in an ideal biodegradable stent. These blend films could also be used as the tissue engineering scaffolds. Due to their mechanical properties, especially their elastomeric nature, tailorable degradation property and biocompatibility, these blend  materials could also  be  used for soft tissue engineering.  Depending  on  the  desired application,  the  degradation rate  of  the blend can be tailored and controlled by modifying the relative composition of the two types of PHAs (Rathbone et al., 2010). Another potential application of these blend films could also be in the area of drug delivery. Due to the surface erosion degradation mechanism, the controlled release of drugs can be achieved (Gopferich, 1996).  In conclusion, this study led to the development of P(3HO)/P(3HB) blends with increased Young's modulus, tensile strength, thermal stability and tailorable biodegradability as compared to neat P(3HO) film. The results of the cytotoxicity assessment have demonstrated that these blend films are not toxic to the HMEC-1 cells. With further improvement in the tensile strength, these novel blends could also be used for the development of biodegradable stents.      
Part II    Endothelial cells act as an interface between the blood and the vessel wall. In order to avoid a vascular dysfunction, it is imperative to maintain a healthy endothelial layer. In recent times, studies have been carried out to understand the function and the characteristics of the endothelial cells. The findings have suggested that the endothelial cells alter their morphology and function depending on their alignment (Uttayarat et al., 2008; Anderson and Hinds, 2011). However, these studies were carried out in the presence of the blood flow. One of the techniques employed in understanding the behaviour of endothelial cells under static conditions is the micropatterning technique. Using this technique, micro topographical features are created on the surface of the substrate on which the cells are cultured under static 




 conditions. These topographical cues allow cells to adhere and proliferate in an aligned   fashion  (Thery,  2010).  It   is   a   known   fact   that   surface  topography determines the biocompatibility of a biomaterial by governing various important processes and properties such as protein adsorption, wettability, cell adhesion, proliferation and migration (Duncan et al., 2007). In this study, P(3HO)/P(3HB) 50:50 blend films were surface micropatterned using the laser micropatterning technique to allow the cells to grow in an aligned manner or give a definite orientation to the cells. Bearing in mind the potential application of these micropatterned blend films as platform materials for the development of a biodegradable  stent  ,  their  biocompatibilty  with  the  endothelial  cells  is  crucial. Previous studies have shown that the formation of an endothelial cell monolayer on the surface of artificial conduits have resulted in a decreased thrombus formation and  intimal  thickening  (Kidd  et  al.,  2003).  Some  of  the  biomaterials  have  been deemed  incompatible  and   toxic   due   to   their  inability   to   integrate  with   the surrounding tissues. Therefore, it is extremely important for a biomaterial to be able to encourage the adhesion and proliferation of specific cells (Hallab et al., 2001)   As mentioned earlier, surface topography determines the biocompatibility of a biomaterial (Duncan et al., 2007). Microstructural studies of the micropatterned blend film samples were studied using SEM. The SEM images confirmed that microgrooves had been successfully created using the laser micropatterning technique. The surface roughness measurements of the micropatterned blend films were carried out using AFM. This was done to study the effect of micropatterning on the surface roughness of the blend films. Hence, there was a drastic increase in the surface roughness of the micropatterned surface due to the micropatterning. Increased surface roughness is an inevitable outcome of most surface micropatterning techniques. However, the extent depends on the type of the micropatterning technique and the material (Gogolides et al., 2006). As mentioned in part I, surface roughness is known to play a significant role in cell adhesion and proliferation,   providing   cells   with   adhesion   points   for   migration   (Hao   and Lawrence, 2006a). Previous studies have shown that the cells prefer to attach to the  rough  surface  of  the  implants  compared  to  the  smooth surface.  Therefore, several investigations have been carried out on the micropatterning of the implants for better cell attachment (Hallab et al., 2001). 




 Water contact angle studies were carried out on the micropatterned blend films. Surface micropatterning of the blend films by laser micropatterning lowered their water contact angle, making them more hydrophilic compared to the plain blend film. In a similar experiment conducted by Yu et al., a polycarbonate (PC) film was surface micropatterned using Laser Interference Lithography (LIL) to study the in 
vitro cell response. They observed that surface micropatterning led to a decrease in the water contact angle by 10 degrees compared to the unfabricated PC film. They also found that this decrease in the water contact angle was advantageous for cell adhesion (Yu et al., 2005). In another experiment conducted by Li et al., a polyethylene terephthalate film was micropatterned using laser ablation. They studied the effect of the micropatterning on the equilibrium water contact angles. They found that the water contact angle of the laser modified surface was lower compared to the unmodified surface (Li et al., 2003). This decrease in the water contact  angle  of  the  micropatterned blend  film  could  be  due  to  the  increased surface roughness previously seen in this study. Previous studies have shown that hydrophilic surfaces are favourable for cell attachment and proliferation (Li et al., 2003). Therefore, an increase in the hydrophilicity of the biomaterial is a desirable property   Another characterisation that was done on the fabricated blend film samples was the protein adsorption test. In this study, there was an increase in the total protein adsorption in the micropatterned blend film compared to the plain P(3HO)/P(3HB) 50:50 blend film. Therefore, this increase in the total protein adsorption was  most  likely due to the increase in the hydrophilicity and the increase in the surface roughness. The results in this study was in agreement with the results of previous studies stating that surface roughness, hydrophilicity and total protein adsorption are interrelated (Das et al., 2007). In a study carried out by Sato and Murahara in 2012, a poly(tetrafluroethylene)(PTFE) material was modified using excimer laser irradiation. They measured the total protein adsorption on the modified samples and compared it to the total protein adsorbed on to the unmodified samples. They stated that there was a marked increase in protein adsorption on the modified samples  compared to  the  unmodified samples.  They made  an  important observation  that  the  higher  amount  of  protein  was  attached  to  the  modified samples with a lower water contact angle. This demonstrated that an increase in 
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 hydrophilicity resulted in an increase in protein adsorption (Sato and Murahara,  2012). Several studies have been carried out in the past to surface fabricate various materials to enhance protein adsorption to improve the biocompatibility of the material (Hao and Lawrence, 2004).  Mechanical characterisation of the fabricated blend film samples was carried out to evaluate the effect of the surface modification on bulk properties such as Young’s modulus, tensile strength and elongation at break. There was a decrease in the Young’s modulus and the tensile strength values of the micropatterned blend films. However, there was an increase in the elongation at break values of the micropatterned blend films compared to the plain blend films. These values were statistically tested using t-test and the difference were considered significant when the *p<0.05. The decrease in the Young’s modulus values of the micropatterned blend films were considered to be statistically significant. However, the decrease in the tensile strength and the increase in the % elongation at break value were considered to be statistically insignificant. This demonstrated that the bulk properties of the blend film  remained intact  while the surface characterisations have shown that there were drastic changes in the     surface properties of the fabricated blend film. One of the major advantages of using laser micropatterning technique over the other chemical modification methods is that it does not affect the bulk properties of the biomaterial (Li et al., 2003). This was confirmed in this study where there was very little change in the mechanical properties post laser micropatterning.  Cell  culture  studies  were  carried  out  to  determine  the  effect  of  the  surface micropatterning on the adhesion and the proliferation of the HMEC-1 cells. There was   an   increased  cell   adhesion  on   the   micropatterned  blend   film   samples compared to  the  plain  blend  film  samples.  Apart  from  the  obvious reason,  i.e. surface micropatterning, this increased cell adhesion could also be due to factors such as increased hydrophilicity and protein adsorption. Hallab et al., demonstrated that the increased surface roughness due to the laser modification resulted in an increase in number of the 3T3 MC fibroblast cells adhering to the polymer surface (Hallab et al., 2001).      
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 At   the  end  of  the  7th    day,  there  was  47%  increase  in  the  percentage  cell proliferation on the laser micropatterned surface compared to the plain blend films. In an experiment conducted by Dadsetan et al., in 2001, polyethylene terephthalate (PET) films were modified using laser irradiation. Microstructures of various dimensions were created on the surface of these PET films. In order to study the effect  of surface micropatterning on cell  response, they cultured L929 fibroblast cells on these PET films. They demonstrated increased cell proliferation on these micropatterned PET films. They concluded that this increase in cell proliferation was   due   to   the   change   in   surface  topography  and   increased  hydrophilicity (Dadsetan et al., 2001). Rebollar et al., conducted a study where a polystyrene foil was modified using  laser irradiation. The surface topography of  the  polystyrene foils were modified and Human Embryonic Cells (HEK-293), Chinese hamster ovary (CHO-K1) cells and skeletal myoblasts were grown on this modified surface. They observed an  increase in  the  cell  attachment and the  proliferation of  all  the  cell types on the modified polystyrene foils compared to the untreated foils (Rebollar et 
al., 2008).  Hence, the finding reported in this study is in agreement with the results obtained by several researchers in the past.   SEM studies were carried out to observe the alignment and morphology of the HMEC-1 cells on the micropatterned blend films compared to the plain blend films. It is  known  from the  literature that  the alignment  and the morphology of the endothelial cells is determined by the blood flow. It is also known that aligned and elongated endothelial cells exhibit healthy characteristics. Several attempts have been  made  to  obtain  an  aligned growth  of  endothelial cells  with  an  elongated morphology  under  static  conditions  (Gray  et  al.,  2002).  The  micropatterning technique has been used widely in recent times due to its ease of handling, time efficiency and its ability to produce various micropatterns with precision. They                   
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 have  been  used  for  surface  fabrication  of  vascular  grafts,  stents  and  tissue engineering scaffolds (Thery, 2010; Anderson and Hinds, 2011). When  the  cells  are  grown  on  the  surface  with  grooves,  they  tend  to  align themselves  along  the  direction  of  the  groove  and  change  their  morphology. However, the alignment of the cells depends on the dimensions such as the width and the depth of the grooves present on the surface (Wilkinson et al., 2002). During cell migration on the flat surface, the cytoskeleton of the cells migrate from near the nucleus towards the periphery of the cells in different direction whereas on the micropatterned surface, the cell microfilaments responsible for the cell movement bundle together and migrate along the direction of the groove (Wilkinson et al., 2002). Therefore, cells cultured on the micropatterned surfaces seem to grow in an  aligned fashion compared to the cells on the flat, smooth surface.  Several studies have been conducted to demonstrate the effect of micropatterning on the alignment and the morphology of the endothelial cells. In one of the studies, endothelial cells were cultured on silicon platforms patterned with microchannels of 25-220 µm width.  The authors observed increased alignment of the endothelial cells on the micropatterned silicon platform compared to the unmodified surface. They also observed that the endothelial cells displayed an elongated morphology. They stated that the endothelial cells became increasingly elongated with decrease in the size of the microchannels on the surface of the silicon platform (Gray et al., 2002).  Li et al., 2001 demonstrated that 80% of the cells seeded on the surface modified PET films were aligned in a definite direction. They made an observation that the width of the microgroove played a significant role in the orientation of the cells. They observed that the laser micropatterned surface affected the focal adhesion points  as  well  as  the  cell  migration  (Li  et al., 2001).  In  a  study  conducted by Uttayarat et al., microgrooves of various dimensions were created on the surface of the silicon wafers. Human aortic endothelial cells (HAEC) were cultured on these surface modified silicon wafers in the absence of the flow. They observed that the 3D microgrooves on the surface provided an important stimulus that guided the cells to migrate in a definite direction. 90% of the HAEC cells were aligned parallel to   the   microgrooves.   They   made   an   important   observation   that   the   3D microgrooves provided additional anchorage sites compared to  the unmodified    
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 surfaces,  thereby  increasing  the   cell   adhesion  followed   by   aligned   growth  (Uttayarat et al., 2008).  In another study, bovine aortic endothelial cells were cultured on a collagen strip micropatterned with the creation of parallel grooves of three different widths such as 15, 30 and 60 µm. The authors observed that the cell alignment and elongation was   higher   on   the   micropatterned  surface   of   all   widths   compared  to   the unmodified surface. However, the cell alignment and the elongation were highest in the grooves with the smallest width (15 µm). The authors stated that this was due to the smaller area available for the endothelial cells to spread causing the morphology of the cells to become elongated and to migrate along the direction of the groove (Li et al., 2001). The results in this part of the study were in agreement with the findings of the previous studies.  In  conclusion, surface micropatterning of  the  P(3HO)/P(3HB) 50:50 blend film using laser, increased their surface roughness, hydrophilicity and total protein adsorption. Mechanical characterisation confirmed that the bulk properties of the blend films were not drastically affected by surface micropatterning.     Cell  culture  studies  showed  that  there  was  increased  cell adhesion and cell proliferation on the fabricated blend films compared to the unfabricated blend films. SEM imaging showed that the cells had proliferated in an aligned manner.   
Part III    One of the most desirable characteristics of an ideal stent is its ability to deliver drugs at the site of injury to prevent in stent restenosis (Cantor  et al., 2000). In this study,  P(3HO)/P(3HB)  50:50  blend  film  were  investigated  for  their  ability  to deliver aspirin in a controlled manner. The P(3HO)/P(3HB) 50:50 blend film containing aspirin was successfully prepared by using the solvent casting method.                 
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 The effect of aspirin loading on the surface, mechanical, thermal and degradation properties of these blend films were studied. In vitro drug release studies were carried out. The FTIR spectrum confirmed the presence of the aspirin within the P(3HO) matrix. Detailed surface analysis was carried out to investigate the effect of drug loading on the surface topography of the blend films using SEM. A uniform surface of the blend film with aspirin was revealed compared to the rough surface of the blend film without aspirin using SEM. The results indicated that aspirin was homogenously dispersed within the matrix of the blend film. Similar observation was made in a study where the surface of the aspirin loaded polyesterurethane network appeared to have a uniform surface. The authors attributed this to the homogenous dispersion of aspirin within the network in an amorphous form (Zhang et al., 2010). Pang et al., demonstrated a correlation between the % drug loading and the surface topography. The authors observed the formation of voids on the surface of the films with higher loading of ibuprofen compared to lower drug loading concentrations (Pang et al., 2011). Similar observations were made where theophylline and salicylic acid crystals were visible on the surface of the chitosan films at a drug loading higher than 10% and 30% drug loading respectively. The authors concluded that this was due to the crystallization of the theophylline crystals during the film processing (Puttipipatkhachorn et al., 2001). At 15% aspirin loading, no aspirin crystals were visible on the surface of the blend films. In future, different drug loading concentrations could be studied to have an indepth understanding of the effect of drug loading on the surface topography. Surface  roughness  of  these  blend  films  with  aspirin  as  well  as  the  blend  film samples without aspirin were measured using the AFM. AFM measurements were in agreement with the SEM results. This decrease in the surface roughness of the blend films with aspirin could be due to the homogenous dispersion of the aspirin within  the  matrix  of  the  blend  film.  The  absence of  the  aspirin crystals  on  the surface  of  the  blend  film  also  revealed  that  the  aspirin  was  present  in  an amorphous form (Zhang et al., 2010). In order to evaluate the effect of the aspirin loading on the wettability properties of the blend film, water contact angle studies were carried out. This decrease in the water contact angle indicated that the presence of aspirin within the blend film had 




 increased its hydrophilic properties compared to the blend film without aspirin.  It is a known fact that aspirin is a hydrophilic drug and has a water solubility of 3 mg/ml (Aubrey-Medendorp et al., 2008). It is known that wettability is generally related to the surface roughness of the biomaterial (Das et al., 2007). However, AFM results have shown that there was a decrease in the surface roughness of the blend  film  with  aspirin. Therefore, in  this particular  study,  the increase in  the hydrophilicity of the blend film could be solely attributed to the presence of the hydrophilic aspirin within the blend film. Similar observations were made by Paul and Sharma in 1997, where there was  an increase in the hydrophilicity of the aspirin  loaded  PVA  membranes  compared to  the  unloaded  PVA  membrane.  A decrease in  the  water  contact  angle  with  the  increase in  the  concentration of aspirin within the membrane was observed. This increase in the hydrophilicity was attributed to the presence of hydrophilic aspirin within the PVA membranes (Paul and Sharma, 1997). A similar effect was also observed when hydrophilic BioglassTM particles were incorporated within the P(3HB) composite films (Misra et al., 2008). The total protein adsorption test was also carried out on the blend film with aspirin to  assess  the  effect  of  the  presence  of  the  aspirin  within  the  blend  film.  As mentioned previously, protein adsorption is generally found to be higher on the hydrophilic surface (Hao and Lawrence, 2006b). This was in agreement with the results  of  this  study.  The increased protein adsorption on  the  blend film  with aspirin  compared to  the  blend  film  without  aspirin  is  most  likely  due  to  the increase in the hydrophilicity owing to the presence of aspirin within the matrix. The   model   protein   used   in   this   study   was   Bovine   serum   albumin   (BSA). Jeyachandran et al., demonstrated that 95% of Bovine BSA was adsorbed on the hydrophilic surface while  the  hydrophobic surface was  saturated  at  50%.  The authors observed that the molecular confirmation and the adsorption strength of BSA varied on both the surfaces (Jeyachandran et al., 2010). This was in agreement with the results observed in this study. Another study demonstrated that there was an  increase in  the total  protein adsorption on the gentamicin loaded polyvinyl alcohol/dextran hydrogel compared to the unloaded gel. The authors attributed this increase in the protein adsorption to the presence of the hydrophilic drug gentamicin (Hwang et al., 2010). Similar observations were made where there was an increase in the total protein adsorption on the tetracyline loaded microsphere films  compared  to  the  unloaded  film.  This  was  due  to  the  increase  in  the 




  hydrophilicity  of  the  tetracycline  loaded  film  compared  to  the  unloaded  film (Francis et al., 2010). This increase in the protein adsorption was considered to be an encouraging result. Another characterisation that was done on these  blend films  with aspirin was the indirect cytotoxicity testing. This was carried out to determine the effect of the aspirin on  the growth  of HMEC-1 cells.  Considering the potential application  of these P(3HO)/P(3HB) 50:50 blend films with aspirin as the base material for the drug  eluting  stent  development, it  is  very crucial  that  they demonstrate compatibility with the HMEC-1 cells. There was an increase in the % cell viability with the blend films with aspirin compared to the blend without aspirin. Podhaisky 
et al., conducted an experiment to study the effect of aspirin Bovine pulmonary artery endothelial cells (CCL 209) under oxidative stress conditions. They demonstrated that the presence of aspirin at an anti-thrombotic concentration helped maintain the endothelial integrity and preserved their function as compared to the endothelial cells incubated without the aspirin (Podhaisky et al., 1997). This finding   was   supported   by   another   study   that   confirmed   the   anti-oxidative properties of aspirin on vascular tissues (Wu et al., 2002). Similar findings were reported where, aspirin at a therapeutic concentration prevented endothelial cells senescence or ageing by inducing the production of nitric oxide and by reducing the oxidative  stress  (Bode-Boger  et  al.,  2005).  This  could  be  the  reason  for  the increased viability of the HMEC-1 cells in the presence of blend films with aspirin. The results of this study were considered to be very encouraging and established the potential of these blend films with aspirin in the area of drug eluting biodegradable stents.  Thermal characterisation of  these  blend  films  with  aspirin  were  carried out  in order to investigate the effect of aspirin loading on the thermal properties of the blend films. There was a decrease in the glass transition temperature (Tg) of the blend films with aspirin compared to the blend films without aspirin. This result indicated that there was an increased mobility within the amorphous region of the polymer blend with aspirin compared to the blend film without aspirin causing a decrease in the Tg (Siepmann and Gopferich, 2001).  Also, the decrease in the Tm of the blend film with aspirin confirmed the decrease in the overall crystallinity. This indicated that the aspirin was incorporated within the crystalline region of the polymer blend causing disruption within the crystalline arrangement, leading to 




  the decrease in Tm values. Renard et al., observed a decrease in the melting temperature of the ibuprofen loaded within the PLGA film. The authors attributed this to the decrease in the crystallinity of ibuprofen (Renard et al., 2004).  Zhang et 
al., observed the absence of the melting peak of aspirin when loaded within the polyesterurethane network. The authors concluded that the absence of the melting peak was due to the presence of the aspirin within the network in an amorphous form (Zhang et al., 2010).   In this study, heating scan from -50°C to 200°C , the polymer blend  were  subjected  to  the  cooling  scan  from  200°C to  -50°C  during which  the  polymer  blend  crystallized.  The  P(3HO)/P(3HB)  50:50  blend  film samples without aspirin crystallized at a lower temperature whereas the   blend film with aspirin crystallized rapidly at a higher temperature. This result confirmed that there was a decrease in crystallinity due to the incorporation of the aspirin within the blend film. A similar observation was made where there was a decrease in the Tg, Tm  and the Tc  of the polyvinyl/dextran hydrogel loaded with gentamicin compared to the unloaded hydrogel (Hwang et al., 2010). Another study similarly demonstrated a decrease in the overall crystallinity of the PLGA film loaded with ibuprofen compared to the unloaded PLGA film. The authors concluded that this decrease in the crystallinity of the films was confirmed using the X-ray diffraction technique (XRD) and was responsible for the decrease in their thermal properties (Pang et al., 2011).  Mechanical characterisation of these blend films with aspirin were carried out to investigate the effect of drug loading on the mechanical properties of the blend films. Addition of aspirin in the blend films had a drastic effect on their mechanical properties. The tensile strength and the Young’s modulus values of the blend  films with aspirin   were lower compared to the blend films without aspirin. However, the % elongation at break values was higher indicating an increase in the flexibility with the addition of aspirin. These results were in agreement with the DSC results that indicated a decrease in the overall crystallinity of the blend film with aspirin. Zilberman and Persson, 2002 observed a similar decrease in the tensile strength and the Young’s modulus of the dexamethasone loaded Poly(L-Lactide) or PLLA film. The authors observed that    this decrease was due to the incorporation of the dexamethasone molecules within the matrix of the film rather than on the surface. They also observed that this decrease in the tensile strength and the Young’s modulus was due to the poor interaction between the dexamethasone molecules 




  with the polymer matrix (Zilberman and Persson, 2002).   Another similar study demonstrated  a   decrease  in  the  tensile  strength  of  the  aspirin  loaded  PVA membrane with the increase in the concentration of aspirin within the membrane. The % elongation at break values however increased with the increase in the concentration  of  aspirin.  The  authors  concluded  that  the  increase  in  the  % elongation at break values was due to the decrease in the crystallinity of the aspirin loaded PVA membranes allowing less inhibited movement of the polymer chains within  the  membranes  (Paul  and  Sharma,   1997).  Hence,  increase  in  the  % elongation at break value of the blend film with aspirin in this study indicated an increase in the flexibility which is a direct consequence of a decrease in the crystallinity. The findings of this study suggested that the aspirin loading had a drastic effect on the mechanical properties of the blend film. One would need to significantly improve the  mechanical properties of these films  in order to  make them suitable in biodegradable stent development. Another important characterisation that was carried out on these blend films with aspirin was the in vitro degradation study. According to literature, it is known that polyhydroxyalkanoates degrade via  surface erosion. Due  to  this,  they are considered to be suitable for controlled drug delivery studies (Pouton and Akhtar, 1996). During surface erosion, degradation initiates on the surface of the polymer and proceed towards the core. The integrity of the polymer is maintained for a longer period of time (Siepmann and Gopferich, 2001). It is known that the water absorption is directly proportional to the progressive degradation of the material (Naraharisetti et al., 2005). This could explain the higher percentage of weight loss in the P(3HO)/P(3HB) 50:50 blend film with aspirin compared to the P(3HO)/P(3HB) 50:50 blend film samples without aspirin. Previously, it has been demonstrated  that  the  presence  of  the  aspirin  molecules  increased  the hydrophilicity of the P(3HO)/P(3HB) 50:50 blend film. This would have led to the increased water uptake by the blend films during their incubation in PBS media. Increased water uptake, eventually increased the degradation rate. Frank et al., demonstrated a similar increase in the water uptake by the PLGA film loaded with lidocaine compared to the film without the drug. This increased water uptake resulted in a greater weight loss in the lidocaine loaded PLGA film. SEM images of the lidocaine loaded PLGA film after the drug release revealed  a rough surface with the pores and blisters indicating visible mass loss (Frank et al., 2005). In another study carried out by Paul and Sharma, 1997, there was an increase in the water 




  uptake in the PVA membranes containing a higher concentration of aspirin molecules. They attributed this to the presence of the hydrophilic aspirin within the PVA membranes. Zhang et al., demonstrated a similar increase in the degradation rate of the polyesterurethane network loaded with the aspirin. They attributed this to the increase in the hydrophilicity of the polyesterurethane network due to the presence of aspirin. The authors concluded that upon water absorption, aspirin which is an acidic drug (pka= 3.49), dissociated within the polyesterurethane network,  thus  affecting  the  pH  of  the  drug  loaded  polyesterurethane  network thereby accelerating its degradation (Zhang et al., 2010). Drug release kinetics is known to be dependent on a large number of different  factors including the type of the polymer, geometry, thickness and the surface area of the drug delivery vehicle, mode of release, type of the drug, drug loading concentration and the pH of the release medium (Acharya and Park, 2006). In this study, aspirin was released from the blend film in a controlled manner and a very low burst release effect was observed. It is known that the burst release occurs due to surface associated drugs (Pouton and Akhtar, 1996). The low burst release observed in this study attributed to the presence of the aspirin within the blend matrix rather than on the surface. The burst release of 9±1.5%   observed in this study was   significantly lower compared to the PLGA based in situ gel containing the PEG400 delivery system containing aspirin that   showed a burst release of 30.9±1.2%  (Tang and  Singh,  2008).  Chen  et  al.,  demonstrated an  aspirin  burst release of 21% within 1 minute from the magnetic nano composites with 23% drug loading (Chen et al., 2012). From the drug release pattern obtained in this study, it is evident that the drug  release occurred in two stages. The drug release from the P(3HO)/P(3HB) 50:50 blend film during the first stage would have occurred due to surface erosion. The rate of the drug release was slow during this stage. The drug release in the second stage would have been accelerated due to the increase in water uptake by the blend film with the drug which resulted in increased degradation. The presence of aspirin which is hydrophilic in nature would have accelerated the penetration of water molecules, thereby having a significant effect on drug release. The finding of this study was in the agreement with drug release pattern of the aspirin loaded polyesterurethane  film.  The  authors  described  the  release  of  aspirin  in  three different stages. There was no burst release effect. This was due to the cross linking 




  network of the polyesterurethane that  prevented degradation. Drug release rate increased during the second stage due to the increase in the water uptake which accelerated the diffusion of the drug from within the network. The drug release rate decreased during the third stage due to the low concentration of the drug within the network (Zhang et al., 2010). In  conclusion,the  drug  release  pattern  in  this  study  demonstrated  controlled  release of aspirin throughout the release period. This suggested that the aspirin P(3HO)/P(3HB) 50:50 blend with aspirin would be suited for the drug delivery applications. In future,a further investigation into the antithrombotic effect of the released aspirin from the blend film could be carried out. Previous studies have shown that it is critical to maintain the therapeutic index (TI) of the drug. One of the studies demonstrated the anti-thrombotic effect of the aspirin by carrying out platelet adhesion test. The authors incubated the aspirin loaded PVA membranes in the  platelet  rich  plasma.  The  SEM  micrographs  revealed  the  anti-thrombotic property of the aspirin loaded PVA membranes (Paul and Sharma, 1997). A similar experiment could be carried out in the future to investigate the anti-thrombotic property of the P(3HO)/P(3HB) 50:50 blend film containing aspirin . 
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Chapter 6: Introduction   
INTRODUCTION  Poly  (3-hydroxybutyrate) or  P(3HB)  is  a  member  of  the  polyhydroxyalkanoate (PHA) family which includes -R(3HA) monomer units (Sudesh et al., 2000). P(3HB) is one of the most commonly occurring SCL-PHAs (Huisman et al., 1989; Valappil et 
al., 2007). In 1926, Lemoigne identified lipid like inclusions within Bacillus 




















Chapter 6: Results 
 
6.1 Preparation of the P(3HB) solvent cast film with and without aspirin and their characterisation.  P(3HB) produced was used to prepare a solvent cast film and aspirin was added to the P(3HB) film. P(3HB) film with and without aspirin were prepared using the solvent casting method. P(3HB) was     dissolved in dichloromethane in order to obtain a polymer concentration of 5wt%. In order to prepare P(3HB) film with aspirin, aspirin was dissolved in dichloromethane and mixed with the polymer solution  to  achieve a  drug  loading  of  15wt%.  The  polymer  solution  containing aspirin was mixed well by sonication and then cast into a glass petri dish immediately to achieve a uniform distribution of aspirin within the polymer matrix. P(3HB) film without aspirin was  prepared to investigate the effect of drug loading on the properties of the film. The film was air dried for one week. Films of 0.18 mm thickness were produced as shown in Figure 6.1.                  
(a) (b)  
Figure 6.1: Solvent cast (a) P(3HB) film and the (b) P(3HB) film with aspirin  The presence of the aspirin within the P(3HB) matrix was analysed using FTIR.   
6.1.1 Fourier Transform Infrared Spectroscopy (FTIR):  FTIR analysis was carried out on the P(3HB) film with and without aspirin using the method described in section 2.6.1. This analysis was performed to confirm the presence of aspirin within the matrix of the P(3HB) film. The IR Spectrum of the (a) P(3HB) film with aspirin (-) and the (b) P(3HB) film (-) is shown in Figure 6.2. 

























Figure 6.2: The FTIR spectra of the (a) P(3HB) film with aspirin and the (b) P(3HB)  film.   The characteristic absorption peaks at 1750 cm-1  corresponding to the carbonyl group and an absorption peak at 1605 cm-1, corresponding to the benzene ring and absorption peak at 2800 cm-1 corresponding to the carboxylic group present in the chemical  structure  of  aspirin,  were  all  observed  in  the  P(3HB)  film  containing aspirin (Li et al., 1999). This confirmed the presence of aspirin within the matrix of the P(3HB) film.    
6.1.2 Scanning electron Microscopy  Microstructural studies of the P(3HB) film samples with and without aspirin were carried out using SEM as described in section 2.9.1.  The surface topography of the P(3HB) film containing aspirin was compared to the topography of the P(3HB) film without aspirin as shown in Figure 6.3. The SEM images revealed that a new topography was introduced in the P(3HB) film with aspirin due to the addition of aspirin within the matrix of the P(3HB) film. 








                    
(a) (b)  
Figure 6.3: SEM images of the (a) P(3HB) film (b) P(3HB) film containing aspirin.    The surface of the P(3HB) film with aspirin appeared to have a rough topography compared to the P(3HB) film without aspirin. At 15% drug loading, aspirin crystals were observed on the surface of the film, indicating that aspirin had crystallized during the synthesis of P(3HB) film. The films were further characterised using Atomic Force Microscopy (AFM).   
6.1.3 Surface Roughness  In order to evaluate the effect of the aspirin incorporation on the surface roughness of the film, AFM analysis was carried out on the P(3HB) films with and without aspirin, as described in section 2.9.3. The AFM images of the surface of the P(3HB) film  and  the  P(3HB)  film  with  aspirin  are  shown  in  Figure  6.4.  The  surface roughness of the films  was  determined by  calculating typical  root mean  square (rms) values as shown in Figure 6.4. 
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(a) (b)   
Figure 6.4: The AFM images of the (a) P(3HB( film (b) P(3HB) film with aspirin.   The change in the topography of the P(3HB) film with aspirin was confirmed using AFM. The rms value of the P(3HB) film was calculated to be 0.24 ± 0.1 µm whereas the rms value of the P(3HB) film with aspirin was calculated to be 0.60 ± 0.3 µm. The surface roughness of the P(3HB) film with aspirin was 199% higher than the P(3HB) film without aspirin.  This confirmed that the presence of aspirin increased the surface roughness of the film.   
6.1.4 Water Contact Angle  Water contact angle measurements were carried out to study the effect of aspirin loading on the wettability of the P(3HB) films, as described in section 2.9.4  . It is known  from  literature  that  polymer  films  with  θ values  less  than  70o    are  considered to be hydrophilic in nature whereas θ values greater than 70o    are considered to be hydrophobic in nature (Peschel et al., 2008). The results of the water contact angle measurements are shown in Figure 6.5. 





































P(3HB) film P(3HB) aspirin film   
Figure 6.5: Static water contact angle measurements of the P(3HB) film and the P(3HB) film with aspirin. (n = 3). The data were compared using t-test and the difference were considered significant when *p<0. 05.  The water contact angle of the P(3HB) film with and without aspirin was 73.5○ ± 1 and 77○±3     respectively which is higher than 70○ and hence, they were both considered  to    be    hydrophobic  in    nature.    There  was    an    increase  in    the hydrophilicity of the P(3HB) film due to the presence of aspirin, however this increase was not significant.  
6.1.5 Protein Adsorption Test  The protein adsorption test was done to measure the overall protein adsorbed on the P(3HB) film with and without aspirin. This test was carried out to determine the effect of aspirin loading on protein adsorption on the P(3HB) film, as described in the section 2.9.7. The results of the protein adsorption tests have been summarised in Figure 6.6. 






                      
Figure 6.6: Protein adsorption on the P(3HB) film and the P(3HB) film with aspirin (n = 3). The data were compared using t-test and the difference were considered significant when *p<0. 05.  Protein adsorption on the P(3HB) film was 414±3 µg/cm2 while that on the P(3HB) film with aspirin was 739±2 µg/cm2. Hence, there was 78% increase in the amount of protein adsorbed on to the P(3HB) film due to the addition of  aspirin compared to the P(3HB) film without aspirin. This increase in the protein adsorption was statistically significant (*p<0. 05).     
6.1.6 Indirect Cytoxicity Testing  The samples of P(3HB) film and the P(3HB) film containing  aspirin were incubated in the DMEM for 24 hours at 370C. Simultaneously, HMEC-1 cells were cultured for 24 hours in 24 well plates at a concentration of 1000,000 cells/ml. The DMEM medium from step 1 was then exposed to the cells and cultured for another 24 hours. This was done to study the effect of the degradation products of the samples on the HMEC-1 cells. These studies were carried out as described in section 2.9.8 . The results of the tests are shown in Figure 6.7. 






































Figure 6.7: Indirect toxicity testing of the P(3HB) film with and without aspirin  (n  = 3). Cells grown in DMEM, in the absence of polymer were taken as untreated and the cells grown in the presence of 4% hydrogen peroxide were taken as the positive control. The data were compared using ANOVA and the difference were considered significant when *p<0. 05.  HMEC-1 cells grown in DMEM without any polymer showed a highest cell viability percentage of 100±0.3%, followed by the P(3HB) film with aspirin which showed a cell  viability  percentage  of  96.6±0.8%  .  P(3HB)  film  samples  without  aspirin showed a cell viability percentage of   95.0±0.9% while the   lowest percentage of cell viability of 6.2±0.0% was observed when the HMEC-1 cells were grown in 4% hydrogen peroxide, a chemical that is induces cell death. The increase in the % cell viability  in  the  P(3HB) film  with  aspirin  compared to  the  P(3HB) film  samples were not statistically significant.  
6.1.7 Differential Scanning Calorimetry  Thermal properties such as the melting temperature (Tm), glass transition temperature (Tg) and the  crystallization temperature(Tc) of the P(3HB) films with and without aspirin were analysed using DSC, as described in section 2.9.6.   This was done to study the effect of aspirin on the thermal properties of the P(3HB) film. The results are summarised in Table 6.1. 





Samples Tm (°C) Tg (°C) Tc (°C) P(3HB) film 170.3 ± 0.0 10.0 ± 0.0 109.5 ± 0.0 P(3HB) film with 
 aspirin 136.0 ± 0.5, 160.3 ±  0.7 9.0 ± 1.3 101.0 ± 0.2 
Table 6.1: Thermal properties of the P(3HB) films with and without aspirin (n = 3).   The melting temperature (Tm) of the P(3HB) film with aspirin was lower compared to the Tm   of the P(3HB) film without aspirin. A peak at 136.0°C was detected during the heating scan which corresponded to the Tm of commercial aspirin. The crystallization temperature (Tc) of the P(3HB) film with aspirin was also lower compared to the P(3HB) film without aspirin. During the cooling run (200°C to - 50°C), the P(3HB) film crystallized rapidly at a higher temperature compared to the P(3HB) films with aspirin. The glass transition temperature (Tg) of the P(3HB)  film with aspirin was also lower compared to the P(3HB) film without aspirin.    
6.1.8 In vitro degradation study in PBS 
6.1.8.1 Water absorption  
In vitro degradation study was carried out on the P(3HB) film samples with and without aspirin to examine the effect of aspirin on the degradation properties of the P(3HB) films. The percentage of water absorbed (%WA) by the P(3HB) films  with and  without  aspirin were  measured by  incubating  the  film  samples  in  the  PBS media for a period of 3, 15 and 30 days, as described in section 2.10. 










 The data obtained at the end of the incubation are presented in Figure 6.8.                    
(a) (b)                    
(c)   
Figure 6.8: Water absorption (%WA) by the P(3HB) and P(3HB) film samples with aspirin for a period of (a) 3 days (b) 15 days and (c) 30 days ( n=3). The data were compared using t-test and the difference were considered significant when *p<0. 05.   The % water absorbed by the P(3HB) film on day 3 was 1.4±0.3%. It increased progressively to 11.1±1% and 16.2±0.1% at day 15 and 30 respectively. Similarly, the % water absorbed by the P(3HB) film containing aspirin on day 3 was 5±0.4% which increased significantly to 31.9±0.9% and 35.8±0.6% on day 15 and day 30 respectively.  The   %   water   absorbed  by   the   P(3HB)  film   with   aspirin   was significantly higher compared to the P(3HB) film without aspirin(*p<0. 05). 
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6.1.8.2 Weight Loss  Percentage weight loss (%WL) of the P(3HB) films with and without aspirin were measured by incubating the film samples in PBS media for a period of 3, 15 and 30 days, as described in section 2.10. The data obtained at the end of the incubation period is represented in Figure 6.9.                    
(a) (b)                     
(c)  
Figure 6.9: % Weight Loss (WL) in the P(3HB) film with and without aspirin at (a) day 3 (b) day 15 and (c) day 30 ( n=3). The data were compared using t-test and the difference were considered significant when *p<0. 05.   The % weight loss (%WL) in the P(3HB) film on day 3 was 1.5±0.3% . It increased gradually to 4.7±1% on day 15, followed by 6.2±1.0% on day 30. A similar trend was observed in the P(3HB) film samples with aspirin where there was gradual increase in the % weight loss with time. On day 3, the % weight loss was 3.1±0.4%, 
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 which  increased  to  7.1±0.9%  on  day  15.  On  day  30,  the  %  weight  loss  was  10.2±0.6%. From the data, it was clear that  the % weight loss was significantly higher in the P(3HB) film with aspirin compared to the P(3HB) film without aspirin ( *p<0. 05).    
6.1.9 In vitro drug release studies 1 cm2 of the P(3HB) film samples with aspirin, in triplicates, were immersed in PBS  release medium. Their drug release rates were measured as described in section  
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Figure 6.10: In vitro release profile of aspirin from the P(3HB) film with aspirin for a period of 30 days ( n=3).   Aspirin was released throughout the period of 30 days. 92% of the total drug was released during this period. An initial burst release of 12.5± 7.0% was observed on day 1. After this initial burst, a controlled release of aspirin was obtained, where 28.8% of the total drug was released within the first 7 days. Finally, after 30 days,  the cumulative aspirin release was 92%. 
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 It is a known fact that aspirin upon hydrolysis loses its therapeutic activity. Therefore, it is very crucial to release aspirin in its chemically stable form (Aubrey- Medendorp et al., 2008).  The amount of chemically stable aspirin  in the released samples and in the control aspirin solution in PBS is shown in Figure 6.11.     
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Figure 6.11: In vitro release profile of chemically stable aspirin in the released samples from the (a) P(3HB) film with aspirin and (b)  control aspirin standard for a period of 30 days ( n=3).   At the end of the release period, 79.8%  of chemically stable aspirin was released from the P(3HB) film samples containing aspirin compared to the 27.2% of the chemically stable aspirin present in the control aspirin solution incubated under same conditions. The percentage of chemically stable aspirin released from the P(3HB) film with aspirin was higher compared to the control aspirin solution. 
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SECTION II  
6.2 Synthesis of P(3HB) microspheres   P(3HB) microspheres were produced using a solid-in-oil-in-water emulsion technique. 0.3g of P(3HB) was dissolved in 6 mL of dichloromethane and agitated for 3 min. This mixture was then transferred into the first water-in-oil emulsion (w/o) of 48 mL of 0.8% w/v polyvinyl alcohol (PVA) solution, and stirred at 800 rpm for 5 min. This solution was transferred to a second water-in-oil-in water emulsion (w/o/w) of 120 mL of 0.1% w/v aqueous PVA solution, forming the second-oil-in-water emulsion. This emulsion was stirred at 800 rpm for 4 hours to form P(3HB) microspheres. The resulting microspheres were isolated by centrifugation and then  washed three times with  the distilled water  and freeze dried. While preparing the microspheres containing aspirin, aspirin was added to 48 mL 0.8% PVA solution which was later added to the 120 mL of 0.1% PVA  solution (Francis et al., 2011). Aspirin was encapsulated within these microspheres. These P(3HB) microspheres     and the P(3HB) microspheres with aspirin were characterised using FTIR.    
6. 2.1 Characterisation of the P(3HB) microspheres  
6.2.1.1 Fourier Transform Infrared Spectroscopy (FTIR)  P(3HB) microspheres with and without aspirin were analysed by FTIR as described in  section 2.6.1.  This  was  done to  detect  the  presence of  aspirin encapsulated within the P(3HB) microspheres. The IR Spectrum of the (a) P(3HB) microspheres (-) and the (b) P(3HB) microspheres with aspirin (-) is shown in Figure 6.12. 
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Figure 6.12: The FTIR spectra of the (a) P(3HB) microspheres with aspirin and the  (b) P(3HB) microspheres without aspirin.   The signature absorption peaks at 1750 cm-1  and 1680 cm-1  corresponding to the presence of carbonyl groups and an absorption peak at 1605 cm-1 corresponding to the benzene ring present in the chemical structure of aspirin were not observed in the P(3HB) microspheres with aspirin (Li et al.,1999). This indicated that at 15% drug loading, it was not possible to detect the presence of the drug within the microspheres. The drug concentration was too low compared to the polymer concentration. Therefore, encapsulation efficiency test was carried out to detect the presence and quantify the presence of aspirin within the microspheres.   
6.2.1.2 Encapsulation efficiency  The % encapsulation efficiency of the P(3HB) microspheres was calculated using the following equation (1) EE% = Experimental drug loading/Actual drug loading x 100----------- (1) Encapsulation efficiency was calculated by dissolving 5 mg of P(3HB) microspheres with aspirin in 1 mL of dichloromethane. After the microspheres had completely dissolved, 5 ml of water was added. Aspirin is hydrophilic in nature and hence would  be  found  in  the  water  phase  which  was  later  analysed  using  High performance Liquid Chromatography (HPLC) (Francis et al., 2011). 
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 In this study, the encapsulation efficiency of the P(3HB) microspheres with the average size of 30 µm was found to be 50%.   This test confirmed the presence of aspirin within the microspheres.    
6.2.1.3 Scanning electron Microscopy:  Microstructural studies of the P(3HB) microspheres with and without aspirin were carried out using SEM as described in section 2.9.1. This was done to examine the effect of the aspirin encapsulation on the surface topography of the P(3HB) microspheres. The SEM images of the microspheres are shown in Figure 6.13.                     
(a) (b)   
Figure 6.13: SEM images of the (a) P(3HB) microspheres and the (b) P(3HB)  microspheres containing aspirin aspirin. Scale bars = 30 µm.   The SEM images revealed that the surface morphology of the P(3HB) microspheres was rough and porous compared to  the P(3HB) microspheres with aspirin. The SEM images also revealed that the encapsulation of aspirin within the P(3HB) microspheres reduced the porosity of the microspheres. This reduction in the porosity was further confirmed by carrying out porosity studies.   
6.2.1.4 Porosity studies  The porosity (ε) of the P(3HB) microspheres with and without aspirin was determined  using  the  liquid  displacement  method  (Francis  et  al.,  2011).  The porosity was calculated using the following equation (2): 






  Vp (Volume of the matrix pores) = (W2 – W3 – Ws) / ρe  Vs (Volume of the matrix polymer phase) = (W1 – W2 ±±Ws) / ρe  
Ε = Vp/ (Vp+ Vs) = (W2 – W3 – Ws) / (W1 – Ws) --------------- (2)    W1  is the weight of the cylinder filled with ethanol before the immersion of the microspheres, W2  is the weight of the cylinder, the ethanol and the sample after removing  excess  ethanol,  W3     is  the  weight  of  the  cylinder  and  ethanol  after removing the microspheres and Ws is the actual weight of the microsphere sample used in the porosity measurement (Francis et al., 2011). The  average  porosity  of  the  P(3HB)  microspheres  was  51±2%  compared  to  39.0±1.3% of the P(3HB) microspheres with aspirin, as shown in Figure 6.14.                          
Figure 6.14: Porosity measurements of the P(3HB) microspheres and P(3HB) microspheres containing  aspirin ( n=3). The data were compared using t-test and the difference were considered significant when *p<0. 05.   The porosity studies confirmed that the encapsulation of aspirin within the P(3HB) microspheres reduced their porosity significantly (*p<0.  05). The entrapment  of drug within the pores of the polymer could have led to this decrease in the porosity of the microspheres with aspirin (Chee et al., 2008). 
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Figure 6.15: The amount of the Rose Bengal dye adsorbed onto the surface of the P(3HB) microspheres with and without aspirin, as a function of an increase in the Rose Bengal dye concentration.  The amount of the dye adsorbed onto the P(3HB) microspheres with aspirin was higher compared to the P(3HB) microspheres without aspirin. This is most likely due to the presence of a hydrophilic drug encapsulated within the P(3HB) microspheres. This showed that the presence of aspirin within the microspheres increased the hydrophilicity of the P(3HB) microspheres. 







6.2.1.6 Protein adsorption  To determine the overall protein adsorbed on the surface of P(3HB) microspheres with and without aspirin, protein adsorption test was carried out as described in 
section 2.9.7. This was done to understand the effect of the encapsulated aspirin on protein adsorption. The results of the protein adsorption test have been summarised in Figure 6.16.                          
Figure 6.16: Protein adsorption on the P(3HB) microspheres with and without aspirin (n = 3). The data were compared using t-test and the difference were considered significant when *p<0. 05.    The total amount of protein adsorbed on to the P(3HB)  microspheres with aspirin was 1313 ± 1µg/mg which was significantly higher than the total amount protein adsorbed on to the P(3HB) microspheres without aspirin which was 996± 2 µg/mg (*p<0. 05).  
6.2.1.7 Differential Scanning Calorimetry  Thermal properties such as the melting temperature (Tm), glass transition temperature (Tg) and the         crystallization temperature (Tc) of the P(3HB) microspheres with and without aspirin were analysed using DSC, as described in 
section 2.9.6.  This  was  carried out  to  understand the  effect  of  aspirin encapsulation on the thermal properties of the P(3HB) microspheres. The results have been summarised in Table 6.2. 









Samples Tm (°C) Tg (°C) Tc (°C) P(3HB) 
 microspheres 169.9 ± 0.9 9.8 ± 0.5 102.3 ± 0.6 P(3HB) aspirin 161.5 ± 0.9, 8 ± 0.3 9.1 ± 1.0 80.6 ± 1.5 
Table  6.2:  Thermal  properties of  the  P(3HB)  microspheres with  and  without  aspirin (n = 3).   The Tm,  Tc, and Tg  of the P(3HB) microspheres with aspirin were lower compared to the P(3HB) microspheres. An additional peak at 81°C was observed in the DSC thermogram of the P(3HB) microspheres with aspirin. It is known that the melting temperature of aspirin is 136°C. Hence, a shift in the melting temperature of aspirin was observed.  
6.2.2 In vitro degradation study in PBS 
6.2.2.1 Water absorption  
In vitro degradation study was carried out on the P(3HB) microsphere with and without aspirin samples to examine the effect of aspirin on the degradation properties of the P(3HB) microspheres. The percentage of water absorbed (%WA) by   the   P(3HB)   microspheres  with   and   without   aspirin   were   measured  by incubating the microsphere samples in the PBS media for a period of 3, 15 and 30 days, as described in section 2.10. The data obtained at the end of the incubation is presented in Figure 6.17.                  
(a) (b) 






                 
(c)  
Figure 6.17: Water absorption (%WA) by the P(3HB) microspheres with and without aspirin for a period of (a) 3 days (b) 15 days and (c) 30 days ( n=3). The data  were compared using t-test  and the difference were considered significant when *p<0. 05.  The % water absorbed by the P(3HB) microspheres on day 3 was 5±0.6%. It increased progressively to 11±0.5% and 14.2±0.9% on day 15 and 30 respectively. Similarly, the % water absorbed by the P(3HB) microspheres with aspirin on day 3 was 11.3±0.5%, which increased significantly to 28.6±1.7% and 37.6±0.4% on day 15 and day 30 respectively. The % water absorbed by the P(3HB) microspheres with  aspirin  was  significantly  higher  compared  to   the  P(3HB)  microspheres without aspirin.   
6.2.2.2 Weight Loss  Percentage  weight  loss  (%WL)  of  the  P(3HB)  microspheres  with  and  without aspirin were measured by incubating the microsphere samples in PBS media for a period of 3, 15 and 30 days, as described in section 2.10. The data obtained at the end of the incubation period is represented in Figure 6.18. 






                 
(a) (b)                    
(c)   
Figure 6.18: % Weight Loss (WL) in the P(3HB) microspheres with and without aspirin at (a) day 3 (b) day 15 and (c) day 30 (n=3). The data were compared using t-test and the difference were considered significant when *p<0. 05. The % weight loss (%WL) in the P(3HB) microspheres on day 3 was 2±0.6% . It increased gradually to  6.1±0.9% on day 15, followed by 8.8±0.9% on day 30. A similar trend was observed in the P(3HB) microspheres with aspirin, where there was gradual increase in the % weight loss with time. On day 3, the % weight loss was 7.9±1% which increased to 15.3±0.4% on day 15. On day 30, the % weight loss was 28.6±0.7%. From the data, it was clear that the % weight loss was significantly higher   in   the   P(3HB)   microspheres  with   aspirin   compared   to   the   P(3HB) microspheres (*p<0. 05). 
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Figure 6.19: In vitro release profile of aspirin from the P(3HB) microspheres with aspirin for a period of 30 days ( n=3).   86.6±5% of the total drug encapsulated within P(3HB) microspheres was released within 15 days of the release period. An initial burst release of 26.6±1% was observed on day 1. This could be due to the presence of aspirin on the surface of the microspheres (Kassab et al., 1997). This burst release was higher compared to the burst release observed in the P(3HB) film with aspirin. However, it was lower compared to the PLGA based in situ gel delivery system for aspirin which showed a burst release of 30.9±1.2% (Tang and Singh, 2008). From the drug release pattern, it appeared that the drug release occurred through the water channels created within the microspheres. Previous studies have shown that aspirin loses its therapeutic activity upon hydrolysis, therefore it is crucial to release    aspirin    in    its    stable    form    (Aubrey-Medendorp    et    al.,    2008). 

















 The amount of chemically stable aspirin  in the released samples and in the control  aspirin solution in PBS is shown in Figure 6.20.   
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Figure 6.20: In vitro release profile of chemically stable aspirin in the released samples from the (a) P(3HB) microspheres  with aspirin and (b)   control aspirin standard for a period of 30 days ( n=3).  At the end of the release period, 53.2%  of chemically stable aspirin was released from P(3HB) microsphere samples with aspirin which  was higher compared to the 27.2%  of  the  chemically stable  aspirin  present  in  the  control  aspirin  solution  incubated under same conditions.                              
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DISCUSSION  In  this  study,  P(3HB)  films  and  P(3HB) films  containing  aspirin were  prepared using the solvent casting technique to investigate their potential as a drug delivery system for the controlled release of aspirin. Simultaneously, P(3HB) microspheres and P(3HB) microspheres containing aspirin were also produced using solid-in-oil- in water emulsion technique for the same purpose. The influence of aspirin loading on  the microstructural, thermal and degradation properties of the P(3HB) films were  studied.  In vitro drug  release  rate  were  calculated.  Similarly,  the  effect  of aspirin loading on the surface, porosity, thermal and the degradation properties of the P(3HB) microspheres were also studied.  
SECTION I   To  detect  the  presence of  aspirin  within  the  P(3HB) matrix,  FTIR  analysis  was carried out. The FTIR spectrum confirmed the presence of the aspirin within the P(3HB) matrix (Li et al., 1999).  Microstructural studies of the P(3HB) film with and without aspirin were studied using SEM. SEM images revealed that a new topography was introduced in the P(3HB) film with aspirin due to the addition of aspirin. Aspirin crystals were visible on the surface of the P(3HB) film. A similar observation was made where theophylline and salicylic acid crystals were visible on the surface of the chitosan films at a drug loading higher than 10% and 30% drug loading respectively. The authors stated that this was due to the crystallization of the theophylline crystals during   the   film   processing  (Puttipipatkhachorn  et  al.,   2001).   In   a   similar experiment carried out by Wang et al., bovine serum albumin (BSA) was added to the  chitosan/poly-co-vinyl  film.  SEM  images  revealed  that  BSA  loaded chitosan/poly-co-vinyl had a rough topography compared to the unloaded film (Wang et al., 2005). The results in this study indicated that aspirin crystals had crystallized during the processing of the film, thereby increasing the roughness of the film. This increase in the surface roughness of the P(3HB) film with aspirin was further analysed using AFM. AFM analysis confirmed that the presence of aspirin had  increased the  surface roughness of  the  film.  Similar  results  were  obtained when rifampicin was added to poly-co-vinyl film. There was an increase in the surface roughness of the poly-co-vinyl film compared to the unloaded film. The authors attributed  this to the heterogenous dispersion of rifampicin within the 




  poly-co-vinyl matrix (Lee et al., 2007). Contrasting results were obtained in a study where the surface of the aspirin loaded polyesterurethane network appeared to have a smooth surface compared to the unloaded network. The authors attributed this to the homogenous dispersion of aspirin within the network. The authors also stated  that  the  aspirin  was  present  in  an  amorphous form  within  the  network (Zhang et al., 2010). The results in this study indicated that  the aspirin crystals were present in its crystalline form within the P(3HB) film.  Water contact angle measurements were carried out to study the effect of aspirin loading on the wettability of these P(3HB) films. The water contact angles of the P(3HB) film with and without aspirin  were higher than 70o  and hence, they were both considered to be hydrophobic in nature (Peschel et al., 2008). However, there was an increase in the hydrophilicity of the P(3HB) film due to the presence of aspirin.     It is known that PHAs are hydrophobic in nature whereas aspirin is hydrophilic and has a water solubility of 3 mg/ml (Aubrey-Medendorp et al., 2008). Hence, we can conclude that the presence of aspirin within the P(3HB) film had increased the hydrophilic properties of the film.   A similar observation was made where  there  was   an   increase  in   the  hydrophilicity  of   the  PVA  membranes containing aspirin compared to the PVA membrane without aspirin. The authors also observed a decrease in the water contact angle with the increase in the concentration of aspirin within the membrane. They attributed this increase in the hydrophilicity to the presence of hydrophilic aspirin within the PVA membranes (Paul and Sharma, 1997). Similar findings were reported by Hwang et al., where the hydrophilic properties of the polyvinyl alcohol/dextran hydrogel was enhanced as a result of the addition of gentamicin which is hydrophilic in nature (Hwang et al., 2010). Addition of hydrophilic polyethylene glycol (PEG) to the hydrophobic PLLA film also enhanced the hydrophilic properties of the film (Lee et al., 2005).  Studies in the past have shown that the increase in the surface roughness of the biomaterial leads to a decrease in the water contact angle (Elias et al., 2008). Therefore, in this particular study, the results indicated that the decrease in the water contact angle of the P(3HB) film with aspirin was due to the presence of the hydrophilic aspirin crystals on the surface of the film, causing an increase in the surface roughness.  Another  characterisation  that  was  done  on  the  P(3HB)  film  samples  with  and without aspirin was the protein adsorption test. Total protein adsorbed on the P(3HB) film with aspirin was higher compared to the P(3HB) film without aspirin. 




  Several investigations have been made to understand the relationship between the surface roughness, wettability and protein adsorption (Elias et al., 2008). In an experiment conducted by Rechendorff et al., the surface of the tantalum samples were  modified to  increase  their  surface roughness.  Due  to  the  increase  in  the surface roughness, the surface area of the tantalum film samples also increased by around 20%.   In order to study the effect of the surface roughness on   the total protein adsorption, two different proteins such as fibrinogen and Bovine serum albumin (BSA) were adsorbed on to the tantalum films. The authors observed that there was 70% increase in the adsorption of the fibrinogen which was much higher compared to the increase in the surface area. In the case of BSA, there was 20% increase in the adsorption which corresponded to the increase in the surface area. The authors concluded that the increased fibrinogen adsorption was due to the protein anistropy caused due to the increase in the surface roughness. They attributed the low BSA adsorption to the post adsorption relaxation effects of BSA. The  authors  concluded  that  the  total  protein  adsorption  increased  with  the increase in the surface roughness when the roughness did not induce any confirmational changes on the structure of the protein (Rechendorff et al., 2006). Another study demonstrated an increase in the      protein adsorption on the nanostructured   titanium   dioxide   samples   with   the   increase   in   the   surface roughness.   The   authors   observed   that   a   rough   topography   led   to   protein aggregation within the pores, thereby creating protein nucleation sites. With the increase in the surface roughness, the number of the protein nucleation sites increased, thereby increasing the total protein adsorption (Scopelitti et al., 2010). Apart from the surface roughness, another reason for the increase in the protein adsorption could  be  the  increase in  the  hydrophilicty of  the  P(3HB) films  with aspirin   compared  to   the   films   without   aspirin.   Misra   et  al.,   conducted  an experiment  where   hydrophilic  BioglassTM    particles  were   incorporated  within P(3HB) composite films to improve the physical properties of the composite film. They   observed  a   significant   increase   in   protein   adsorption  on   the   P(3HB) composite films containing hydrophilic BioglassTM  particles compared to the plain P(3HB) films. They concluded that the increased protein adsorption was due to increased hydrophilicity and surface roughness of the P(3HB)/BioglassTM particles composite films compared to the plain films (Misra et al., 2008).    From these findings,  we  could  conclude  that  the  increase  in  the  protein  adsorption in  the P(3HB) films with aspirin was due to the presence of hydrophilic aspirin crystals on 




  the surface of the film, thereby increasing its hydrophilicity and roughness. According to literature, it is known that protein adsoprtion regulates important processes such as cell adhesion, differentiation, in vivo inflammatory responses. Therefore, the results in this study indicating an increase in the total protein adsorption was considered to be an encouraging result. This would increase the biocompatibilty of these P(3HB) films with aspirin.  In order to study the effect of the degradation products of the P(3HB) film samples with and without aspirin on the HMEC-1 cells, indirect cytotoxicity testing was carried out. It is known that PHAs are bicompatible in nature and the degradation product of P(3HB) which is 3-hydroxybutyric acid is  a natural metabolite present in the human blood at a concentration of 3-10 mg/100 mL of the blood (Hocking and Marchessault, 1998). The results of the cytoxicity tests confirmed that the degradation products of the P(3HB) films with and without aspirin were not toxic in nature. However, % cell viability was higher in the media containing aspirin. In an experiment conducted by Grosser and Schroder in 2003, vascular endothelial cells were grown in varying concentration of aspirin. They concluded that the presence  of  aspirin  improved  the  integrity  of  the  endothelial  cells  and  also provided antioxidative protection by activating the nitric oxide-cGMP signalling pathway in the endothelial cells (Grosser and Schroder, 2003).  Thermal properties of the P(3HB) films with and without aspirin were analysed using  DSC. The melting  temperature (Tm)  of  the P(3HB) films  with  aspirin was lower  compared  to  the  P(3HB)  films  without  aspirin.  A  peak  at  136.0°C  was detected during the heating scan which corresponded to the Tm of the commercial aspirin. A decrease in the Tm usually occurs when the crystalline region of the polymer is disrupted. This disruption could have occurred due to the presence of aspirin  within the  crystalline  region of  the  film.  The  cold  crystallization temperature  (Tc)  of  the  P(3HB)  films  with  aspirin  was  lower  compared to  the P(3HB) films. The decrease in the Tc  often occurs due to the decrease in the overall crystallinity of the film. This decrease in the Tc  could be due to the presence of aspirin   within   the   crystalline   region   of   the   polymer.   The   glass   transition temperature (Tg) was lower compared to the P(3HB) films without aspirin. The decrease in Tg occurs due to the increased mobility within the amorphous region of the polymer. The decrease in the crystallinity causes an  increase in the mobility of the amorphous region. This result is in agreement with an observation made by 




  Westedt et al., where the Tg  of the PVA-g-PLGA film decreased with the addition of paclitaxel which is a hydrophilic drug. They explained that this decrease in the Tg was due to the drug being molecularly dispersed within the matrix of the polymer (Westedt et al., 2006). A similar observation was made by Glaessl et al., where there was a decrease in the Tg of the polymethylacrylate film with the increase in the loading percentage of metoprolol tartrate within the film (Glaessl et al., 2009). It is known that a weak interaction between the drug and the polymer could also lead to the the decrease in Tg of the drug loaded films (Alexis, 2005). There was a decrease in the melting temperature, glass transition and the crystallization temperature of the Poly(L-lactic acid) composites due to the addition of ibuprofen (Dagnon et al., 2009).   
In vitro degradation study was carried out on the P(3HB) film samples with and without aspirin to examine the effect of aspirin on the degradation properties of the P(3HB) films. The percentage of water absorbed (%WA) by the P(3HB) films with and without aspirin were measured. Previously in this study, it was found that the addition of aspirin molecules within the P(3HB) films increased the hydrophilic properties of the film. The presence of the hydrophilic drug could have lead to the increased water uptake. This progressive increase in the water uptake, with time, by  the P(3HB) films  with  aspirin could be  due  to  the desorption of the aspirin crystals  present  on  the  surface of  the  film,  creating  pores  and  water  channels (Bazzo  et  al.,  2009).  Similar  results  were  obtained  when  hydrophilic dexamethasone was incorporated within the chitosan films. The presence of dexamethasone improved the surface wettability of the chitosan films, thereby increasing the water uptake (Rodrigues et al., 2009). The addition of   hydrophilic paclitaxel within the polyvinyl alcohol grafted poly(lactic-co-glycolactic) or (PVA-g- PLGA) film accelerated their water absorption when incubated in PBS media (Westedt et al., 2006). In this study, P(3HB) films with aspirin demonstrated increased water absorption compared to the P(3HB) films without aspirin. The percentage of water absorbed (%WA) by the P(3HB) films with and without aspirin were measured. From the data, it was clear that the % weight loss was higher in the P(3HB) film containing aspirin compared to the P(3HB) film without aspirin. This was in agreement with the finding reported by Naraharisetti et al., that the water absorption is directly proportional to the progressive degradation of the material (Naraharisetti et al., 2005). A similar observation was made by Giunchedi et al., 




  where the rate of degradation of the PLGA microparticle accelerated with the incorporation of diazepam, compared to the unloaded PLGA microparticle (Giunchedi et al., 1998). Zhang et al., demonstrated an increase in the degradation rate of the polyesterurethane network loaded with the aspirin. They attributed this to the increase  in   the  hydrophilicity  of  the  polyesterurethane  network  due   to   the presence of aspirin. The authors also stated that upon water absorption, aspirin which is an acidic drug (pka = 3.49) dissociated within the polyesterurethane network, affecting the pH of the drug loaded polyesterurethane network, thereby accelerating its degradation (Zhang et al., 2010). In this study, P(3HB) film samples with and without aspirin were incubated in the PBS media devoid of any enzymes, therefore degradation occurred via hydrolysis. 
In vitro drug release studies were carried out to measure the drug release rates using HPLC. Burst release of 12.5± 7% was observed on day 1. This could be due to the presence of surface bound aspirin (Kassab et al., 1997). This burst release was much lower compared to the PLGA based in situ gel delivery system for aspirin which showed a burst release of 30.9±1.2% (Tang and Singh, 2008). It is known that there are three main mechanisms of drug release from the biodegradable polymers. The first mechanism involves the release of drug which is covalently bound to the polymer backbone. The release occurs when the polymer backbone is hydrolytically cleaved. The second mechanism involves the release of drugs due to polymer degradation. The third mechanism involves the release of drugs from the polymer matrix via diffusion, combined with surface erosion (Dash and Suryanarayanan, 1992).      The drug release rate is dependent on the type of encapsulated drug, the polymer used and the mode of release (Poletto et al., 2007). In this study, sustained release of aspirin was obtained throughout the period of release. The drug release pattern demonstrated that the release of aspirin was slow until the 7th day. This was due to the release of drugs via surface erosion. The increase in the water uptake due to the presence of hydrophilic aspirin crystals would have most likely led to increased degradation causing an accelerated drug release after the 7th day. 





SECTION II  In the second part of this study, P(3HB) microsphere with and without aspirin were synthesised. FTIR analysis was not able to detect the presence of aspirin within these microspheres. Therefore, encapsulation efficiency study was carried out to determine  and  quantify  the  amount  of  aspirin  encapsulated  within  the microspheres. The encapsulation efficiency of the P(3HB) microspheres with the average size of 30 µm was found to be 50%. It is a known fact that the increase in the encapsulation efficiency prevents the loss of the drug and increases the dosage of the treatment (Freiberg and Zhu, 2004). One of the factors that affect the encapsulation efficiency is the microsphere size. Previous studies showed that with the decrease in the size of the microspheres, there was an increase in encapsulation efficiency. The encapsulation efficiency of the P(3HB-co-3HV) microspheres with an average size of 399 µm was 20.2% compared to 30.1% exhibited by the microspheres with the average size of 340 µm (Sendil et al., 1999). Yang et al., demonstrated that the encapsulation efficiency was dependent on the microsphere preparation temperature. They observed 50% encapsulation at both high (38oC) and low temperature (4oC). They stated that the sphere and the water were immiscible at a low temperature causing drug encapsulation within the rapidly forming sphere wall during the evaporation process. They also observed that at a high temperature, solvent evaporation occurred rapidly, causing the hardening of the sphere wall (Yang et al., 2000). Another factor that influences the encapsulation efficiency is the concentration of the polymer within the organic phase. Previous studies have shown an increase in the encapsulation efficiency with the increase in polymer concentration within the organic phase (Ghaderi et al., 1996). One of the studies demonstrated that the encapsulation efficiency was dependent on the type of the polymer used for the synthesis of the microspheres. 46% and 21% encapsulation efficiency were obtained for the PGA and PLGA microspheres respectively. They were prepared under identical conditions. They explained that this could be due to the faster precipitation of PGA (Le Corre et al., 1994).  Microstructural studies of the P(3HB) microspheres with and without aspirin were carried out using SEM. The SEM images revealed that the surface morphology of the P(3HB) microspheres without aspirin were rough and porous compared to the P(3HB) microspheres with aspirin. The surface property of the microspheres is hugely influenced by the type of the solvent used. In this study, dichloromethane 




  was used as the solvent to dissolve P(3HB) during the preparation of the microspheres as aspirin as well as P(3HB) were soluble in dichloromethane. Dichloromethane has a miscibility of 1 in 50 parts in water compared to the other solvents such has chloroform, which has a miscibility of 1 in 200 parts (Sahoo et al., 2002). Similar  results were obtained by  Yang  et al.,  when dichloromethane was  used during the preparation of PCL and PLGA microspheres (Yang et al., 2000). On the contrary, uniform spherical P(3HB) microspheres were obtained by Francis et 
al., when chloroform was used as the solvent for the fabrication of P(3HB) microspheres (Francis et al., 2011). Apart from the type of the solvent used, the volume of the solvent used during the synthesis of the microspheres is known to affect the surface morphology of the microspheres. If the volume of the solvent is lower than the optimal volume, the water molecules trapped on the surface, as well as within the microspheres, evaporate leaving a rough topography. The porosity studies  confirmed  that  the  encapsulation  of  aspirin  within  the  P(3HB) microspheres reduced their porosity. The entrapment of drug within the pores of the polymer could have led to this decrease in the porosity of the P(3HB) microspheres with aspirin (Chee et al., 2008). This could also explain the initial burst release of the encapsulated drug when the microspheres were immersed in the release medium. Previous studies have shown that  porosity is an  important factor in determining the rate of drug release. Rate of drug release is faster when the porosity is higher (Yang et al., 2000). Another study demonstrated a decrease in the porosity of the microspheres by replacing water with methanol in the first emulsion phase (Tuncay et al., 2000). Previous studies have shown that the rate of the solvent evaporation during the microsphere synthesis also directly affects the porosity of the spheres (Freiberg and Zhu, 2004).  The surface hydrophobicity of P(3HB) microspheres with aspirin were measured. Higher concentration of hydrophilic Rose Bengal dye was bound to the surface of the P(3HB) microspheres with aspirin compared to the P(3HB) microspheres without aspirin. This showed that the presence of aspirin, which is hydrophilic in nature, within the microspheres increased the wettability of the P(3HB) microspheres. Another reason for this increased hydrophilicity could also be the presence of residual PVA on the surface of the microspheres. PVA is hydrophilic in nature and it was used in this study as an emulsifier during the synthesis of the microspheres. Even  though,  the  microspheres were  prepared in  0.8%  of  PVA, 




  higher amount of residual PVA could have been present on the surface of the microspheres with aspirin. In future, determination of the residual PVA concentration on the P(3HB) microspheres with and without aspirin would explain the effect of aspirin loading on the residual PVA concentration. One study demonstrated an increased Rose Bengal dye binding on the surface of the PLGA microspheres with higher residual PVA concentration on the microspheres (Sahoo 
et al., 2002).  Another characterisation that was done on the P(3HB) microspheres with and without aspirin was the protein adsorption test. The total amount of protein adsorbed on to the P(3HB) microspheres with aspirin was higher compared to the protein  adsorbed on  to  the  microspheres without  aspirin.  Microspheres have  a large surface area and therefore when injected within the human body, they come in contact with the extensive area within the body. Incompatibility of the microspheres would lead to a strong immune reaction (Shishatskaya et al., 2002). Previous studies have shown that protein adsorption enhances cellular processes such as cell adhesion and migration, thereby increasing the compatibility of the biomaterial with the mammalian cells which are anchorage dependent in nature (Keselowsky et al., 2003). One of the important factors that influence protein adsorption is surface hydrophilicity. Previously, in this study, we found that the P(3HB) microspheres with aspirin were more hydrophilic compared to the P(3HB) microspheres without aspirin. Therefore, this increase in the adsorption of the protein could have occurred due to the hydrophilic surface of the microspheres with aspirin.   A similar observation was made by Francis et al., when hydrophilic gentamicin was loaded within the P(3HB) microspheres. The protein adsorption was much higher in the presence of the drugs compared to the unloaded P(3HB) microspheres. This increase was thought to be due to the hydrophilic surface of the gentamicin loaded P(3HB) microspheres (Francis et al., 2011). The increase in the protein adsorption by the P(3HB) microspheres containing aspirin was considered to be an encouraging result.  In order to examine the effect of aspirin encapsulation on the thermal properties of P(3HB) microspheres, properties such as the melting temperature (Tm), glass transition temperature (Tg) and the crystallization temperature(Tc) of the P(3HB) microspheres with and without  aspirin were analysed using DSC. The Tm, Tc, and Tg of  the  microspheres  with  aspirin  were  lower  compared  to  the  microspheres. 




  Without aspirin. The decrease of 8.4°C in the Tm  of the P(3HB) microspheres with aspirin indicated that the drug was encapsulated within the crystalline structure of the polymer, hence interrupting the crystal structure. Due to this disruption of the crystalline structure, there was a decrease in the overall crystallinity of the polymer, which led to the decrease in the Tc of the P(3HB) microspheres with aspirin. The Tg of the P(3HB) microspheres with aspirin were     lower compared to the P(3HB) microspheres without aspirin. The decrease in the Tg  usually occurs when there is an increased mobility within the amorphous region of the polymer. This decrease in the Tg  indicated that the presence of aspirin within the crystalline region of the polymer and the overall decrease in the crystallinity of the polymer, led to an increased mobility of the amorphous region of the polymer. There was a decrease in the melting temperature of the aspirin. Previous studies have shown that the change in the thermal properties of the microspheres, due to the addition of any drug indicates an  interaction between the polymer and the drug (Sahoo  et al., 2005). This indicated an interaction between the aspirin and the P(3HB) polymer. Bidone et al., demonstrated a decrease in the melting temperature of the ibuprofen when encapsulated within P(3HB) microspheres. The authors stated that this decrease in the melting temperature of the ibuprofen was due to the presence of ibuprofen within the microsphere in both amorphous and crystalline forms. The authors also reported the decrease in the Tg and Tc       of the ibuprofen loaded microspheres compared to the unloaded P(3HB) microspheres. They explained that the presence of ibuprofen affected the crystalline structure of the P(3HB) (Bidone 
et al., 2009). Another study demonstrated a decrease in the Tg and Tm of the PLLA- PLGA  microspheres  loaded  with  etanidazole  compared  to  the  unloaded microspheres (Lee et al., 2002). A similar observation was made by Francis et al., when gentamicin was incorporated within the P(3HB) microspheres. There was a decrease in the crystallinity of the polymer causing a decrease in the Tm of the gentamicin loaded P(3HB) microspheres, compared to the unloaded microspheres (Francis et al., 2011). Berthold et al., used DSC to detect the modification of drug within   the   chitosan  microspheres.  They  observed  a   sharp   peak   at   341.9°C, indicating the Tm   of the prednisolone which was encapsulated within the chitosan microspheres. The authors stated that there was no interaction between the drug and the chitosan. Therefore, in this study there was an interaction between the aspirin molecules and P(3HB) (Berthold et al., 1996). 





In vitro degradation studies were carried out on the P(3HB) microsphere samples with and without aspirin to examine the effect of aspirin on the degradation properties of the P(3HB) microspheres. The percentage of water absorbed (%WA) by  the  P(3HB)  microspheres with  and  without  aspirin  were  measured. The  % water absorbed by the P(3HB) microspheres with aspirin was much higher compared to  the P(3HB) microspheres without aspirin. Aspirin is a hydrophillic drug and therefore, this could have lead to the increased water uptake.  Previously in this study, it was found that the aspirin molecules were trapped within the pores of the polymer. After the dissolution of aspirin in the release media, water channels were  created  within  the  microspheres.  This  progressive  increase  in  the  water uptake  with  time  could  be  due  to  the  increase  in  the  network  of  these  water channels created during drug dissolution (Bazzo et al., 2009). Similar results were obtained by Francis et al., where there was an increase in the water uptake by the gentamicin loaded P(3HB) microspheres compared to the unloaded microspheres (Francis et al., 2011). Bazzo et al., stated that there was an increase in the water absorption by the piroxicam loaded P(3HB) microspheres      compared to the unloaded microspheres. They concluded that this rapid uptake of water by the microspheres occurred when  the  drugs  trapped  within  the  pores  of  the microsphere created a network of water channels during its dissolution in the release media (Bazzo et al., 2009). Percentage weight loss (%WL) of P(3HB) microspheres with and without aspirin  were also measured. From the data, it was clear that the % weight loss was higher in the P(3HB) microspheres with aspirin compared to the P(3HB) microspheres without aspirin. In this study, the P(3HB) microsphere samples with and without aspirin were incubated in the PBS media. Previous studies have shown that water absorption is directly proportional to the progressive  degradation  of  the  material  (Naraharisetti  et  al.,  2005).  The  rapid ingress of water through the network of water channels created within the microspheres would have accelerated the hydrolytic degradation of the polymer (Bazzo et al., 2009). In future, molecular weight analysis by gel permeation chromatography would confirm the effect of aspirin loading on the degradation of the P(3HB) microspheres .  According to  literature, the drug release kinetics are affected by  several factors such  as  the  structure  of  the  drug  delivery  vehicle,  type  of  the  drug  and  the properties of the polymer such as its molecular weight, crystallinity and its mode of 




  degradation. It  is  known  that  a  drug  release  pattern  demonstrating a  constant release of drug with respect to time without any burst release effect is desirable (Freiberg and Zhu, 2004). In vitro drug release studies were carried out to measure the drug release rates from the P(3HB) microspheres using HPLC. 86.6% of the total  drug encapsulated within the P(3HB) microspheres was released within 15 days of the release period. From the drug release pattern, it appeared that the drug dissolution occurred through the  water channels created within the microspheres. It is known that P(3HB) is very crystalline in nature and the mode of drug release from the P(3HB) matrix usually depends upon the morphology of the drug delivery matrix (Bidone et al., 2009). According to the literature, it is known that the size of the particle is inversely proportional to the surface area available for the drug release. Therefore, faster  drug  release  rate  is  obtained for  the  particles  of  smaller size offering  a  large  surface  area  for  the  drug  release  (Sahoo  et  al.,  2005).  In  one experiment, isosorbide dinitrate was encapsulated within the P(3HB) microspheres at  3% drug loading. The average diameter of the P(3HB) microspheres obtained was 0.85 µm which was exceptionally small compared to the avarage size of 30 µm obtained in  this  study.  The porosity of  72% of the isosorbide dinitrate  loaded P(3HB) microspheres was much higher compared to the 39% porosity of the P(3HB) microspheres with aspirin obtained in this study. The authors observed that the 80% of the encapsulated drug was released within the 12 hours of incubation. They concluded that these isosorbide dinitrate P(3HB) microspheres were unsuitable for parenteral applications due their fast drug release rate (Kim et al., 2000b). Another factor  that  plays  a  significant  role  in  the  drug  release  rate  is  the  %  porosity (Freiberg and Zhu, 2004). Previous studies have shown that the drug release rate is affected by the porosity of the microspheres. Several researchers have observed an increase in the drug release rates with the increase in the porosity of the drug delivery matrix (Ghaderi et al., 1996; Yang et al., 2000). In another study, ibuprofen encapsulated within the P(3HB) microspheres with 16% drug loading observed and with an average diameter of 22 µm showed a burst release of 21.63%, within 1 hour of the incubation. The total release of the drug was obtained within 33 hours of   incubation.  There  was   no   mention  of  the   porosity  of   the  drug  loaded  microspheres, however,  the  SEM  images  revealed a  highly  porous  surface  with large pores (Bidone et al., 2009). The drug release observed in this study was much slower compared to the previous findings. However, in comparison to the aspirin release  rates  from  the  P(3HB)  film,  aspirin release  was  much  faster  from  the 








        
Chapter 7        






7.1 CONCLUSION  Polyhydroxyalkanoates have become one of the most attractive biomaterials in recent times. They are biodegradable, biocompatible and sustainable.  There is a huge interest in the commercial exploitation of these PHAs (Hazer and Steinbuchel, 2007; Khanna and Srivastava, 2005). However, one of the major hindrances in the commercialization  of  these  PHAs  is  its  high  price.  Some  of  the  most  effective strategies to reduce the cost of the PHA production have been the use of cheap carbon  sources,  the  use  of  metabolically  engineered  strains,  efficient  mode  of fermentation and the use of  statistical  mode of optimisation (Lee et al., 2005; Hong 
et al., 2009).  The  first  part  of  this  project  involved  the  economical production  of  MCL-PHAs using renewable and cheap carbon sources such as sugarcane molasses, biodiesel waste and pure glycerol. Pseudomonas spp have been known to produce MCL-PHAs. They utilize both structurally related and unrelated carbon sources and accumulate diverse MCL-PHA monomer units (Diard et al., 2002). Therefore, in this study P. 








  these novel P(3HO)/bacterial cellulose composites would be well suited for tissue engineering applications. Biocompatibility is one of the most important features of an excellent tissue engineering scaffold. The cell culture data obtained from this study revealed promising results by demonstrating good cell growth and proliferation on the composites.  In this part of the study, P(3HB) was produced by B. cereus SPV using the Kannan and  Rehacek  media,  in  a  batch  mode.  The  polymer  produced  was  identified as P(3HB) using FTIR and GC. In addition, novel, multifunctional 2D P(3HO)/P(3HB) blend films with varying percentages of P(3HO) and P(3HB) such as P(3HO)/P(3HB) 80:20, P(3HO)/P(3HB) 50:50 and P(3HO)/P(3HB) 20:80 were developed to assess their suitability in the development of biodegradable stents and scaffolds in tissue engineering.  These blend films were characterised with respect to their mechanical, thermal and surface properties. They were also characterised for their bioactivity using HMEC-1 cells and their degradation properties. The results highlighted that the addition of P(3HB) within the P(3HO) matrix enhanced the mechanical and thermal properties of these blend films compared to the neat P(3HO) film. P(3HB) played   a   significant  role   in   introducing  a   new   surface   topography   thereby increasing the surface roughness compared to the neat P(3HO) film. The hydrophilicity of these blend films increased by lowering the water contact angle. The addition of P(3HB) also affected the total protein adsorption on the blend films. Protein adsorption plays an important role in cell adhesion and survival. Hence, protein adsorption is crucial in evaluating a biomaterial for tissue engineering applications (Rai et al., 2011). Protein adsorption was higher in the blend films containing P(3HB) compared to the neat P(3HO) film. Indirect cytotoxicity results showed that  these  blend  films  were  not  toxic  to  the  HMEC-1 cells.  The  %  cell viability on the blend films was higher compared to the neat P(3HO) film. From the 




  490 MPa, 193 GPa and 40% respectively. It has a radial strength value of 135 KPa. Radial strength is key in determining the success of the stent after its implantation within the body. In  order to  meet the clinical  requirements, the radial strength value should be in a range of 80-120 KPa (Feng et al., 2011).     With further improvement in mechanical properties, these novel blends could be used for the development of  biodegradable stents.  They  could  also  be  used as  scaffolds for tissue engineering applications. It  is a  known  fact  that  surface topography determines the biocompatibility of a  biomaterial by governing various important processes and properties such as the protein adsorption, wettability, cell adhesion, proliferation and migration (Duncan 













   
7.2 Future work  Based on the results of this particular study, there are several potential areas that could be investigated in the future.   
7.2.1 Statistical optimisation of the MCL-PHA production using cheap carbon 
sources Statistical method such as response surface analysis could be used to optimize the production  of  MCL-PHAs  using  the  cheap  carbon  sources  to  achieve  higher  yield. Further, optimisation using different modes of fermentation such as fed batch would also be interesting.   
7.2.2 P(3HO)/bacterial cellulose composites  The surface fabrication of these composite films using Laser micropatterning technique and culturing of different cell lines on these modified surfaces would be an interesting area of research. Apart from the 2D films, construction of 3D scaffolds for other biomedical applications such as cartilage tissue engineering would be of interest.   
7.2.3 P(3HO)/P(3HB) blends  In this study, a stent prototype was successfully developed. However, due to lack of time it could not be fully characterised. Development of a stent prototype with a novel stent design and its complete characterisation would be very interesting and relevant. Incorporation of anti-mitotic drugs such as paclitaxel within the stent prototype and monitoring their drug release pattern would be the next step forward. Cell culture and degradation studies  of  these  stent  prototypes  would  be  of  interest.  Finally,  in vivo studies using these stent prototypes would be of great interest.   
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